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Abstract……. 
 
Quiescence is essential for long-term maintenance of adult stem cells and tissue 
homeostasis. The adult mammalian brain was recently discovered to harbour 
populations of neural stem cells in at least two neurogenic regions: the 
subventricular zone (SVZ) of the lateral ventricles, and the subgranular zone (SGZ) 
of the hippocampus. Adult hippocampal neural stem cells (AHNSCs) are a mostly 
quiescent population, whose activation is tightly controlled by a complex range of 
signals derived from their niche. How exactly these signals are interpreted by 
AHNSCs to regulate quiescence is not fully understood. The proneural bHLH 
transcription factor Ascl1 is crucial for AHNSC activation, and degradation of Ascl1 
protein by the E3 ubiquitin ligase Huwe1 is an important mechanism to allow active 
neural stem cells to return to quiescence.  
 
Here I present the discovery that Ascl1 is unexpectedly expressed and transcribed 
in quiescent NSCs in vivo, and is suppressed at the protein level to maintain 
quiescence of NSCs. In order to investigate the molecular mechanisms regulating 
AHNSC quiescence, and to circumvent the complexities of the neurogenic niche, 
we have developed an in vitro model of AHNSC quiescence. We have found that 
the in vitro model robustly reproduces the quiescent stem cell state of NSCs in 
vivo. We undertook a candidate approach to identify regulators of Ascl1 protein and 
NSC quiescence and identified the inhibitor of differentiation (Id) protein, Id4, as a 
novel quiescence factor. Functional studies in vitro in combination with genetic 
approaches in vivo confirmed that Id4 is expressed in quiescent hippocampal 
NSCs, maintains NSC quiescence, and mediates the inhibition of Ascl1 protein in 
quiescent NSCs, by sequestration of its E-protein binding partners. Finally, we 
investigated the niche signals regulating Id4 expression, and discovered that it is 
regulated in a complex manner likely by more than one signalling pathway. 
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Impact Statement 
 
Our human bodies are constantly being regenerated thanks to populations of stem 
cells we keep with us throughout adult life. However, these stem cells can become 
dysfunctional and deregulated with age or disease. Too little activation will result in 
not enough tissue regeneration, too much could exhaust the stem cells too early, 
and complete deregulation of stem cells could lead to aggressive cancers.  
 
Evidence is emerging that adult humans may have neural stem cells that actively 
contribute new neurons to the brain, but reduction or deregulation of this production 
is associated with depression, age-related cognitive decline, and 
neurodegeneration, all of which are major current health concerns in the United 
Kingdom and globally. These diseases lack effective treatments, and result in 
terrible suffering for patients and families, as well as disabling a large percentage of 
the workforce resulting in economic consequences. 
 
However, research into the mechanisms regulating neural stem cells could hold a 
key to alleviating these diseases. We have discovered a novel mechanism which 
tightly controls the quiescent state of adult neural stem cells. The protein Id4 is 
expressed in neural stem cells and acts as a block on activation, holding stem cells 
back until they’re needed.  
 
The fields of adult neurogenesis and adult stem cell research will benefit from the 
discovery of this novel molecular mechanisms for future research, as well as by 
utilising the model of quiescent neural stem cells presented in this thesis.  
 
This research also has implications for human health and ageing. By understanding 
what causes stem cells to maintain a healthy level of activity, we can begin to 
identify environmental factors that help this process, such as particular diets or 
social and learning activities, providing people with practical advice to maintain a 
healthy brain and body well into old age.   
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By specifically targeting Id4, with designer drugs for example, we could potentially 
activate stem cells that have become dormant with age or disease, thereby tapping 
into an endogenous regenerative capacity within the brain. This would be 
particularly useful for sufferers of depression and neurodegeneration, who require 
more therapeutic intervention.  
 
Understanding how stem cells function in the brain is also important for guiding the 
development of stem cell therapies for brain injuries or stroke; if we know what 
causes stem cells to remain active or become dormant, we can ensure that stem 
cells transplanted into the brain remain active and generate the neurons when and 
where we want them to.   
 
Finally, understanding how neural stem cell activity is regulated is valuable 
knowledge for research into brain cancers. Glioblastomas have stem-like cells 
which can be quiescent and evade chemotherapy, therefore if we discover Id4 is 
responsible for this quiescence, we can target it, potentially improving the primary 
treatment of the cancer and helping to prevent recurrence.   
 
There is realistic scope to translate the research presented here into new drugs 
and therapies, and the work will be published in a well-respected peer-reviewed 
scientific journal. 
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Chapter 1. Introduction 
Adult mammalian tissues need to be repaired and regenerated throughout life in order 
to maintain function in the face of environmental and cellular damage that occurs from 
injury, disease and ageing. Many cell types are constantly turned-over in adult humans 
to replace old or damaged cells, such as the skin, hair, blood, muscle and intestinal 
epithelium. The source of this regenerative capacity lies with populations of specialised 
stem cells that exist within the different tissues, where they can divide asymmetrically 
to self-renew and generate progenitor cells that will differentiate into the mature cell 
type of their tissue, replacing their old or damaged counterparts.  
 
Up until the middle of the last century, it was strongly believed that the adult 
mammalian brain was excluded from the list of tissues with a regenerative capacity. 
The long-held dogma “no new neurons” referred to the idea that humans were born 
with all the neurons they would ever have, and once lost would not be replaced. 
However, after a series of experiments demonstrated the existence of proliferating cells 
within the adult rodent brain, the existence of functional neural stem cells in mammals 
has been found in (although not limited to) the subventricular zone (SVZ) of the lateral 
ventricles, and the subgranular zone (SGZ) of the dentate gyrus (DG) in the 
hippocampus.   
 
In this thesis, I will explore the regulation of adult mammalian neural stem cells within 
the SGZ, specifically the mechanisms controlling the maintenance of and activation 
from quiescence. In the following chapter, I will summarise the current knowledge in 
the field of adult neurogenesis with a specific focus on the biology of neural stem cells 
and the regulation of their quiescence. I will explore the current understanding of the 
quiescent stem cell state, and the known signals and mechanisms regulating the 
activation of neural stem cells from quiescence, highlighting the importance of the 
neurogenic niche, as well as the methods used to study these cells. I will then 
introduce the Inhibitor of Differentiation (Id) family of proteins as a potential new 
regulator of NSC quiescence.  
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1.1 Adult neurogenesis  
1.1.1 The history of adult neurogenesis 
Adult neurogenesis is the process of generating new neurons in the adult brain. This 
was an unthinkable phenomenon up until the 1980’s, where before the consensus 
amongst researchers was with the conclusions of celebrated neurobiologist Santiago 
Ramón y Cajal, who postulated (translated from Spanish), “In the adult centre, the 
nerve paths are something fixed, finished, immutable: everything may die, nothing may 
be regenerated.” (Ramón y Cajal, 1928). Such a brutal conclusion was understandable 
in the light of the fact the brain is comprised primarily of post-mitotic neurons, however 
left small hope for therapies targeting regeneration in the brain. In the face of 
scepticism and criticism from his contemporaries, Joseph Altman challenged the long-
held belief of “no new neurons” in 1963 with the publication of his research showing 
evidence of proliferating cells in the brains of adult rodents (Altman, 1963). Altman 
described cells labelled with a thymidine analogue [H3]-thymidine, which gets 
incorporated into the DNA of dividing cells and can be detected by autoradiography, in 
several regions of the adult rodent brain, including a particularly proliferative zone in 
the dentate gyrus of the hippocampus (Altman, 1963; Altman and Das, 1965), as well 
as the neocortex and olfactory bulb (Altman, 1966, 1969). It wasn’t until about two 
decades later that Altman’s observations were corroborated, with the description of 
adult neurogenesis in canaries using the same technique (Goldman and Nottebohm, 
1983). These studies in songbirds also started to provide a functional relevance of 
adult neurogenesis, namely in seasonal song learning, which helped to drive interest in 
the field. This was followed a decade later by the successful isolation of cells from the 
adult mouse brain (striatum and dissections including the hippocampus) which 
demonstrated stem cell properties in vitro (Reynolds and Weiss, 1992; Richards et al., 
1992). Teleost fish including zebrafish were also shown to have widespread progenitor 
proliferation in the adult brain (Zupanc et al., 2005; Zupanc and Horschke, 1995). 
However, a major step forward in the field came from the introduction of a new 
thymidine analogue, the now widely-used bromodeoxyuridine (BrdU) (Kuhn et al., 
1996) which is able to be detected by immunocytochemistry, and therefore much more 
practical. Gould and colleagues used BrdU to demonstrate the existence of adult 
neurogenesis in the neocortex of adult macaques (Gould et al., 1999), revealing adult 
neurogenesis was present in primates, and subsequent studies demonstrated adult 
neurogenesis in several other Old World and New World primates (reviewed by (Yuan 
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et al., 2014)). Finally, a handful of studies have found evidence for (and against) adult 
hippocampal neurogenesis in humans, which I will discuss in more depth in Section 
1.1.3.   
1.1.2 The ‘what’ and ‘where’ of adult neurogenesis 
Neurogenesis is defined as the production of new functional neurons from precursor 
cells that are found within specialised locations in the brain, termed neurogenic niches, 
which provide vital physical and molecular cues to support the maintenance and 
activity of the stem cells. In the adult rodent brain, the areas of significant neurogenesis 
are the subventricular zone (SVZ) of the lateral ventricles, which generate newborn 
neurons that integrate into the olfactory bulb; and in the subgranular zone (SGZ) of the 
dentate gyrus (DG) in the hippocampus (Figure 1.1).  
 
 
Figure 1.1. Documented regions of neurogenesis in the adult rodent brain 
Shown in red are the two most well-studied neurogenic regions, the dentate gyrus in the 
hippocampus, and the olfactory bulb, for which new neurons arise from the subventricular 
zone and migrate via the rostral migratory stream. Areas of pink indicate regions for which 
low levels of neurogenesis have been reported, including the hypothalamus, amygdala, 
striatum and neocortex. Image reproduced from (Gould, 2007) with permission of the rights 
holder, Springer Nature. 
 
Newborn neurons in the DG migrate very short distances to integrate into the granule 
cell layer. Other areas with low level neurogenesis have also been discovered, 
including in the amygdala, striatum and neocortex in rodents and macaques, as well as 
the hypothalamus in rodents (Gould, 2007) (Figure 1.1). I will describe neurogenesis in 
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the mouse SVZ and SGZ in more detail below in Section 1.1.5-6, as these are the 
neurogenic regions most relevant for the work presented in this thesis.  
1.1.3  Adult neurogenesis in humans 
The evidence for adult neurogenesis in humans was first shown in 1998 by Eriksson 
and colleagues, who controversially demonstrated the incorporation of BrdU in the 
hippocampus of cancer patients, whose brain tissue was analysed post-mortem 
(Eriksson et al., 1998). Further evidence for adult human neurogenesis in vivo has 
been more difficult to obtain for obvious reasons, however neural stem/progenitor cells 
have been isolated from adult human hippocampus and subventricular zone (SVZ) 
following surgical excision, and demonstrated to undergo in vitro neurogenesis 
(Kukekov et al., 1999; Roy et al., 2000). Post-mortem immunocytochemical staining for 
the neuronal precursor marker Doublecortin (Dcx) has also suggested the existence of 
neurogenesis in the adult human hippocampus (Knoth et al., 2010). More recently, two 
inspired studies measured the level of Carbon14 (14C) in genomic DNA isolated from 
the striatum (Ernst et al., 2014) and hippocampus (Spalding et al., 2013) of human 
post-mortem brain tissue, from people who lived in an area that had been the site of 
nuclear bomb testing in 1955. By plotting the concentration of 14C in neuronal cells at 
the time of post-mortem against the environmental 14C concentration at the time of 
birth, the authors were able to estimate whether new carbon had been incorporated 
into these neuronal cells by cell division, and determined a small percentage of 
neuronal cells were newly generated in adulthood in the striatum (Ernst et al., 2014) 
whilst 700 new neurons were incorporated into the adult human hippocampus each 
day, with little decline into old age (Spalding et al., 2013). However, there has been 
debate about whether the levels of neurogenesis in humans was more than just 
negligible after adolescence (Kempermann, 2011b), and 2018 has seen the 
controversy intensify, with two of the most comprehensive analyses of adult human 
neurogenesis to date, presenting opposite findings. Sorrells and colleagues suggest 
there is no evidence for neurogenesis after childhood, based on the 
immunohistochemical analysis of markers of proliferating progenitors and immature 
neurons in 59 patient samples from foetal stage to 77 years old (Sorrells et al., 2018). 
In contrast, Boldrini et al., find evidence for neurogenesis in 28 men and women aged 
14 to 79, with little decline over age (Boldrini et al., 2018). The authors of both studies 
used similar immunohistochemical analysis to determine the presence of 
neurogenesis, although the estimates of new neuronal production presented by 
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Boldrini et al., were from stereological analysis which may give an over-estimation. 
Clearly the presence of active and functional adult neurogenesis in humans is still yet 
to be fully clarified, which will require many more studies and new techniques before a 
consensus is reached (recently reviewed by (Kempermann et al., 2018)). In contrast to 
hippocampal neurogenesis, olfactory bulb neurogenesis is reportedly very low or 
absent in humans (Bergmann et al., 2012; Sanai et al., 2004; Wang et al., 2011). 
 
1.1.4  Function of adult neurogenesis 
In lieu of strong and conclusive direct evidence for neurogenesis in adult humans, 
understanding its function can help to inform whether it may exist and be relevant for 
human health. The dentate gyrus directly inputs into the hippocampus, the function of 
which is reported to include spatial navigation, learning and memory, and pattern 
separation, including integrating new information into a previously learned environment 
(Goncalves et al., 2016; Kempermann, 2012). Neurogenesis in the SGZ may actively 
contribute to the function of hippocampus, as retrovirally labelled newborn neurons 
have been observed to integrate into the hippocampal circuitry in mice and show 
electrophysiological properties of mature GC neurons after a period of 4-8 weeks (Gu 
et al., 2012; van Praag et al., 2002). Specifically reducing the number of newborn 
neurons in mice affects spatial memory, including the long-term memory required to 
tackle the Morris water maze, as well as context-dependent memory in fear 
conditioning tasks (Goncalves et al., 2016). These two memory functions are also 
thought to function in cognitive flexibility, or the ability to discern change in a previously 
learned environment, including pattern separation (Kempermann, 2012). An age-
related decline in pattern separation performance has been reported for humans (Stark 
et al., 2010), which could imply a similar function of the hippocampus between rodents 
and humans.  
 
Neurogenesis in the SVZ generates new neurons for the olfactory bulb, a structure in 
the forebrain that processes sensory inputs from olfactory neurons in the nasal cavity. 
A direct role for adult SVZ neurogenesis in odour discrimination has not been fully 
demonstrated, although levels of neurogenesis and olfactory reaction time have been 
shown to be positively correlated (Lazarini and Lledo, 2011). It is interesting that SVZ 
neurogenesis is active in mammals such as rodents and canines, but reportedly low in 
humans, which could be reflect our comparatively poor olfaction abilities, at least in 
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comparison with canines and rodents. Despite this, there is evidence to suggest 
impaired olfaction is a symptom of neurodegenerative and neurologic diseases (Godoy 
et al., 2015), which as I will discuss shortly, may result in some cases from impaired 
neurogenesis. This observation could suggest adult SVZ neurogenesis may be present 
and functional in humans, however it could also reflect a direct loss of the olfactory 
neurons, rather than impaired neurogenesis.   
 
There are now many studies describing adult hippocampal neurogenesis in many 
different species, and by observing the phylogenetic map of adult neurogenesis we can 
make assumptions about the evolution and therefore potential function of adult 
neurogenesis (Kempermann, 2012). In his review, Kempermann suggests that 
hippocampal neurogenesis would provide an increased level of flexibility within the 
adult brain. Whilst a certain level of neuronal rigidity is required to remember important 
learned behaviours, a level of cognitive flexibility would allow for adaptation in 
changeable environments Therefore, one could imagine that neurogenesis in the 
hippocampus would facilitate adaptation to humans who were very mobile, both in 
terms of hunting, and also moving to new home environments.  
 
An evolutionary perspective of adult neurogenesis can inform us to a point, but a more 
acute measure of the function of adult neurogenesis can be obtained from symptoms 
of disorders that reportedly show impaired neurogenesis in the DG. Humans frequently 
display an age-related cognitive decline (Lazarov and Marr, 2013), and there is 
evidence for decreased DG volume with age (O'Shea et al., 2016) and a modest age-
related decline in hippocampal neurogenesis (Spalding et al., 2013), however it is not 
clear whether there is a direct link between decreased neurogenesis and cognitive 
performance in aged humans. Psychiatric disorders such as anxiety, depression and 
schizophrenia have been associated with altered neurogenesis and reduced 
hippocampal volume (Goncalves et al., 2016). Impaired neurogenesis is particularly 
implicated in depression, due to the observation that ablating neurogenesis in adult 
rodents leads to an increase in depression- and anxiety-like behaviours (Revest et al., 
2009). Antidepressant drugs can also directly increase levels of neurogenesis in the 
SGZ (e.g. (Huang and Herbert, 2006); reviewed by (Miller and Hen, 2015)), and 
neurogenesis has been shown to be required for the behavioural effects of 
antidepressant treatment in mice (Miller and Hen, 2015; Santarelli et al., 2003). 
Impaired adult hippocampal neurogenesis has also been associated with 
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schizophrenia, particularly as mutations in DISC1, a well characterised susceptibility 
gene for schizophrenia, has been shown to play important roles in newborn GC neuron 
survival and maturation (Duan et al., 2007; Kvajo et al., 2008). Epilepsy is another 
human disorder associated with increased excitability in the DG, and seizures are able 
to activate neural stem cells, potentially leading to further aberrant neurogenesis and 
increased over-excitability (Jessberger and Parent, 2015). Neurodegenerative 
diseases in adult humans, such as Alzheimer’s Disease (AD), Parkinson’s Disease 
(PD) and Huntington’s Disease (HD), also commonly display impaired neurogenesis as 
part of their pathology (reviewed by (Winner and Winkler, 2015)). Neurodegenerative 
disorders appear to combine the gradual loss of mature neurons through dysfunction 
and death, in combination with a reduction in neurogenesis. Moreover, many of the 
symptoms that appear years before a diagnosis of AD, PD or HD include those 
described as diseases of impaired hippocampal neurogenesis such as depression, 
anxiety, and learning and memory problems (Winner and Winkler, 2015). Therefore, 
gaining a thorough understanding of the factors that regulate adult neurogenesis, that 
are observed to be changed in early neurodegenerative conditions, may lead to 
improved early diagnosis and therapeutic interventions targeting neurogenesis in these 
patients.    
 
1.2 The stem cell niche 
1.2.1 Common features of adult stem cell niches 
The concept of a stem cell “niche” was first put forward by R. Schofield in his study of 
haematopoietic stem cells, where he suggests that the behaviour or fate of the stem 
cell depends upon the surrounding cells it is associated with (Schofield, 1978). The 
“niche” concept was further brought into the spotlight by studies of the stem cell 
microenvironment in the Drosophila gonad (Lin, 2002). Niches have since been 
described for several adult mammalian stem cell populations, including the bone 
marrow haematopoietic stem cell niche (reviewed by (Boulais and Frenette, 2015)), the 
hair follicle for follicular bulge stem cells and the intestinal crypts for crypt base 
columnar stem cells (reviewed by (Moore and Lemischka, 2006)), and the muscle for 
satellite cells (reviewed by (Yin et al., 2013)). The definition of the niche has evolved to 
describe a microenvironment of cells organised in a specialised 3-dimensional 
architecture, such that it can provide the maintenance and survival of undifferentiated 
Chapter 1 Introduction 
24 
 
stem cells, as well as acting as a hub of signalling such that it can exert spatiotemporal 
control of stem cell activity. These features are common amongst all the stem cell 
niches, and the importance of the niche in providing a protective environment 
promoting stemness is highlighted by the challenges faced attempting to culture 
various adult stem cells in vitro (McKee and Chaudhry, 2017). The challenge to 
recapitulate the in vivo niche has led to some ingenious developments, including micro-
patterned culture substrates, 3-D culture protocols, and the use of various biomaterials 
to mimic the stiffness and 3D architecture of the niche (Griessinger et al., 2014; Joo et 
al., 2015; McKee and Chaudhry, 2017).  
 
The important regulatory function of the hippocampal stem cell niche was 
demonstrated by early heterotopic transplantation experiments, in which cultured adult 
hippocampal progenitor cells were grafted into other neurogenic regions (the rostral 
migratory stream, containing neuroblasts generated from SVZ NSCs) or the non-
neurogenic cerebellum (Suhonen et al., 1996). The engraftments of the progenitor cells 
into the RMS resulted in migration and differentiation into olfactory bulb neurons, 
whereas those in the cerebellum failed to differentiate, suggesting the neurogenic 
niche provides specific signalling cues to drive proper differentiation. I will next 
describe the architecture of the neurogenic niches in the SVZ and SGZ. 
 
1.2.2 The adult subventricular zone as a neurogenic niche 
The neurogenic niche in the subventricular zone (SVZ) of the lateral ventricles is 
located adjacent to an ependymal cell layer separating the ventricular space from the 
SVZ (Figure 1.2). The stem cells of the SVZ are astrocytic-like cells expressing GFAP, 
and were described to have stem cell properties and generate neurons by retroviral 
lineage tracing (Doetsch et al., 1999b). The SVZ neural stem cells, known as type B1 
cells, extend an apical process with a primary cilium through the ependymal cell layer 
to contact the cerebrospinal fluid inside the lateral ventricle. The B1 cells are in very 
close association with the other niche cells, and are found surrounded by ciliated 
ependymal cells forming a stereotyped pinwheel structure with a single B1 cell in the 
centre (Bond et al., 2015; Fuentealba et al., 2012) (Figure 1.2). A dividing B1 cell will 
generate a proliferating intermediate progenitor cell (IPC or C cell) which will divide a 
number of times before becoming a neuroblast (A cell).  
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Figure 1.2. Scheme of the neurogenic niche in the adult mouse subventricular 
zone 
The subventricular zone (SVZ) is located along the walls of the lateral ventricles (V), shown 
in the schematic coronal cross-section of an adult mouse brain (top left panel). The stem 
cells of the SVZ (light blue; type B1 cells) extend an apical process with primary cilium to 
contact the lateral ventricle, as well as a basal process which contacts the blood vessels 
(BV) of the vasculature. The NSCs are surrounded by their niche cells, including the 
ciliated ependymal cells (yellow; E cells) forming the characteristic pinwheel structure, as 
well as their intermediate progenitor cells (green; type C cells), which generate neuroblasts 
(red; type A cells) destined to migrate via the rostral-migratory stream to the olfactory bulb, 
where they integrate as mature olfactory neurons. Image reproduced from (Fuentealba et 
al., 2012) with permission of the rights holder, Elsevier. 
 
The neuroblasts migrate away from the SVZ to join the rostral migratory stream (RMS), 
a chain of maturing neuroblasts that use one another as a migratory substrate, within a 
glial sheath (Bronner, 2014). During this migration, the neuroblasts will differentiate into 
different subtypes of interneuron, and eventually integrate into the olfactory bulb (Bond 
et al., 2015; Fuentealba et al., 2012). SVZ type B1 cells receive signals from the 
different components of the niche, including from the cell-cell contacts of ependymal 
cells, diffusible signals within the CSF via the primary cilium, as well as signalling from 
the IPCs, neuroblasts and innervation from surrounding neuronal cells. B1 cells also 
have a basal process that ends in a specialised end-foot that contacts blood vessels, 
providing yet another source of niche signalling (Fuentealba et al., 2012) (Figure 1.2). 
Chapter 1 Introduction 
26 
 
1.2.3  The neurogenic niche in the adult mouse hippocampus 
The hippocampal neurogenic niche is located in the subgranular zone (SGZ) of the 
dentate gyrus (DG) (Figure 1.3). The stem cells of the SGZ are radial astrocytic- or 
glial-like cells (RGLs). RGLs are identified by their characteristic morphology, with the 
nucleus in the SGZ (a thin layer of nuclei sandwiched between the granule cell layer 
and hilus), radial process extending through granule cell layer beyond which it 
branches into the molecular layer (Figure 1.3). Like SVZ type B1 cells, RGLs have 
primary cilium located at the base of the radial process (Breunig et al., 2008), enabling 
cilium-mediated signalling. RGLs generate granule neurons via a well characterised 
neurogenic lineage. RGLs in the adult mouse exist in a mostly quiescent state, with a 
small percentage that activate at any given time, to divide asymmetrically to generate 
another RGL and a daughter cell bearing only a short, thin process, which is a 
proliferating intermediate progenitor cell (IPC; type II a, and type II b cells). IPCs divide 
around 3 times, before maturing into neuroblasts or type III cells. These cells can then 
mature into granule cells (Figure 1.3), and if the right survival signals are received, will 
mature and integrate into the hippocampal circuitry (Gu et al., 2012; van Praag et al., 
2002).  
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Figure 1.3. The neurogenic niche of the adult mouse hippocampus 
A) The organisation of the mouse hippocampus, shown by immunohistochemistry for the 
neuronal maker NeuN. The CA1 and CA3 subfields of the hippocampus can be seen 
converging between the characteristic blades of the dentate gyrus (DG), highlighted within 
the dashed box. B) Close up of the dentate gyrus. The neurogenic niche is located in the 
subgranular zone of the inner blades of the DG. C) Schematic of the hippocampal 
neurogenic niche in the dentate gyrus. Radial glial-like stem cells (RGLs/NSCs) are seen 
with their nucleus in the subgranular zone (SGZ) with radial process extending through the 
granule cell layer, and processes branching into the molecular layer. Active RGLs or 
horizontal astrocytes will divide to produce intermediate progenitors (type II a and type II b 
cells), which will proliferate before differentiating over several days into neuroblasts (type III 
cells) and eventually fully differentiating into granule neurons, which migrate a short 
distance into the granule cell layer. The neurogenic lineage exists in close associated with 
other niche cells, including astrocytes (purple), interneurons (red) and blood vessels of the 
vasculature. Reproduced from (Urban and Guillemot, 2014) with permission of the rights 
holder, Frontiers.  
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The DG neurogenic lineage can also be characterised by the expression of particular 
neurogenic transcription factors and cellular markers, such as Tbr2 (IPCs), Dcx 
(neuroblasts) and NeuN (neurons) (Figure 1.4; (Hsieh, 2012; Urban and Guillemot, 
2014)). RGLs are characterised by the expression of GFAP, GLAST, Nestin and Hes5 
mRNA (Figure 1.4), which I will discuss in more detail in the next section. 
 
 
Figure 1.4. Expression of genes defining the neurogenic lineage in the dentate 
gyrus. 
The neurogenic lineage in the subgranular zone of the dentate gyrus can be identified by 
stage-specific markers. Quiescent RGLs (NSCs) are identified by their expression of 
GLAST, GFAP, Nestin, a GFP-reporter of Hes5 transcription (Lugert et al., 2010), as well 
as the lack of expression of Ascl1 and proliferation markers. Ascl1 expression is found in 
active RGLs and intermediate progenitor cells (IPCs; type II a). IPCs also express the  
Hes5:GFP
Nestin
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transcription factor Tbr2, while Doublecortin (DCX) is switched on in neuroblasts (type II b), 
followed by NeuN, which labels more mature neuroblasts and newborn neurons. Modified 
from (Urban and Guillemot, 2014) with permission of the rights holder, Frontiers.    
 
1.2.4 RGLs: from astrocytes to neural stem cells 
RGLs share many properties with the other glial cells of the adult brain, as well as the 
radial glia of the developing CNS (Kriegstein and Alvarez-Buylla, 2009), and indeed 
they were first thought to be DG astrocytes. The characterisation of RGLs as bona fide 
SGZ NSCs began with utilising one of their defining markers, glial fibrillary acidic 
protein (GFAP), a marker of astrocytes but also identified as a marker of SVZ NSCs 
(Doetsch et al., 1999a; Laywell et al., 2000). Seri and colleagues demonstrated that 
retrovirally labelled GFAP+ radial cells, following ablation of dividing cells in the SGZ, 
divide and give rise to progeny that differentiate into granule neurons (Seri et al., 
2001). These results were corroborated by genetic ablation of GFAP-expressing cells 
in the SGZ, which resulted in a loss of neurogenesis (Garcia et al., 2004). Since then, 
more markers of RGLs have been identified including glutamate aspartate transporter 
(GLAST; SLC1A3) (Namba et al., 2005), although GLAST and GFAP are also both 
expressed by astrocytes in the DG and hilus. RGLs also express Nestin (Fukuda et al., 
2003; Seri et al., 2004), Sox2 (Episkopou, 2005; Pevny and Nicolis, 2010; Suh et al., 
2007) and Hes5 (Lugert et al., 2010), however these markers are also expressed by 
IPCs (Figure 1.4). So far, no specific marker for RGLs has been identified, however the 
current markers have enabled a strong progression in the field, with the development 
of transgenic reporters for fate-mapping as well as transgenic manipulations to 
elucidate the behaviour and regulation of the stem cells (Bonaguidi et al., 2012). For 
example, clonal analysis of cells labelled in the tamoxifen inducible 
NestinCreERT2;RosaYFP mouse line revealed that RGLs undergo different modes of 
division, including self-renewing symmetric divisions and asymmetric divisions 
generating neuronal progenitors or astroglia, as well as a few cases of direct 
differentiation without a self-renewing division (Bonaguidi et al., 2011). Interestingly, a 
study published at the same time using Nestin-GFP reporter mice reports that RGLs do 
not undergo expansive symmetric division, instead rapidly divide asymmetrically to 
generate IPCs, with the mother RGLs subsequently differentiating into astrocytes 
(Encinas et al., 2011). In this model, RGLs are lost at the population level, being 
consumed with increasing age (Encinas et al., 2011). The opposing conclusions from 
Chapter 1 Introduction 
30 
 
Bonaguidi et al., and Encinas et al., reflects the important differences when analysing 
as a clonal versus population level. It also may highlight heterogeneity of the RGL pool, 
a concept which is gaining increased attention, due to the implications for studies of the 
regulation and long-term fate of the RGLs. More recently, an incredible feat was 
achieved to live-image RGLs in the adult dentate gyrus over several weeks, in order to 
closely record the self-renewal capacity and lineage relationships of RGLs and their 
progeny, in a longitudinal way (Pilz et al., 2018). RGLs were labelled with tdTomato in 
Ascl1 expressing neural stem and progenitor cells (Ascl1CreERT2 mice), and imaged 
via a cortical window, which revealed most RGLs divide asymmetrically, with a smaller 
proportion of symmetric divisions, as was found by clonal lineage tracing (Bonaguidi et 
al., 2011), and direct neurogenic divisions were also observed (Pilz et al., 2018). 
Interestingly, the authors did not observe any Ascl1-tdtomato RGL returning to 
quiescence for a substantial amount of time, which conversely had been observed by 
other groups (Bonaguidi et al., 2011; Urban et al., 2016), and could identify Ascl1-
expressing RGLs as a more proliferative, dispensable population. This again suggests 
there may be subgroups of RGLs with different contributions to neurogenesis and 
distinct responses to regulating stimuli.  
 
1.2.5 RGL heterogeneity 
Heterogeneity among adult NSCs has been described in the SVZ, where different 
subsets of NSCs along the rostro-caudal axis of the SVZ generate distinct subtypes of 
interneuron (Merkle et al., 2007) (Merkle et al., 2014). A similar regionalisation of RGL 
identify in the DG has not yet been observed. However, RGL heterogeneity is 
highlighted by DeCarolis and colleagues who compared the dynamics and neurogenic 
contribution of RGLs labelled by either the transgenic reporter 
NestinCreERT2;Rosa26YFP or GLASTCreERT2;Rosa26-YFP (DeCarolis et al., 2013). 
The authors demonstrate that the differentially labelled RGLs contribute differently to 
the stem cell pool, with GLAST-expressing RGLs showing higher levels of proliferation 
and neurogenic contribution than Nestin-expressing RGLs, even after ablation of 
proliferating progenitors and activating the stem cells by exercise (mouse wheel 
running) (DeCarolis et al., 2013). Two morphologically distinct subtypes of RGL have 
also been proposed to exist, the classical radial glial-like stem cell and a non-dividing 
astrocytic-like cell lacking a radial process but co-expressing RGL markers (Steiner et 
al., 2006). These astrocytic-like RGLs could represent an early stage of astrocytic 
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differentiation of an RGL, however later studies using Sox2-GFP and Hes5-GFP fate 
mapping (Lugert et al., 2010; Suh et al., 2007) similarly observed two morphologically 
distinct populations of RGLs, the radial and non-radial or “horizontal” astrocyte. 
Interestingly, Suh et al., observed that non-radial Sox2+ cells are the major proliferating 
population in the SGZ, whilst the Sox2+ radial NSCs were rarely dividing (Suh et al., 
2007). Similarly, Hes5:GFP labelled radial and non-radial/horizontal NSCs respond 
differently to neurogenic stimuli, with the non-radial portion proliferating more in 
response to stimulation but are lost with increasing age, whilst the radial NSCs 
proliferate less and persist with age (Lugert et al., 2010). More recently, single-cell 
transcriptomes have been generated from FAC sorted cells dissociated from the adult 
mouse dentate gyrus. This will be discussed in more detail below in Section 1.3.2. 
Single cell transcriptomic data could shed light on transcriptional heterogeneity of adult 
NSCs, however there are limitations. Firstly, such data only provides a single snapshot 
in time, therefore if subtypes of stem cell were identified, it would not be possible to 
follow the behaviour or fate of the cell, so the functional implication of the subtype 
would be difficult to infer. Secondly, single cell transcriptomes can suffer from low 
sequencing depth due to small amounts of mRNA, which creates difficulty 
distinguishing heterogeneity from noise, or distinguishing stable expression of a gene 
from an oscillating expression (although the oscillation of a gene may itself confer 
heterogeneity to a population of stem cells). Finally, this kind of analysis still relies on 
isolating NSCs based on the expression of known markers such as GLAST or Nestin, 
introducing bias which may result in unknown subtypes of NSC being excluded. On the 
other hand, a major benefit of single cell transcriptomic analysis of NSCs has been to 
shed light on the transcriptional signature of quiescent RGLs; their quiescent state can 
be inferred from the low or absent expression of cell cycle and activation genes, 
therefore associated transcriptional features can be observed (discussed in Section 
1.3.2). 
 
RGLs may also be heterogeneous with regards to their likelihood to activate or return 
to quiescence. Urbán and colleagues have identified two subtypes of quiescent RGL; 
the resting population, representing a small number RGLs that have activated and 
divided, and temporarily returned to quiescence; and the dormant population, 
representing the majority of stem cells, that have (very likely) never divided (Urban et 
al., 2016). Regulation of the resting pool is crucial for maintaining neurogenesis in the 
adult DG (Urban et al., 2016).  
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Overall, these studies highlight the possibility that all RGLs are not equal, and may be 
differentially regulated and contribute to neurogenesis in different ways. It is also not 
clear whether the current known markers of RGLs are able to label the entire 
population, or if in fact more subpopulations of RGLs exist. Considering the 
implications of a heterogeneous pool of RGLs for understanding the regulation of 
neurogenesis in homeostasis and disease, it will be highly important to elucidate the 
identity of all adult RGLs in the SGZ.  
 
1.2.6 Embryonic origin of RGLs 
One potential source of RGL heterogeneity could be differential origins of adult RGLs. 
The embryonic origin of adult DG NSCs is not fully known (Berg et al., 2018; Urban 
and Guillemot, 2014). Historically the assumption for the origin of adult DG NSCs has 
been that they originate from the whole length of the embryonic dentate 
neuroepithelium (DNE), from where GFAP-expressing cells migrate towards the SGZ, 
and give rise to granule neurons from early stages of DG development and continuing 
throughout adulthood (Seri et al., 2004). However, recent lineage tracing experiments 
of sonic hedgehog (SHH)-responsive cells suggests that a subset of adult neural stem 
cells are induced at peri-natal stages in the most ventral portion of the hippocampus, 
from where they are induced by SHH, and migrate dorsally to populate the whole 
length of the adult DG, where they contribute to adult DG neurogenesis (Li et al., 
2013). This has opened up the possibility of separate populations of adult NSCs, 
originating from different embryonic or peri-natal stages of development. RGLs in the 
adult DG could potentially be either a continuation of RGLs from development, or a 
separate population of NSCs set-aside in development, becoming activated in 
adulthood (Berg et al., 2018; Encinas et al., 2013). Further lineage tracing experiments 
would help to fully elucidate the origins of adult SGZ NSCs, such as has been done for 
the embryonic origin of SVZ NSCs (Fuentealba et al., 2015). However, the recent 
explosion of single-cell RNA-sequencing has enabled a far deeper exploration into the 
transcriptional of identity of NSCs from development to adulthood. The Linnarsson lab 
has produced a database of single cell RNAseq data for all cells in the DG across 
postnatal development, an extraordinary feat that provides an unprecedented insight 
into the gene expression of RGLs throughout development and adulthood (Hochgerner 
et al., 2018). The authors show a shift in RGL identity from embryonic to adult during 
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the second postnatal week, and further critical examination of gene expression 
changes will surely reveal insights into the embryonic origin of adult DG RGLs, and 
potential novel mechanisms of their regulation.   
 
1.3 Stem cell quiescence 
Before I describe the known extrinsic and intrinsic mechanisms regulating 
neurogenesis, and specifically their effects on RGL activation, I will explore the concept 
of stem cell quiescence, discussing how it is defined and what is known of quiescence 
in RGLs. In this way, I will focus my discussion of the signals and molecules regulating 
RGLs on their influence on quiescence and activation, a central concept to my thesis.  
 
1.3.1 What is quiescence?  
Quiescence is defined as a reversible state of cell cycle exit, or when cells reside in the 
‘G0’ cell cycle state often for prolonged periods of time, but with the ability to re-enter 
the cell cycle. It is distinct from terminal differentiation or senescence due to its 
reversibility under normal conditions (post-mitotic cells are in some cases able to re-
enter the cycle e.g. reactive astrocytosis, however this is usually as a result of injury or 
other extreme stimulus). The G0 cell cycle state is not fully understood, currently 
defined by a 2n DNA content and the absence of cell cycle gene expression (Cheung 
and Rando, 2013). Historically, quiescence was thought to perhaps represent a very 
long or paused G1 phase, and particularly thought to be a state of inactivity with low 
levels of cellular activity. Early studies of cellular quiescence supported this view, such 
as the observation that serum deprivation results in inhibition of protein synthesis and 
induces quiescence of 3T3 cells (Larsson et al., 1985; Zetterberg and Larsson, 1985). 
Interestingly, these cells would only enter quiescence if they were in early G1 at the 
time of serum deprivation, indicating the quiescent state exists in close relationship 
with the cell cycle, and that it may be an actively regulated state, rather than a result of 
loss of cellular function. Techniques to evaluate the transcriptional and biological 
characteristics of quiescent cells have improved vastly over the past few years, 
resulting in a much more finessed understanding of quiescence as a distinct and 
complex cellular state. RNA sequencing, for example, has enabled the generation of a 
‘transcriptional signature’ of quiescence.  
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1.3.2 Transcriptional signature of quiescence 
Quiescence is akin to an actively maintained state of dormancy. Despite the 
observation that quiescent stem cells have a low RNA content (Fukada et al., 2007; 
Huttmann et al., 2001), recent transcriptomic studies on prospectively isolated 
quiescent stem cells has demonstrated quiescence to involve the active transcription of 
hundreds of genes (reviewed by (Cheung and Rando, 2013)), and has been performed 
for hair follicle stem cells (Blanpain et al., 2004), satellite cells (Fukada et al., 2007) 
haematopoietic stem cells (Forsberg et al., 2010), and adult neural stem cells. 
Common groups of genes were found to be regulated in all populations of quiescent 
stem cell, such as a downregulation of genes involved in cell cycle progression, DNA 
replication and RNA processing, and upregulation of genes involved in transcriptional 
regulation and stem cell maintenance (Cheung and Rando, 2013). Several studies 
have performed bulk or single-cell RNA sequencing on prospectively isolated quiescent 
NSCs from the adult SVZ, a feat made possible by the identification of a handful of 
markers specifically distinguishing quiescent from active NSCs, such as EGF receptor, 
and more recently LeX (Beckervordersandforth et al., 2010; Codega et al., 2014; 
Morizur et al., 2018). This is in contrast to the DG, where there are no good markers to 
distinguish quiescent and active NSCs by FACS. Nevertheless, single cell RNAseq 
analysis of quiescent DG RGLs was achieved by FAC sorting all RGLs from the adult 
dentate gyrus, followed by retrospective bioinformatic grouping of cells along a 
‘pseudotime’ axis based on a continuum of transcriptional changes from most 
quiescent to most active (Shin et al., 2015). In this way, the genes most enriched in 
quiescent RGLs were identified. Much like for quiescent stem cells in other adult 
niches, quiescent SVZ and SGZ NSCs downregulate genes involved in cell cycle and 
RNA processing, but interestingly display a signature of upregulated genes involved in 
cell adhesion, cell-cell signalling, mitochondrial function and metabolic changes 
(Beckervordersandforth et al., 2010; Codega et al., 2014; Morizur et al., 2018; Shin et 
al., 2015) (Figure 1.5). Lipid metabolism is particular enriched in quiescent NSCs, and 
had been previously shown to be enriched in FAC sorted Sox2:GFP+ NSCs from the 
DG, highlighting metabolism as an important process in NSCs (Bracko et al., 2012). 
The metabolic state of quiescent radial glial-like cells is predominantly glycolytic with 
low levels of oxidative phosphorylation (OxPhos) and likely with de novo lipogenesis 
(Knobloch et al., 2013), but upon activation switches towards the mitochondrial 
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electron transport chain (ETC) and OxPhos for energy (Beckervordersandforth, 2017) 
(Figure 1.5). Moreover, the mitochondria themselves are shown to be distributed 
differently in quiescent vs active hippocampal NSCs in vivo, with a higher mitochondrial 
volume in the primary process of NSCs than of active NSCs/progenitor cells 
(Beckervordersandforth, 2017). Strikingly, NSC metabolism can directly regulate 
quiescence/activation, as shown by direct manipulation of NSC fatty acid metabolism, 
either via deletion of carnitine palmitoyltransferase 1a, or the metabolite malonyl-CoA, 
induced NSC exit from quiescence and increased proliferation (Knobloch et al., 2017).  
 
 
Figure 1.5. Molecular and metabolic features of hippocampal NSCs from 
quiescence to activation. 
Single cell RNA sequencing of adult hippocampal NSCs identifies cellular features of NSC 
quiescence, including high expression of cell-cell signalling components such as receptors, 
a predominantly glycolytic metabolism with some fatty acid metabolism, low levels of 
ribogenesis which correlates with lower levels of transcription compared with active NSCs, 
and a G0 cell cycle state. Modified from (Shin et al., 2015) with permission of the rights 
holder, Elsevier. 
1.3.3 Function of quiescence  
Quiescence is a functionally important cell state for any long-lived organism, enabling 
preservation of self-renewing stem cells over many years. Quiescence allows stem 
cells to be maintained in a dormant state until required to generate a progenitor cell for 
tissue homeostasis. The benefit of this form of reversible dormancy, over having a 
continually proliferating pool for example, is likely to be the prevention of accumulation 
of DNA and cellular damage; if a stem cell only needs to divide once to generate a 
progenitor which itself can divide several more times, it will enable functional levels of 
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regeneration with a reduced number of proliferative stem cell divisions, reducing the 
risk of introducing deleterious DNA mutations, and preventing a stem cell from 
becoming senescent (irreversibly exited from the cell cycle). Nevertheless, any cell that 
persists in an organism for many years will eventually accumulate DNA damage, as 
well as be exposed to environmental stress, and risk accumulating damage such as 
from oxidative stress and hypoxia. The transcriptional and metabolic profile of 
quiescent stem cells suggests this cellular state actively protects the stem cell from 
these stresses (Cheung and Rando, 2013; Tsai, 2016). For example, the FOXO 
transcription factors are often highly expressed in quiescent stem cells, including 
FoxO3 in adult NSCs (Renault et al., 2009), and these TFs protect cells from oxidative 
stress and hypoxia by inducing the expression of protective genes (Yeo et al., 2013). 
Quiescence may also encourage genomic integrity by non-random segregation of 
sister chromosomes during mitosis, known as the ‘immortal strand hypothesis’, 
specifically segregating the newly synthesised strands of DNA to the new-born 
daughter cell, whilst sequestering the old template DNA in the self-renewing stem cell 
(Charville and Rando, 2011). Although not universally evident, some evidence for this 
hypothesis has been observed in satellite cells and intestinal stem cells (reviewed by 
(Cheung and Rando, 2013)) as well as adult neural stem cell cultures (Karpowicz et al., 
2005). Ultimately, quiescence can function to prevent stem cell damage and depletion 
(from apoptosis or senescence), enabling proper tissue regeneration during age and 
injury. 
 
Quiescence may also enable stem cells to be more permissive to many different 
regulating signals, and respond quickly. Quiescence is associated with low levels of 
mRNA, but is has been suggested that quiescent stem cells are poised to respond, 
quickly expressing mRNA in response to the dominating signal (Cheung and Rando, 
2013). If too many genes were actively transcribed in quiescence, the response to a 
particular signal may be slowed down by cross-talk or interference. Therefore, the 
transcriptional activity of quiescence may enable rapid response of a stem cell to a 
changing environment.  
 
Quiescence has also been observed in tumour stem-like cells, such as in glioblastoma 
(Lathia et al., 2015). Glioblastoma (GBM) is a highly aggressive brain tumour, with a 
high mortality rate due to its wide invasion of the surrounding brain. Isolation of primary 
brain tumours has led to the identification of self-renewing cancer stem cells contained 
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within the tumours, including those with quiescent-like properties (Chen et al., 2012). 
Glioma stem-like cells (GSCs) present a significant problem for treatment, as the 
quiescent state enables evasion from the classic anti-proliferative chemotherapies. The 
surviving quiescent cells are able to reinvade and generate new malignancies. GSCs 
are thought to bear similarities to NSCs, therefore gaining a thorough understanding of 
the molecular regulation of quiescence in adult NSCs should generate potential new 
strategies for targeting quiescent brain tumour cells, either by targeting them for 
destruction, or by preventing their eventual activation from quiescence, such as via 
manipulation of their interaction with their niche (Brooks and Parrinello, 2017; Chen et 
al., 2016).  
 
1.3.4 Identifying quiescent stem cells 
In the absence of a distinctive marker of quiescence (the lack of cell proliferation 
markers has generally been used to identify quiescent stem cells), S-phase label 
retention paradigms have been used to mark very slowly or infrequently dividing stem 
cells (Sottocornola and Lo Celso, 2012; Urban et al., 2016). In essence, mice are 
infused with a thymidine nucleotide analogue (BrdU, EdU, IdU or CldU) over a period 
of time, which will be taken up by all dividing cells, including any stem cell that happens 
to activate and divide in that period. A chase period follows, in which the nucleotide 
analogue is withdrawn, and enough time allowed for actively proliferating cells to dilute 
out the analogue and/or differentiate. Any cell retaining the analogue label at the end of 
the chase period is considered to be slowly dividing stem cell, or a stem cell having 
returned to quiescence, hence the term ‘label retaining cell’. However, this technique 
cannot identify stem cells that have not exited quiescence in the first place. This is 
important for analysis of stem cell activity in the adult neurogenic niches, considering 
the hypothesis that a distinct proportion of RGLs are dormant, having never activated 
and divided (Urban et al., 2016). The hypothesis suggests these cells have functional 
differences to the resting stem cells (Urban et al., 2016), so being able to differentiate a 
dormant RGL from a resting RGL that has temporarily returned to quiescence is 
important for delineating their differential responses to manipulation. It is not clear why 
the majority of RGLs are dormant, but they present an exciting prospect for potential 
therapeutic activation in the aged mouse, harnessing a dormant endogenous 
regenerative capacity within the hippocampus.   
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1.4 Regulation of adult neural stem cells and neurogenesis  
Neurogenesis can be regulated at several stages of the neurogenic lineage. Global 
levels of neurogenesis can be determined by the proliferation rates of IPCs, or the 
survival of newborn neurons (Baptista and Andrade, 2018; Rolando and Taylor, 2014). 
Moreover, the selective elimination of IPCs by microglia is a major regulatory 
mechanism controlling levels of neurogenesis (Sierra et al., 2014; Sierra et al., 2010). 
Historically, most studies have reported regulation of neurogenesis at the population 
level, for example by quantifying total proliferating cells in the DG, or total number of 
NeuN+ newborn neurons. However, these studies often fail to interrogate the cell-
specific effects of manipulations, particularly the effect on RGL activity and fate. 
Control of RGL activation and self-renewal is vital for ensuring a source of new 
progenitors, and maintenance of neurogenesis with age.  
 
RGLs are in close proximity to many different sources of regulatory signals. Regulation 
can come from direct contact with IPCs; diffusible signals from granule neurons, 
interneurons and bushy astrocytes; innervation in molecular layer; and from blood 
vessels. Here I will describe the extrinsic systemic and niche signals that influence 
neurogenesis, specifically focussing on those signals that regulate RGL quiescence 
and activation. 
 
1.4.1 Systemic regulation 
Adult neurogenesis is highly sensitive to and dynamically regulated by physiological 
stimuli, which could reflect the possible function of adult hippocampal neurogenesis for 
adapting to a changing physical and social environment (Goncalves et al., 2016; 
Kempermann, 2012). Physical exercise has been well documented to increase levels 
of neurogenesis in rodents (Kronenberg et al., 2003; Lugert et al., 2010; Steiner et al., 
2008; Suh et al., 2007; van Praag et al., 1999). Exercise specifically increases the 
number of GLAST-expressing RGLs in the DG (DeCarolis et al., 2013), potentially via 
increasing the vascular niche; exercise is thought to promote angiogenesis in the 
niche, which provides a rich source of regulatory signals, which I will describe in more 
detail in Section 1.5.2. Learning and environmental enrichment (EE) both promote 
neurogenesis (Gould et al., 1999; Rolando and Taylor, 2014), suggesting neuronal 
stimulation can affect hippocampal neurogenesis. The social environment also has 
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strong regulatory effects on neurogenesis, both positive and negative depending on the 
form of interaction. For example, social isolation and psychosocial stress, such as 
interaction with an aggressive individual, reduces neurogenesis (Czeh et al., 2007; 
Gould et al., 1997; Lieberwirth et al., 2012). Non-social chronic stress also reduces 
neurogenesis (Mirescu and Gould, 2006). Sex hormones and adrenal hormones 
modulate neurogenesis (Galea et al., 2013; Gould et al., 1992), and mating and 
maternal social interaction increases neurogenesis (Furuta and Bridges, 2005; Mak et 
al., 2007). Many of these reports measure global levels of neurogenesis, or regulate 
neurogenesis downstream of NSCs. Environmental enrichment for example was 
reporter to act on committed progenitors rather than RGLs (Steiner et al., 2008). 
Physical exercise also stimulated proliferation of IPCs, but not RGLs (Lugert et al., 
2010; Steiner et al., 2008). Detailed analysis of RGL activity in response to 
physiological stimuli is required to identify physiological regulators of quiescence. This 
is worth investigating in light of the observation that neurogenesis and the stem cell 
pool decreases with age (sharply immediately after adolescence, then more slowly with 
age), whilst NSC quiescence increases (Encinas et al., 2011; Jaskelioff et al., 2011; 
Kempermann, 2011a; Lugert et al., 2010; Seib et al., 2013). Therefore, identifying 
environmental stimuli that could mitigate this decline could enable rejuvenation of 
neurogenesis, which would be highly useful for human health. Environmental and 
physiological stimuli may not directly act on NSCs; rather, they may modulate elements 
of the neurogenic niche, which in turn directly regulate NSC function. Indeed, ageing of 
the neurogenic niche can directly affect NSC function (Mosher and Schaffer, 2018). I 
will next explore the various mechanisms by which the neurogenic niche can directly 
regulate neural stem cell activity.  
 
1.4.2 Direct regulation of NSCs by the neurogenic niche  
1.4.2.1 Cell adhesion 
The neurogenic niche is a highly complex environment, with various different cell types 
and sources of signalling, as described in Section 1.2. But it is also complicated in light 
of the fact it regulates both the maintenance of NSCs, whilst also regulating the 
proliferation and differentiation of progenitors, and survival of neurons. This multilevel 
regulation demonstrates how localised and specific the regulating signals must be, 
suggesting there is a highly dynamic system of extrinsic signals integrating with 
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intrinsic changes in the responding cell. Part of this specificity is likely achieved through 
adhesion to the niche and local, cell-cell signalling. Expression of vascular cell 
adhesion molecule-1 (VCAM1) is required in SVZ NSCs to maintain their correct niche 
positioning, and disruption of VCAM1-mediated adhesion leads to loss of NSC 
quiescence (Kokovay et al., 2012). Similarly, the integrins, a class of cell adhesion 
molecule, enable contact between NSCs and the endothelial cells of the vascular 
niche, and their expression regulates NSC activity. SVZ NSCs express the laminin 
receptor α6β1-integrin, which is required for NSCs to adhere to the vascular niche and 
maintain a level of quiescence (Shen et al., 2008). Similarly, β1-Integrin is selectively 
expressed on dividing NSCs in the SVZ, and was shown to be required to maintain 
appropriate levels of proliferation of NSCs and IPCs (Kazanis et al., 2010). These 
studies contradict to some extent the observations that proliferative NSCs lie close to 
the vasculature, and endothelial cells can induce proliferation of NSCs in co-culture 
conditions (Shen et al., 2004), highlighting the complexity of the interaction between 
NSCs and their niche. Ottone and colleagues (2014) demonstrated in the SVZ that 
direct endothelial-to-stem cell signalling via ephrinB2 and Jagged maintained the stem 
cells in a quiescent state. Interestingly, the regulation of NSC quiescence by eprhinB2 
and Jagged functioned via independent pathways, highlighting the complexity and 
number of signals that act in combination to tightly control NSC quiescence. This is 
certainly true in the embryo, where β1-integrins in NSCs directly influence levels of 
Notch signalling (Campos et al., 2006), which is itself a highly potent regulator of NSC 
activity in adult neurogenic niches.  
 
1.4.2.2 Notch 
Notch is a well-known signal implicated in the regulation of stem cells in many niches 
(Mourikis and Tajbakhsh, 2014), including the regulation of neural stem cells during 
embryonic development, and has recently received a great deal of attention for its role 
in maintaining the pool of adult neural stem cells (Imayoshi and Kageyama, 2011; 
Kageyama et al., 2008). There are 4 Notch receptors in mammals, Notch1-4, which are 
composed of an extracellular domain, a single transmembrane pass, and an 
intracellular domain. There are also 5 Notch ligands: Dll1, Dll3, Dll4, Jag1, Jag2. Notch 
signalling can be initiated when a cell expresses a ligand and activates the receptor on 
a neighbouring cell, signalling in a trans interaction. Notch can also be activated in cis, 
when a cell expresses both the receptor and the ligand. When a ligand binds to a 
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Notch receptor, y-secretase proteases such as presenilins cleave the receptors to 
release the Notch intracellular domain (NICD). The NICD enters the nucleus and binds 
target DNA along with RBPJk, recruiting coactivators including MAML1 to induce target 
gene expression such as Hes1 and Hes5. Notch pathway components are expressed 
in the neurogenic niche of the SVZ and SGZ. Specifically, RGLs in the adult SGZ are 
capable of receiving Notch signalling due to the expression of the Notch receptors 
Notch1, Notch2 and Notch3 on GFAP-expressing RGLS. Concurrent with the receptor 
expression, Notch signalling is active in more than 90% of GFAP+ RGLs and Sox2+ 
RGLs in the SGZ, as determined by the expression of NICD and genetic reporters of 
Hes1 and Hes5 expression (Breunig et al., 2007; Ehm et al., 2010; Imayoshi et al., 
2010; Lugert et al., 2010; Ohtsuka et al., 2006). The Notch ligand Jagged1 is 
expressed by niche astrocytes and IPCs, and is crucial for maintenance of RGLs via 
feedback from the progenitors to induce a return to quiescence of the stem cells 
(Lavado and Oliver, 2014) (Figure 1.6). Another Notch ligand, Dll1, is similarly 
expressed in IPCs, following asymmetric distribution of the protein to the daughter cell 
during NSC division, and provides a feedback signal from progenitor to stem cell, 
instructing the stem cell to return to quiescence (Kawaguchi et al., 2013). The 
consensus in the field is that Notch is required to maintain the adult stem cell pool, a 
role conserved between rodents and fish (Chapouton et al., 2010), both by inhibiting 
proliferation and maintaining stemness of RGLs by inhibiting cell-cycle exit and 
differentiation, in both the SGZ and SVZ (Alexson et al., 2006; Andreu-Agullo et al., 
2009; Androutsellis-Theotokis et al., 2006; Hitoshi et al., 2002). NSCs in the SVZ also 
express Notch1-3, with Notch3 preferentially expressed by quiescent NSCs (Kawai et 
al., 2017) Notch signalling via Jagged1 has been suggested to promote quiescence by 
inhibiting differentiation, rather than by regulating the cell cycle (Ottone et al., 2014), a 
role similarly suggested for satellite (muscle) stem cells (Bjornson et al., 2012; Mourikis 
et al., 2012; Mourikis and Tajbakhsh, 2014). Manipulation of Notch receptor expression 
has added to the understanding of the role of Notch in NSC regulation, particularly 
highlighting the differential roles of the three receptors in spite of their signalling via the 
same intracellular cascade. Conditional knockout of the Notch1 receptor in Nestin+ 
cells in the DG results in a loss of the NSC and IPC populations (Ables et al., 2010), 
which the authors report to be due to a failure of self-renewal of the stem cells, and 
precocious cell cycle exit. A similar result was obtained using genetic ablation of 
Notch1 in GFAP+ cells, which promoted cell-cycle exit of RGLs and neuronal fate 
determination of progenitors, whereas constitutively active Notch1 signalling increased 
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RGL proliferation (Breunig et al., 2007). In the SVZ, Notch1 is required for activated 
NSCs to self-renew and maintain their stemness (Basak et al., 2012). In contrast, 
Notch2 and Notch3 have been separately shown to be required to maintain quiescence 
of SVZ NSCs (Engler et al., 2018; Kawai et al., 2017). An alternative approach has 
been to conditionally delete RBPJk, the downstream transcriptional effector of 
canonical Notch signalling. Conversely, RBPJk cKO mice showed an initial increase in 
proliferation of the quiescent RGLs and progenitors, followed by a loss of long-term 
maintenance of the stem cell pool, in both the SGZ and SVZ (Ehm et al., 2010; 
Imayoshi et al., 2010). The discrepancy between Notch1 cKO and RBPJk cKO mice 
may be due to different levels of Notch inhibition; signalling via alternative Notch 
receptors in Notch1cKO mice may mediate the phenotype and prevent the activation of 
RGLs observed in RBPJk cKO mice (for which all canonical Notch signalling is 
blocked). Notch signalling is notoriously context dependent, which is evident from the 
differential effects of Notch1 deletion in SVZ NSCs, which results in increased NSC 
proliferation without a subsequent loss of the stem cell pool, unlike in the SGZ where 
the stem cell pool is depleted (Ables et al., 2010; Basak et al., 2012).  
 
1.4.2.3 Neurotransmitters: GABA, Glutamate 
As a result of being located in the brain, neural stem cells are uniquely exposed to 
regulation by neurotransmitters. NSCs in both the SVZ and hippocampus express 
receptors for neurotransmitters, several of which have been identified to regulate NSC 
quiescence. Evidence exists for serotonin, dopamine, glutamate, GABA, acetylcholine, 
nitric oxide, neuropeptide Y and noradrenaline promoting proliferation in the 
neurogenic niches (reviewed by (Berg et al., 2013)), reflecting a complex network of 
feedback from other parts of the brain in regulating NSC quiescence, although it is yet 
to be determined if these factors activate NSCs from quiescence directly. 
 
SVZ NSCs are directly innervated by serotonergic axons originating in the raphe 
nuclei, and their release of 5HT promotes SVZ cell proliferation (Banasr et al., 2004; 
Encinas et al., 2006; Tong et al., 2014). The SVZ also receives innervation from 
GABAergic and glutamatergic neurons of the striatum and cortex, and 
neuromodulatory regulation from dopaminergic innervation from the substantia nigra, 
the latter of which is suggested to promote proliferation in the SVZ (reviewed by 
(Young et al., 2011)). POMC+ neurons of the hypothalamus also directly innervate SVZ 
Chapter 1 Introduction 
43 
 
niche cells including NSCs, and their activity has been shown to promote NSC 
proliferation (Paul et al., 2017). GABA is expressed and tonically secreted by SVZ 
neuroblasts, activating signalling in proximal progenitor cells, limiting their proliferation 
via phosphorylation of histone variant H2AX (Alfonso et al., 2012; Fernando et al., 
2011; Liu et al., 2005; Nguyen et al., 2003). Whether GABA can specifically promote 
quiescence of SVZ NSCs is unclear, however treatment with GABA antagonist 
bicuculline results in specific activation of quiescent NSCs (Pineda et al., 2013) 
suggesting it may also normally promote NSC quiescence. 
 
The dentate gyrus is populated by parvalbumin-expressing (PV+) interneurons, and 
similarly to neuroblasts of the SVZ, the tonic release of GABA from these cells has 
been identified to act directly on hippocampal NSCs, maintaining their quiescence by 
promoting cell cycle exit, inhibiting symmetrical self-renewal and astrocytic 
differentiation (Song et al., 2012a). Interestingly, NSCs can fine-tune their own GABA 
signalling via the cell autonomous expression of diazepam binding inhibitor (DBI), 
which promotes their proliferation (Dumitru et al., 2017). The dentate gyrus also 
receives projections from glutamatergic Mossy Cells in the hilus of both ipsi- and 
contralateral dentate gyri, which directly innervate the NSCs. Interestingly, depending 
on their moderate or high level of activation, Mossy Cells can either indirectly promote 
NSC quiescence via stimulating the release of GABA from DG interneurons, or 
promote activation of the NSCs via direct release of glutamate onto NSCs, respectively 
(Yeh et al., 2018). Glutamate also indirectly induces the activation of hippocampal 
NSCs by inhibiting the release of the Wnt inhibitor Sfrp3 from neurons (Jang et al., 
2013b), and it has been shown to mediate NSC activation following ischaemic injury 
(Nochi et al., 2012). Regulation of NSC quiescence by glutamate may be specific to 
hippocampal NSCs, as receptors for glutamate do not appear to be expressed by SVZ 
NSCs (Lee et al., 2005; Nochi et al., 2012).  
 
1.4.2.4 Vasculature  
As described above, the adult neurogenic niches are highly vascularised, and the 
endothelial cells can directly regulate NSC quiescence (Fuentealba et al., 2012; Shen 
et al., 2004). In the DG, new neurons are generated in close proximity to blood vessels 
(Palmer et al., 2000) and BrdU+Nestin+ or BrdU+GFAP+ NSCs/IPCs were found next 
to capillaries, suggesting the vasculature can provide activating or pro-proliferative 
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signals in the DG as well as the more intensely studied SVZ. I have already explored 
how cell-cell signalling can mediate this effect. However, the vasculature is also the 
gateway to many systemic stimuli carried by the blood. Components in the blood can 
pass the blood-brain-barrier into the SVZ, as shown by injection of a fluorescent dye 
found in the SVZ and not in the cortex (Tavazoie et al., 2008). Heterochronic 
parabiosis, or the exposure of aged animals to the blood of a young animal (and vice 
versa) has emerged as a fascinating insight into the changes that occur systemically 
with age and how they directly affect the functioning of stem cells. For example, ‘old’ 
blood inhibits muscle regeneration, whilst ‘young’ blood restored it (Conboy et al., 
2005; Rebo et al., 2016) via increased Notch activation (Conboy et al., 2005), which I 
have already discussed as a crucial regulator of stem cell quiescence. Young blood 
has also been shown to rejuvenate the regenerative capacity of the liver (Conboy et al., 
2005; Rebo et al., 2016), the CNS (Ruckh et al., 2012; Villeda et al., 2011). Infusion of 
‘young’ blood also improved hippocampal function and increased numbers of Sox2+ 
cells and proliferating cells in the DG (Villeda et al., 2011), whilst ‘old’ blood severely 
deceased number of Sox2+Ki67+ cells in the DG (Rebo et al., 2016). Neither study 
specifically addressed the effect of old vs young blood on NSC quiescence/activation, 
therefore it would be interesting to investigate whether there is a specific effect, 
especially as quiescence of NSCs is reported to increase with age (Lugert et al., 2010; 
Yousef et al., 2015a). However, these studies highlight the vasculature to be a rich 
source of regulation for adult neurogenesis.  
 
1.4.2.5 Vasculature-derived factors: IGF, VEGF, NT-3 
A specific factor known to be carried in the blood and to have a direct effect on NSC 
activity is insulin-like growth factor1 and 2 (Figure 1.6). IGF2 is expressed in SGZ 
GFAP+ Nestin+ Sox2+ NSCs (Bracko et al., 2012), and direct infusion of IGF into the 
brains of adult rats increases progenitor proliferation and overall levels of neurogenesis 
(Aberg et al., 2000). It was not shown in this study whether the effects of IGF were 
direct on stem cell activity, however IGF2 has been shown to directly regulate NSC 
proliferation in an autocrine manner via Akt signalling (Bracko et al., 2012). A 
fascinating link is being uncovered between vascular-derived factors and 
environmental regulators of neurogenesis. For example, circulating liver-derived IGF1 
is required to mediate the exercise-induced increase in neurogenesis in mice, although 
the effects were at the level of neuronal survival, rather than NSC/IPC proliferation 
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(Trejo et al., 2008). The discrepancy over whether IGF signalling directly regulates 
NSC activity of neuronal survival may be a reflection of the source of IGF, systemic vs 
local. Studies in Drosophila have shown that NSCs respond only to local insulin from 
glia in the stem cell niche, which secrete Drosophila insulin-like peptide (DILP), as 
opposed to systemic insulin/IGF signalling (Chell and Brand, 2010). The stem cell 
niche therefore has the capacity to buffer systemic signals, in order to fine-tune 
regulation of neurogenesis. Levels of IGF1 in the hippocampus have also been 
observed to decrease sharply by middle age in rodents, and remain steady thereafter 
(Shetty et al., 2005), mirroring the decline in neurogenesis seen with age, which may 
hint to a direct functional relationship between IGF levels and neurogenesis.  
 
The same study also observed a decline in the neurotrophic factor vascular endothelial 
growth factor (VEGF) (Shetty et al., 2005). VEGF is secreted by endothelial cells and 
directly regulates NSC activity by promoting SGZ NSC self-renewal (Jin et al., 2002; 
Sun et al., 2003). Hippocampal NSCs express VEGF receptor 3, and signalling via this 
receptor both activates NSCs from quiescence, and is required for NSC activation (Han 
et al., 2015). Much like IGF, VEGF mediates environmental factors that regulate 
quiescence, including exercise (Fabel et al., 2003) and environmental enrichment (Cao 
et al., 2004).  
 
Another endothelial-derived factor, neurotrophin 3 (NT-3) is expressed by endothelial 
cells of the vasculature, and is also found in the cerebrospinal fluid, to which the SVZ is 
exposed (Silva-Vargas and Doetsch, 2014). NT-3 promotes quiescence and the long-
term maintenance of SVZ NSCs, by regulating the levels of endothelial nitric oxide 
synthase (eNOS) (Delgado et al., 2014). eNOS catalyses the production of nitric oxide 
(NO), a gaseous signalling molecule which has been shown to inhibit proliferation of 
NSCs in both the SVZ and SGZ (Estrada and Murillo-Carretero, 2005).  
 
Overall, the vascular neurogenic niche is a rich source of local and systemic signals 
regulating neural stem cell activity, both via direct cell-cell contacts and from diffusible 
factors.  
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1.4.2.6 Wnt 
Wnt signalling is prominent in the SGZ, regulating several stages of the neurogenic 
lineage, although its direct role in regulation RGL quiescence is less clear. Canonical 
Wnt signalling proceeds with the binding of diffusible Wnt ligands to the Frizzled Wnt 
receptors and co-receptors such as LRP5/6. Binding induces disassembly of the 
destruction complex, which normally functions to phosphorylate β-catenin, targeting it 
for degradation. Therefore, Wnt ligand binding results in stabilisation of β-catenin, 
which then enters the nucleus, binding TEF/LEF transcription factors, and activating 
target gene expression. Wnt3a is produced by hippocampal astrocytes (Figure 1.6), 
and cultured SGZ NSCs express Wnt receptor Frizzled1 and Dishevelled1 (Lie et al., 
2005), suggesting RGLs have the capacity to respond to Wnt, and lineage tracing 
experiments demonstrated cells in the SVZ and SGZ are responsive to Wnt/ β-catenin 
signalling (Bowman et al., 2013). In co-culture conditions, SGZ NSCs respond to 
hippocampal-astrocyte derived Wnts, and the presence of the Wnt inhibitor sFRP2/3 
inhibited their ability to differentiate into neurons (Lie et al., 2005). Secretion of Wnts 
has been observed for cultured SGZ NSCs, suggesting both autocrine and paracrine 
Wnt signalling for NSCs in vitro (Qu et al., 2010), but has not been shown in vivo. Wnt 
antagonists are also present in the niche; sFRP3 for example is highly expressed by 
DG granule neurons, and is secreted into the niche, and may mediate an indirect 
regulation of RGL quiescence by granule neurons (Jang et al., 2013a) (Figure 1.6). 
Similarly, Dkk1 is expressed by SGZ progenitor cells and neurons, and conditional 
deletion in Nestin+ cells results in increased activation and self-renewal of NSCs, in 
young and aged mice, although the effect on quiescent RGLs was not directly 
examined (Seib et al., 2013). Lentiviral mediated-expression of a Wnt inhibitor in the 
DG resulted in vastly reduced numbers of proliferating neuroblasts, although whether 
Wnt directly affected NSC proliferation was not examined (Lie et al., 2005). Dominant-
negative β-catenin interferes with proliferation of IPCs but not RGLs (Kuwabara et al., 
2009), suggesting Wnt signalling promotes progenitor proliferation, however it is still 
unclear if it can directly activate quiescent RGLs. Overall, Wnt signalling strongly 
promotes neurogenesis, but its role specifically in RGL quiescence/activation requires 
further investigation.  
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1.4.2.7 Shh 
RGLs in the dentate gyrus originate from Shh-responsive progenitors during 
development (Li et al., 2013). Correspondingly, GFAP+ RGLS in the SGZ are Shh-
responsive (Ahn and Joyner, 2005). Shh signalling proceeds via binding of the ligand 
to the receptor Patched (Ptch1) located on the primary cilium. Upon ligand binding, 
Ptch1 releases its repression of the G-protein-coupled receptor Smoothened (Smo). 
Smo subsequently activates the expression of the Gli family of transcription factors, of 
which there are activating (Gli1) and repressive forms (Gli2, Gli3). Shh has been 
repeatedly shown to be necessary for the maintenance and proliferation of SVZ NSCs 
(e.g. (Palma et al., 2005; Petrova et al., 2013) and it appears to be required in the 
same way for SGZ NSCs; loss of the primary cilium on SGZ NSCs, which is required 
for Shh signalling, results in cell cycle exit and reduced progenitor production (Breunig 
et al., 2008). Similarly, conditional deletion of an essential component for cilium 
assembly in GFAP+ RGLs led to a significant decrease in progenitor proliferation and 
subsequently impaired spatial learning, although RGL quiescence was not affected 
(Amador-Arjona et al., 2011). Treatment of cultured SGZ NSCs with Shh and 
overexpression of Shh in the DG also induced progenitor proliferation (Lai et al., 2003) 
although again the direct effect on stem cell activation was not examined. Direct 
induction of stem cell activity by Shh has been shown for SVZ NSCs; activating Shh in 
SVZ NSCs led to an increase in the stem cell pool by inducing self-renewing symmetric 
division of the stem cells (Ferent et al., 2014). 
 
1.4.2.8 FGF2  
Fibroblast growth factor 2 (FGF2) is a well-established neurogenic factor for both 
developmental and adult neurogenesis (Mudo et al., 2009; Woodbury and Ikezu, 
2014). FGF receptor 1 (FGFR1) is essential for neural progenitor proliferation and 
hippocampal formation during development (Ohkubo et al., 2004), and its mRNA is 
expressed in GFAP+BLBP+ stem cells of the postnatal DG (Choubey et al., 2017). 
GFAP+Sox2+ NSCs in the postnatal SVZ also express Fgfr1 (Choubey et al., 2017), 
indicating FGF signalling can modulate neurogenesis at the level of the stem cells in 
adult neurogenic niches. Indeed, there are several reports demonstrating the pro-
proliferative and pro-neurogenic effects of FGF2 infusion in the SVZ (Mudo et al., 
2009). There are conflicting reports regarding the effects of FGF2 on RGL activity in 
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the SGZ. Two studies show that infusion of FGF2 into the lateral ventricles and virus-
mediated overexpression of FGF2 in the DG increases progenitor cell proliferation and 
enhances neurogenesis in the DG, respectively (Rai et al., 2007; Yoshimura et al., 
2001). However, other studies show no effect on cell proliferation or neurogenesis in 
the SGZ following FGF2 treatment (Jin et al., 2003; Kuhn et al., 1997; Mudo et al., 
2007). Interestingly, proliferation of SGZ RGLs and IPCs is not affected in FGF2 
knockout mice (Werner et al., 2011). Although the use of FGF2-null mice in this study 
may introduce the confounding effects of altered hippocampal development, the results 
suggest endogenous hippocampal FGF2 is not required for basal or homeostatic levels 
of NSC proliferation, instead it may potentially mediate systemic or environmental 
neurogenic stimuli, in situations when FGF2 is increased above basal levels (Werner et 
al., 2011). Indeed, FGF2 levels are increased in the hippocampus after kainic acid-
induced seizure or ischemic brain injuries (Bugra et al., 1994; Lin et al., 1997; 
Yoshimura et al., 2001), and the concurrent increase in progenitor proliferation was 
dependent on FGF2 (Yoshimura et al., 2001; Yoshimura et al., 2003). Similarly, 
infusion of FGF2 can restore levels of neurogenesis in the DG and SVZ of aged mice 
(Jin et al., 2003; Kang and Hebert, 2015). Most of these studies report the effects of 
FGF2 signalling at the level of total proliferation or neurogenesis, and do not report the 
specific effects on NSC quiescence and activation. However, FGF2 is a potent mitogen 
and self-renewal factor for in vitro cultures of SVZ and SGZ NSCs (Gage et al., 1995; 
Gritti et al., 1996; Palmer et al., 1995), which I will explore in more detail in Section 1.6 
below.  
 
1.4.2.9 BMP  
Bone morphogenetic protein (BMP) signalling plays a prominent role in regulating 
neurogenesis, both during embryonic development, where it is required for the early 
specification of the medio-dorsal structures of the developing brain, including the 
hippocampus (Urban and Guillemot, 2014), and throughout adult neurogenesis in the 
dentate gyrus (Choe et al., 2015). BMPs are a subgroup of the transforming growth 
factor β (TGFβ) family of extracellular morphogens, which regulate the development of 
a vast number of tissues including the nervous system, and regulate a plethora of 
processes, including patterning, proliferation and differentiation (Liu and Niswander, 
2005). BMP signalling is initiated by the binding of a BMP ligand, of which more than 
20 members have been identified in vertebrates (Bragdon et al., 2011), to the BMP 
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serine-threonine kinase receptor complex. There are two subtypes of BMP receptor; 
the type I receptors comprising BMPRIA, BMPRIB and Activin receptor type 1 
(ACVR1); and BMP type II receptor, or BMPRII. In canonical BMP signalling, upon 
ligand binding the type I receptors become activated and phosphorylate the C-termini 
of their downstream mediators, the Smad1/5/8 DNA-binding proteins, enabling them to 
form a stable heterodimer with Smad4, a common mediator-Smad protein on which the 
other Smads converge. This Smad complex then binds DNA and recruits 
transcriptional co-activators or co-repressors to modulate target gene expression (Liu 
and Niswander, 2005). There is also evidence for non-canonical, Smad-independent 
TGFβ/BMP signalling, via activation of p38, Jun N-terminal kinase (JNK) mitogen-
activated protein kinase (MAPK), phosphoinositide 3-kinase(Pi3K)/Akt and extracellular 
signal-regulated kinase 1/2 (ERK1/2) pathways (Derynck and Zhang, 2003; Moustakas 
and Heldin, 2005; Mu et al., 2012). For example, Smad-independent BMP-induced 
p38/MAPK activity has been reported during differentiation of embryonic stem cells into 
myeloid progenitors (Cook and Evans, 2014); Smad4-deficient breast cancer cells 
have demonstrated TGFβ-induced JNK/MAPK activation (Engel et al., 1999), and in 
Smad4-null colon cancer cells BMP is able to signal via ERK1/2 (Beck and Carethers, 
2007). Smad4 also acts redundantly with TGFβ-induced p38/MAPK signalling to 
pattern the oral epithelium during development (Xu et al., 2008).  
 
Components of the BMP pathway are expressed in adult neurogenic niches, and have 
been shown to have a profound regulatory role in neurogenesis. In the DG, 
Nestin+GFAP+ RGLs express BMPRIA, whilst NeuN+ granule neurons express 
BMPRII (Mira et al., 2010). The source of BMP ligands in the SGZ is not completely 
know, although BMPs including BMP4 are chronically secreted by granule neurons and 
the stem cells themselves (Bonaguidi et al., 2005; Mikawa et al., 2006) (Figure 1.6), 
and BMP4 and BMP6 have been shown to co-localise with endothelial cells and 
microglia, respectively, suggesting several different niche cells can produce BMPs 
(Yousef et al., 2015b). Unlike during development where BMP ligands diffuse across 
tissue to create a morphogen gradient, such as in the neural plate and patterning of the 
spinal cord, BMP ligands in the neurogenic niche of the DG are thought to act more 
locally to the source of secretion, due to the fact the ligands strongly bind the 
extracellular matrix, impeding their diffusion (Hall and Miller, 2004). BMPs have a 
profound effect on adult neurogenesis, acting differentially at two stages of the lineage 
depending on the differential expression of BMP receptor subtype. In BMP receptor II-
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expressing granule neurons, BMP suppresses their differentiation (Bond et al., 2014; 
Mira et al., 2010), whereas it maintains quiescence of BMPR1a-expressing RGLs (Mira 
et al., 2010) (Figure 1.6). Granule neurons, progenitors and Sox2+ RGLs are 
immunoreactive for phospho-Smad1 (Mira et al., 2010), indicating BMP signalling is 
active in these cells. P-Smad1 is specifically excluded from proliferating RGLs, which is 
a direct reflection of the role of BMP in maintaining quiescence of RGLs; when BMP 
signalling in the DG was inhibiting by acute intracerebroventricular infusion of the 
inhibitor Noggin, the number of proliferating RGLs was significantly increased 
(Bonaguidi et al., 2008; Mira et al., 2010). BMP is also required to maintain the pool of 
stem cells in the DG, as demonstrated by the increase in number of newborn NeuN+ 
granule neurons and DCX+ progenitors 21 days after Noggin infusion, at the expense 
of non-radial Sox2+ stem cells (Mira et al., 2010). Conditional deletion of the canonical 
BMP mediator, Smad4, in GLAST-expressing cells similarly led to a transient increase 
in proliferating cells in the DG (although it was not reported whether this included a 
specific increase of RGL proliferation), followed by a loss of the non-radial pool of 
Sox2+ cells, although the radial stem cell pool was spared (Mira et al., 2010). BMP 
signalling is dynamically regulated in the DG by the inhibitors Noggin and Chordin 
which are also expressed in the niche (Fan et al., 2003; Scott et al., 2000). BMP 
signalling also mediates systemic regulation of neurogenesis, such as the exercise-
induced effects on neurogenesis, via an increase in Noggin expression and decrease 
in Bmp4 (Gobeske et al., 2009). Similarly, an increase in BMP signalling in the aged 
hippocampus may mediate the age-related decline in neurogenesis by inhibiting 
progenitor proliferation (Yousef et al., 2015b). BMP signalling also induces quiescence 
of cultured SGZ NSCs, creating the opportunity to investigate this elusive stem cell 
state in a highly tractable in vitro system, described in more detail in Section 1.5 
(Martynoga et al., 2013; Mira et al., 2010; Sun et al., 2011).  
 
BMP signalling also actively regulates neurogenesis in the SVZ, although its direct 
effects on the stem cells is less clear. NSCs and IPCs in the SVZ express BMPRIA and 
BMPRII, as well as BMP2/4, and these cells have the strongest immunoreactivity for p-
Smad1/5/8 (Colak et al., 2008; Lim et al., 2000). Basal levels of BMP in the SVZ 
promotes a neurogenic fate of progenitor cells (Colak et al., 2008), while elevated BMP 
inhibits neurogenesis (Gajera et al., 2010; Lim et al., 2000). The level of BMP in the 
niche can be modulated by Noggin released from ependymal cells (Lim et al., 2000). 
Injection of BMP4 into the ventricles inhibits proliferation in the SVZ, however it was not 
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shown whether this was a result of increased NSC quiescence (Lim et al., 2000). 
BMP7 and BMP4 have been shown to reach SVZ NSCs from the cerebrospinal fluid, 
where they diffuse into the intracellular space and are captured by fractones, finger-like 
basal membrane structures rich in extracellular matrix proteins such as laminins and 
collagens (Douet et al., 2012; Mercier and Douet, 2014). BMP4 and BMP7 signalling 
from fractones inhibits cell proliferation in the SVZ (Douet et al., 2012; Mercier and 
Douet, 2014). Therefore, although the specific effect on NSC quiescence has not been 
analysed, it is plausible that BMPs may promote NSC quiescence in the SVZ and 
warrants further investigation.  
 
 
Figure 1.6. Sources of neural stem cell regulation in the hippocampal neurogenic 
niche. 
SGZ neural stem cells (blue) receive regulating signals from their local niche in the dentate 
gyrus. Interneurons (red), granule neurons (yellow), progenitor cells (green) and astrocytes 
(purple) provide pro-quiescence signals, whilst the vasculature (blood vessel) and 
astrocytes provide pro-activating/proliferative cues. Modified from (Urban and Guillemot, 
2014) with permission of the rights holder, Frontiers.  
 
1.5 In vitro culture systems for studying adult NSCs 
One of the ways in which adult neural stem cells were defined as stem cells, was by 
their ability to self-renew and generate neurons in vitro (Conti et al., 2005; Reynolds 
and Weiss, 1992; Roy et al., 2000). The ability to culture adult NSCs, including 
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following genetic modification or viral transduction, has proved to be a valuable tool to 
complement in vivo studies to precisely elucidate the extrinsic factors and intrinsic 
mechanisms regulating NSCs. Following dissection and dissociation of the dentate 
gyrus or SVZ, NSCs can be cultured in two ways, either as non-adherent floating 
neurospheres (Reynolds and Weiss, 1992) or as an adherent monolayer culture, 
normally on a substrate such as laminin (Ray et al., 1993). FGF2 was identified to be a 
crucial mitogen for the propagation of NSCs in vitro (Palmer et al., 1999), inducing 
stem cell maintenance and self-renewal, as has been reported for SVZ and SGZ NSCs 
in vivo (Mudo et al., 2009; Rai et al., 2007; Yoshimura et al., 2001). Epidermal growth 
factor (EGF) has also been used to induce proliferation and maintain NSCs in culture 
to great effect (Conti et al., 2005), although in vivo it has only been reported to regulate 
subventricular zone NSCs, which expressed EGF receptor in the active state (Aguirre 
et al., 2010), but there are currently no reports of SGZ NSCs being regulated by EGF 
in vivo, which means treatment of SGZ NSCs with EGF in vitro may generate a non-
physiological state. In vitro cultures of adult neural stem cells can be treated with other 
recombinant niche proteins to modulate their activity or induce differentiation, allowing 
interrogation of the molecular regulation of these processes. Addition of BMP4 to the 
culture medium, for example, can induce a quiescent-like state of NSCs (Bonaguidi et 
al., 2008; Mira et al., 2010; Sun et al., 2011), and has been utilised to start to discover 
the intrinsic mechanisms regulating the quiescent neural stem cell state (Martynoga et 
al., 2013). These in vitro culture systems have also been used to show the interaction 
and cross-talk between different signalling pathways; FGF2 is required to maintain 
stemness and suppress astrocytic differentiation in the presence of BMP4, for example 
(Sun et al., 2011). While the in vitro system cannot fully reconstitute the in vivo niche, 
and therefore could result in NSCs responding in non-physiological ways, it still 
provides a highly tenable tool for discovering potential new mechanisms of NSC 
regulation. The number of cells that can be analysed in a single experiment vastly 
outnumber those that can be isolated directly from the adult niche, particularly as NSCs 
must be prospectively isolated by fluorescent activated cell sorting in order to generate 
a pure population, for transcriptional or epigenetic analyses. Technologies are 
improving, such that fewer or single-cells are required for analysis, however these 
experiments are labour intensive and costly, therefore a system which enables a quick, 
straightforward analysis of the effects of a factor or genetic manipulation is highly 
useful.   
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1.6 Intrinsic mechanisms regulating NSC quiescence  
As discussed in Section 1.3.2, the quiescent stem cell state requires activation of many 
different categories of genes, which means there are likely intrinsic factors that induce 
the quiescence transcriptional programme. Moreover, the multiple different niche 
signals that modulate NSC activity need intrinsic factors to mediate their effects. The 
exact network of factors that regulate the quiescence-activation balance of adult NSCs 
is not fully understood, but several factors have been identified to mediate part of the 
programme controlling this balance.  
 
1.6.1 TLX 
TLX is an orphan-nuclear receptor that contributes to patterning of the telencephalon 
during embryonic development (Monaghan et al., 1995), and is also required 
specifically in the adult brain to maintain adult NSCs in an undifferentiated, proliferative 
state (Niu et al., 2011; Shi et al., 2004; Zhang et al., 2008). Overexpression of Tlx 
promotes neurogenesis and improves hippocampal functioning (Murai et al., 2014). 
The pro-proliferative effect of TLX is in part mediated by activating Wnt/β-catenin 
signalling (Qu et al., 2010). The induction of Wnt7a by TLX in cultured NSCs could 
induce the proliferation of co-cultured NSCs (Qu et al., 2010), suggesting it can 
regulate NSC proliferation in both an autocrine and paracrine manner. Interleukin-
1beta (IL-1β), the most abundant pro-inflammatory cytokine in the brain, has been 
shown to directly inhibit TLX in hippocampal progenitors, suppressing their proliferation 
(Ryan et al., 2013), suggesting inhibition of TLX may mediate NSC quiescence.  
 
1.6.2 MicroRNAs 
MicroRNAs (miRNAs) are short (22-24 nucleotide) strands of non-coding RNAs, 
conserved from plants to humans, which negatively regulate mRNA gene transcripts by 
complementary base-pairing, inducing the cleavage or destabilisation of the mRNA 
(Fabian et al., 2010). A handful of miRNAs have been identified to regulate NSC 
activity, although most of their identified function concern promotion of neuronal 
differentiation (e.g. miR-124, miR-132 (Kawahara et al., 2012)). miR-9 is a neural-
specific miRNA, conserved in Drosophila, zebrafish and mammals, and expressed in 
both embryonic and adult NSCs in the mouse (Kapsimali et al., 2007; Kawahara et al., 
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2012). During development, miR-9 suppresses the expression of genes implicated in 
neural stem cell maintenance and quiescence, such as Tlx and REST (Coolen et al., 
2013; Packer et al., 2008; Zhao et al., 2009). In the adult zebrafish pallium, miR-9 
controls the balance between NSC quiescence and activation (Katz et al., 2016). The 
function of miR-9 in adult murine NSCs is yet to be investigated but based on its 
function in other populations of NSCs, would be an interesting miRNA to investigate 
with regards to regulation of NSC quiescence.  
 
1.6.3 Ascl1 
Ascl1 (achaete scute like 1; Mash1) is a basic helix-loop-helix (bHLH) transcription 
factor, and part of the group of proneural proteins identified in Drosophila in the 1980’s, 
which induce neural fate in mammalian embryonic progenitor cells (Guillemot, 2007; 
Guillemot and Hassan, 2017). The basic domain of bHLH transcription factors such as 
Ascl1 slots into the main groove of the DNA, and in this way mediates the binding of 
the TF to DNA, at specific hexanucleotide sequences, known as E-boxes (Bertrand et 
al., 2002). The HLH domain enables dimerization with other bHLH proteins, and Ascl1 
requires heterodimerisation with E-protein binding partners in order to be stabilised, 
bind DNA and activate target gene expression (Imayoshi and Kageyama, 2014a; 
Sharma et al., 2015). 
 
Ascl1 is expressed in the developing ventral telencephalon of mice, where it promotes 
the specification of progenitors into GABAergic neurons, as well as inducing embryonic 
progenitor cell proliferation (Bertrand et al., 2002; Castro et al., 2011; Imayoshi and 
Kageyama, 2014a). Ascl1 is also expressed in the outer radial glia of the developing 
neocortex in humans (Hansen et al., 2010), suggesting its function may be conserved 
in human embryonic neurogenesis. Ascl1 has multiple, context dependent functions 
promoting neural fate determination endogenously in embryonic progenitors, and also 
when overexpressed in astrocytes and fibroblasts Ascl1 can reprogram these cells into 
neurons (Berninger et al., 2007; Wapinski et al., 2013). Ascl1 also promotes the cell 
cycle of neural progenitors, as a result of its activation of target genes involved in cell 
proliferation, such as CyclinD1 (Castro et al., 2011; Urban et al., 2016). Despite its 
powerful neurogenic and pro-proliferative function during embryonic development, 
Ascl1 is dispensable for development of the DG (Galichet et al., 2008) and proliferation 
of progenitors in the postnatal DG (Andersen et al., 2014). This is surprising in light of 
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its recently discovered role in adult neurogenesis. Ascl1 is expressed in proliferating 
progenitors and a small proportion of active NSCs in the adult DG and SVZ (Kim et al., 
2011), and its expression is absolutely required for activation of NSCs from 
quiescence, as conditional ablation in stem cells results in complete loss of activation 
and subsequent loss of neurogenesis in both niches (Andersen et al., 2014). In the 
absence of Ascl1, kainic acid-induced seizures are unable to induce neurogenesis 
(Andersen et al., 2014), indicating neurogenic niche signals can act at the earliest 
stage of the lineage, converging on Ascl1 to activate stem cells from quiescence.  
 
The regulation of Ascl1 is still not fully understood, however it is known that Notch 
target genes Hes1 and Hes5 transcriptionally repress Ascl1 in embryonic NPCs to 
maintain an undifferentiated state (Imayoshi and Kageyama, 2014a). Interestingly, 
Ascl1 and other bHLH proteins have been demonstrated to oscillate in embryonic 
neural progenitors, and the oscillatory vs stable high vs stable low expression 
determines whether Ascl1 promotes cycling behaviour, neuronal differentiation or 
enables other fate determinants to dominate (respectively) (Imayoshi et al., 2013). 
Surprisingly, Ascl1 overexpression is also able to promote the differentiation of IPCs of 
the DG into oligodendrocytes, a cell type never normally generated by these cells 
(Jessberger and Gage, 2008), perhaps a result of its abnormally high and stable 
expression. 
 
Ascl1 is also regulated post-translationally. Cyclin-dependent kinases can 
phosphorylate Ascl1 protein at multiple sites, preventing its ability to bind DNA and 
promote neuronal differentiation in embryonic NSCs (Ali et al., 2014). Akt signalling has 
been shown to regulate Ascl1 stability in the embryonic brain (Oishi et al., 2009), 
raising the possibility that IGF/Akt signalling could mediate its pro-proliferative effects 
by stabilising the activation factor Ascl1. Notch signalling, in addition to transcriptional 
repression of Ascl1, has also been shown to rapidly induce the degradation of Ascl1 at 
the protein level in cultured cancer cells (Sriuranpong et al., 2002). Ascl1 is also 
regulated at the protein level in RGLs in the adult DG, by the HECT domain E3 
ubiquitin ligase Huwe1, which binds Ascl1 protein in active RGLs and targets it for 
proteasomal degradation (Urban et al., 2016). The reduction of Ascl1 protein levels in 
active RGLs is essential for their ability to switch off Ascl1-induced proliferation genes, 
and return to quiescence, and also to allow proliferating progenitors to progress 
towards neuronal differentiation (Urban et al., 2016). Protein-level regulation of Ascl1 in 
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RGLs is therefore crucial for maintaining the stem cell pool and allowing the proper 
progression of neurogenesis.   
 
1.6.4 FoxO3 
Most of the transcription factors involved in NSC activity promote the expression of 
genes involved in activation such as cell cycle genes, and quiescence is achieved by 
the inhibition of these factors. As previously discussed, IGF/Akt signalling can induce 
proliferation of NSCs in adult neurogenic niches. Part of the mechanism for this may be 
due to inactivation of the forkhead transcription factor FoxO3. FoxO3 has been 
identified as a ‘quiescence factor’ expressed in Sox2+ cells and required to maintain 
self-renewal of SGZ and SVZ neural stem cells, as FoxO3 ablation results in loss of the 
stem cell pool (Renault et al., 2009; Paik et al., 2009). IGF/Akt signalling 
phosphorylates FoxO3, causing it to be excluded from the nucleus, resulting in loss of 
FoxO3 activity (Tzivion et al., 2011) and therefore loss of NSC quiescence. 
Interestingly, the gene targets of FoxO3 have been shown to include genes involved in 
glucose metabolism and metabolic enzymes (Yeo et al., 2013). Metabolic changes can 
directly activate NSCs in adult neurogenic niches (Beckervordersandforth, 2017), 
raising the possibility that FoxO3 may induce quiescence via regulating NSC 
metabolism. Another potential mechanism of FoxO3-mediated quiescence is by 
competition with Ascl1 for DNA binding of target genes. ChIP-seq analysis has shown 
that FoxO3 shares many transcriptional targets with Ascl1 (Webb et al., 2013), 
suggesting when FoxO3 is in the nucleus, it acts as a repressor of Ascl1 target genes 
by physically blocking Ascl1 binding.  
 
1.6.5 Pten 
Upstream of Akt signalling, phosphatase and tensin homologue (Pten) is required to 
maintain quiescence of RGLs (Bonaguidi et al., 2011). Pten is a tumour suppressor, 
and has been shown to be crucial for quiescence and long-term maintenance of the 
stem cell pool, by supressing self-renewing symmetric divisions and by gating G0-to-
G1 cell cycle entry in neural stem cells as well as other adult stem cells such as 
satellite cells (Bonaguidi et al., 2011; Groszer et al., 2006; Yue et al., 2017). Deletion of 
Pten in RGLs of the adult DG leads to activation from quiescence and an increase in 
symmetric self-renewal, however the subsequent differentiation of RGLs leads to 
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depletion of the pool over time (Bonaguidi et al., 2011). This is in contrast to Pten 
deletion in SVZ NSCs, where an expansion of the stem cell pool is not negated by 
increased differentiation, leading to a net increase in neurogenesis over time 
(Gregorian et al., 2009). Mechanistically, Pten dephosphorylates Akt, thereby inhibiting 
its activity including repression of FoxO3 (Song et al., 2012b). 
 
1.6.6 Cell cycle proteins; p21, p27, p57 
The entry into and exit from quiescence is dynamically regulated in concert with the cell 
cycle. Quiescent NSCs in Drosophila have different activation dynamics depending on 
the stage of the cell cycle in which they are arrested - G2 or G0 - and the entry into G2 
quiescence involves the degradation of Cdc25 (Otsuki and Brand, 2018). Therefore, 
the regulation of cell cycle genes is likely to be intimately associated with the regulation 
of NSC quiescence and activation. The cyclin-dependent kinase inhibitors p27 and p57 
are expressed in quiescent (Ki67 negative) Sox2-expressing and Nestin+GFAP+ RGLs 
in the adult DG, and p21 is expressed in NSCs in the adult SVZ, where they are 
reported to be required for long-term NSC maintenance and to maintain NSC 
quiescence by inhibiting the cell cycle (Andreu et al., 2015; Furutachi et al., 2013; 
Kippin et al., 2005; Marques-Torrejon et al., 2013; Porlan et al., 2013). Loss of p57 or 
p27 in RGLs of adult mice leads to a loss of RGL quiescence and subsequent increase 
in neurogenesis (Andreu et al., 2015; Furutachi et al., 2013), and p57 is reduced in the 
nuclei of RGLs in exercising mice, indicating it can be regulated by environmental 
neurogenic stimuli (Furutachi et al., 2013).   
1.6.7 REST 
Another factor identified to directly repress activation genes is the transcriptional 
repressor REST (repressor element 1-silencing transcription). REST functions in 
embryonic NSCs to repress the expression of neuronal genes (Ballas et al., 2005), and 
is expressed in quiescent and active NSCs of the adult DG where it is required to 
maintain NSCs in a quiescent and undifferentiated state (Gao et al., 2011; Mukherjee 
et al., 2016), partly via repression of Ascl1 expression (Gao et al., 2011).  
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1.6.8 NFIX 
Another transcription factor that can directly induce a quiescent neural stem cell state 
is NFIX. NFIX is highly expressed in quiescent adult hippocampal NSCs both in vitro 
and in vivo, and is bound to many active enhancers in BMP4-induced quiescent NSCs 
in vitro (Martynoga et al., 2013). Suppression of NFIX in the BMP4-induced quiescent 
culture model shows more than a third of the genes induced by BMP4 are also 
regulated by NFIX (Martynoga et al., 2013), regulating the expression of genes central 
to the quiescent cell state, including genes involved in cell junctions, cell adhesion and 
carbohydrate metabolism. Moreover, NFIX-null mice develop defects in RGL 
positioning and morphology in the SGZ, in addition to an increase in proliferation of 
NSCs (Martynoga et al., 2013), suggesting that cell adhesion and cell-contacts are 
important regulators of NSC quiescence.  
 
1.6.9 Id proteins 
The inhibitor of differentiation (Id) family of proteins play an important role in embryonic 
neurogenesis, by inhibiting the action of proneural bHLH transcription factors (Jung et 
al., 2010), and they are beginning to be identified as potential regulators of neural stem 
cell maintenance in adult neurogenic niches. I will therefore next describe what is 
currently known the expression, regulation and function of the Id proteins, particularly 
with their role in neurogenesis.  
 
1.7 The Inhibitor of Differentiation proteins  
1.7.1 Structure and conservation of Id proteins 
Id proteins are evolutionarily conserved molecules, found in Drosophila to humans. 
There are four identified Id proteins in mammals, Id1-4, whilst Drosophila have just 
one, Extra macrochaetae (Emc). The defining feature of Id proteins is the HLH domain, 
which has extensive sequence homology between the four mammalian Ids, as well as 
the lack of DNA-binding domain, differentiating Ids from the bHLH transcription factors 
(Ling et al., 2014). The HLH domain mediates dimerization of the Ids with bHLH 
proteins. Due to the lack of DNA-binding domain in Id proteins, dimerization of Ids with 
bHLHs results in dominant-negative inhibition of bHLH function. Interestingly, there is 
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limited homology between the four Ids outside of the HLH domain, with 7-24% amino 
acid differences, which may reflect the surprising lack of redundancy between the 
factors (Patel et al., 2015) (Figure 1.7). Id4 is the longest protein out of the Id family, 
although only the first 2 out of 3 exons are protein coding; the 3rd exon is a 
3’untranlsated region. Id4 is in fact the most divergent of the family, with many amino 
acid variations in the N- and C-terminal domains, suggesting it is in fact a remote 
homologue of Id1-3, and may have unique functions (Patel et al., 2015).  
 
 
Figure 1.7. Conservation of Id1-4 protein sequence.  
A. Protein sequence alignments for the four mammalian Id proteins. High level of 
conservation can be seen for the helix-loop-helix domains between the four Id proteins, 
whilst the alanine-rich N-terminal and proline-rich C-terminal domains are more divergent, 
particularly for Id4. Conserved residues are highlighted in black and grey. B. The 
divergence of Id4 in terms of full protein sequence can be seen by phylogenetic analysis. 
Id1 and Id3 are more closely related in terms of structural homology, while Id2 and Id4 are 
more diverged. C. Protein sequence alignment for only the HLH domain of Id1-4. D. The 
phylogenetic relationship based on just the HLH domain shows now that Id1 and Id2 are 
more closely related, whilst Id3 and Id4 are more diverged. Overall Id4 is the most diverged 
Id protein based on protein sequence. Reproduced from (Sharma et al., 2015) with 
permission of the rights holder, Elsevier. 
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1.7.2 Expression of Id proteins in embryonic and adult CNS 
The Id genes and proteins have complex expression patterns and dynamics during 
embryonic development and in the adult mouse (Jen et al., 1997). Id knockout mice 
have provided some insight into the wide-reaching functions of Ids during development, 
with roles including (but not limited to) angiogenesis, heart development, mammary 
gland development, and haematopoiesis (Yuan et al., 2015). Id2 mRNA is mostly 
ubiquitously expressed during development, which reflects the fact Id2 knockout mice 
have the most severe phenotype of all the Id KO mice (Yokota et al., 1999). During 
embryonic neurogenesis, Id1 and Id3 are expressed in dividing neuroblasts and have 
nearly overlapping expression patterns (Jen et al., 1997). This may confer redundancy, 
as the Id1 or Id3 single null mutants show no neural phenotype, whereas Id1/Id3 
double knockout mice have smaller brains than littermates, likely as a result of 
premature neuronal differentiation, as well as altered glucose and lipid metabolism, 
and ultimately embryonic lethality (Lyden et al., 1999). Id4 mRNA has a significantly 
different expression pattern than the other Ids during embryonic development, primarily 
expressed in the central nervous system, and complementary to the other Id genes 
(Jen et al., 1997). Id4 null mice present with growth retardation and premature 
neuronal differentiation, which results in the adult brain being severely reduced in size, 
with fewer neurons and glia (Ruzinova and Benezra, 2003). Id4 expression is also 
observed in several adult human tissues including the brain, thyroid, testis and 
pancreas (Rigolet et al., 1998) and plays a central role in mammary gland development 
and ovary function in mice (Best et al., 2014; Dong et al., 2011). The divergent 
expression patterns of the four Ids during development may explain the lack of 
redundancy and different phenotypes in the single embryonic null mice (Yuan et al., 
2015).   
 
In the adult CNS, GFAP+ NSCs in the SVZ have been shown to highly express Id1, 
with expression decreasing in differentiating neuroblasts (Nam and Benezra, 2009). Id1 
expression was found to be higher in TAPs, but lower in non-dividing quiescent NSCs, 
suggesting Id1 promotes a self-renewing stem cell identify in NSCs in the adult (Nam 
and Benezra, 2009). Id1 was also found to be expressed in RGLs in the DG, but it was 
not shown whether Id1 was higher in active or quiescent RGLs, and its function in 
RGLs was not explored (Nam and Benezra, 2009). Id3 expression is detected in a 
small population of proliferating cells in the DG, and highly expressed in neurospheres 
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derived from the hippocampus (Bonaguidi et al., 2008), however it was not directly 
assessed whether Id3 is expressed specifically in NSCs, nor was its function explored. 
In the SVZ, Id3 is expressed in almost all NSCs and proliferating progenitor cells 
(Bohrer et al., 2015). Id4 expression has not yet been reported in the adult neurogenic 
niches, however in single-cell RNAseq analysis of the transcriptional signature of 
quiescent-to-active NSCs in the DG, Id4 was shown to be the top most enriched gene 
in quiescent RGLs (Shin et al., 2015).  
 
1.7.3 Regulation of Id expression  
The expression of Id1-4 is induced by BMP/Smad signalling in a variety of cell types 
(Lasorella et al., 2014; Ling et al., 2014). Id4 for example is a direct downstream target 
of BMP4 in neural progenitor cells (Samanta and Kessler, 2004). Id expression can 
also be induced by receptor tyrosine kinase signalling, including EGF and FGF2 
(Lasorella et al., 2014). Notch signalling in murine embryonic stem cells has also been 
shown to induce the expression of the Id proteins (Meier-Stiegen et al., 2010). Id 
proteins are also highly regulated at the protein levels, and have a short half-life, with 
Id1-3 degraded by the ubiquitin-proteasome pathway (Bounpheng et al., 1999; 
Lasorella et al., 2014). Id4 can also be degraded via the ubiquitin-proteasome pathway, 
however it is less sensitive to this form of degradation, and it is not known which 
protein mediates its degradation (Bounpheng et al., 1999; Lasorella et al., 2014). 
Interestingly, Id1-3 have been shown to be inhibited by Id4 itself by heterodimerisation 
(Sharma et al., 2015), and Id4 may in fact promote E47 activity when the ratio of Id 
proteins favours Id4 (Sharma et al., 2015). The expression of Id genes and stability of 
the proteins is also affected in the context of cancer by a variety of mechanisms 
(Lasorella et al., 2014), highlighting the complexity of regulation of the Id genes. 
 
1.7.4 Function of Id proteins  
1.7.4.1 Inhibition of Class II bHLH factors and E-proteins by Id proteins 
E-proteins were first identified as dimeric transcription factors that regulate the IgG 
enhancer in B cells, and found to bind to Ephrussi-box sequences of DNA (CANNTG), 
and hence termed E-proteins. Drosophila harbour a single E-protein, Daughterless 
(Da), whilst mammalian E-proteins consists of E12 and E47, generated by alternative 
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splicing of the E2A gene (also known as TCF3), E2-2 (TCF4), and HEB (TCF12). E-
proteins are expressed in many different cell types and have a wide range of functions. 
E12 or E47 homodimers for example can inhibit proliferation by inducing the 
expression of CDKIs such as p15, p16, p21, p27 and p57. However, they are well 
known as functional heterodimer partners of the class II bHLH transcription factors, 
which includes MyoD in muscle stem cells, TAL1 in HSCs, and Ascl1in NSCs. It is 
thought that E-proteins stabilise bHLH monomers, and facilitate DNA-binding specificity 
of bHLHs, mediating their diverse tissue- and timing-specific activities. The Id proteins 
also function independently of E-proteins or bHLH inhibition. Id2 directly interacts with 
retinoblastoma (Rb) protein during development, inactivating Rb and subsequently 
enabling cell-cycle progression (Lasorella et al., 2000). 
 
Despite the ability of Id proteins to inhibit class II bHLH TFs via direct binding of the 
HLH domain, it is thought that they predominantly bind E-proteins, thereby out-
competing class II bHLHs for their heterodimerisation partner and rendering them 
unable to bind their DNA targets (Duncan et al., 1992) (Figure 1.8). It is certainly true 
that Id1 has a higher binding affinity for E-proteins than bHLH transcription factors 
(Ruzinova and Benezra, 2003). 
 
 
Figure 1.8. Protein-protein interactions between IDs, Class II bHLHs and E-
proteins 
Left panel: In the absence of Id proteins, Class II bHLH proteins (green) and E-proteins 
(blue) heterodimerise via their HLH domains, mediating binding of bHLH factors to their 
target DNA via their DNA binding domains (orange) and activating gene expression. Right 
panel: When Id proteins (red) are expressed at a sufficient level, they sequester the E-
proteins, leaving bHLH factors undimerised and unable to bind their target DNA, and 
targeted for ubiquitin-proteasomal mediated degradation (red asterisk).  
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1.7.4.2 The role of Id proteins in stem cell maintenance 
The classical role of Id proteins is, as their name suggests, inhibiting the differentiation 
of stem cells. Ids also often promote stem cell proliferation, therefore are considered 
important factors for stem cell maintenance (Ling et al., 2014). As described above, Id 
proteins block E-protein function (Peverali et al., 1994), which in turn inhibits E-protein 
mediated differentiation (Ling et al., 2014). Id-mediated inhibition of E-proteins will also 
indirectly block the E-protein induction of CDKIs, thereby promoting cell cycle 
progression (Yuan et al., 2015). The Id proteins have been reported to regulate stem 
cell self-renewal in a number of different ways. Id1, Id2 and Id4 promote self-renewing 
proliferation of cortical NSCs, and inhibit their neuronal differentiation, via interfering 
with binding of NeuroD/E47 complexes to their DNA targets (Jung et al., 2010). Id1 and 
Id2 are also required for NSC self-renewal in the embryonic telencephalon, by 
repressing the expression of cell adhesion regulator Rap1GAP, thereby preventing the 
delamination and migration of progenitors from the ventricular surface (Niola et al., 
2012). Id1, Id2 and Id3 expression at low levels maintain stemness of NSCs by 
sustaining expression of Hes1, by blocking Hes1 auto-repression (Bai et al., 2007). 
Moreover, Id2 and Id4 contribute to maintenance of the undifferentiated state of NSCs 
by suppressing oligodendrocyte commitment via inhibition of the bHLHs Olig1 and 
Olig2 (Samanta and Kessler, 2004). These studies demonstrate the variety of ways in 
which Id proteins can regulate stem cell maintenance.  
 
Due to their regulation of stem cell maintenance and proliferation, Id proteins also play 
major roles in oncogenic pathways, and are overexpressed in many cancer cell types, 
including glioblastoma (Lasorella et al., 2014; Ling et al., 2014). Id1 for example, is 
required for glioma stem cell maintenance via to adherence to their vascular niche, by 
blocking E-protein induction of the rap1gap gene (Niola et al., 2013). Expression of all 
four Ids have been shown to be individually increased in separate studies of brain 
cancer tissue analyses (Lasorella et al., 2014), which highlights their powerful function 
in neural stem cell maintenance. Interestingly, Id3 and Id4 act as tumour suppressors 
in some circumstances (Wang and Baker, 2015). Id4 for example is epigenetically 
silenced in a wide variety of cancers (Patel et al., 2015), including glioblastoma (Martini 
et al., 2013). The expression of Id proteins in adult gliomas suggests they could be 
expressed in and have functional importance in regulating adult NSCs. 
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The function of the Id proteins has not been extensively explored in the adult 
neurogenic niches. As mentioned above, Id1 expression is specifically high in SVZ 
NSCs (Nam and Benezra, 2009), and ablation of Id1 and Id3 (but not Id1 alone) 
reduces the self-renewal capacity of the NSCs (Nam and Benezra, 2009). Id1 is also 
reported to be expressed by GFAP+ RGLs in the SGZ, although its function in SGZ 
NSCs has not yet been explored (Nam and Benezra, 2009). Id1 has, however, been 
demonstrated to be expressed mostly in quiescent NSCs of the adult zebrafish pallium, 
where it is sufficient and necessary to promote NSC quiescence (Rodriguez Viales et 
al., 2015). As in the embryonic brain, Id1 and Id2 have been demonstrated to repress 
the expression of Rap1Gap in NSCs of the postnatal SVZ, thereby promoting adhesion 
of the stem cells to their niche (Niola et al., 2012), a property that is vital for maintaining 
NSC quiescence (Ottone et al., 2014). Id3 is expressed in SVZ NSCs and progenitors 
downstream of BMP2 signalling, where it represses E47 to promote astrocytic 
differentiation of SVZ NSCs following injury but is indispensable for normal NSC and 
progenitor cell functioning (Bohrer et al., 2015).  
 
Ascl1 is an essential transcription factor for activation of adult neural stem cells from 
quiescence and proliferation of progenitors (described in Section 1.7.3) and as a Class 
II bHLH transcription factor, is a prime target for negative regulation by Id proteins 
(Figure 1.8). Such negative regulation has been demonstrated to occur in embryonic 
neural progenitor cells (Shou et al., 1999) and in an in vitro culture system of 
neuroendocrine lung cancer cells, in which BMP2 induces the expression of Id1, which 
in turn outcompetes Ascl1 for its E-protein binding partner E47 (Vinals et al., 2004). 
Interestingly, this mechanism inhibits Ascl1 function not only by inhibiting its DNA 
binding, but also by destabilising Ascl1 and promoting its degradation (Vinals et al., 
2004). The authors demonstrate that it is the balance of Id-to-E proteins that regulates 
Ascl1 activity and stability. Considering the central role for Ascl1 in adult NSC activity, 
and the emerging expression of Id proteins in neurogenic niches, it would be highly 
interesting to investigate whether this relationship exists in adult neural stem cells. This 
is particularly fascinating in light of a recent study using mathematical modelling, which 
suggests Id proteins can potentiate the transcriptional repression of Ascl1 in quiescent 
NSCs by blocking the auto-repression of Hes gene expression (Boareto et al., 2017), 
much like that which was observed in embryonic NSCs between Id1-3 and Hes1 (Bai 
et al., 2007).  
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1.8 Aims of the present work 
Stem cells in adult tissues, including neural stem cells of adult neurogenic niches, must 
balance long-term production of progenitors while minimising the accumulation of 
genetic and metabolic damage, in order to maintain the stem cell pool. Excessive stem 
cell activation would result in premature exhaustion of the stem cell pool, whilst too little 
activation would result in a deficit of new-born cells for the tissue, impairing tissue 
homeostasis. Dynamic and stringent regulation of the switch between stem cell 
quiescence and activation is essential for the stem cell pool to appropriately respond to 
the demands of the tissue.   
 
The discovery of neural stem cells in dedicated niches in the adult mammalian brain 
has revealed the prospect that the brain may have endogenous regenerative 
capabilities. This has exciting clinical potential, for example tapping into the pool of 
quiescent neural stem cells to regenerate hippocampal neurogenesis in 
neurodegenerative conditions, or understanding the niche signals required to sustain 
and differentiate transplanted stem cells. Similarly, delineating the environmental and 
systemic stimuli that regulate NSC activity, and how these change with age to increase 
NSC quiescence, could enable possibly simple treatments for mitigating age-related 
cognitive decline. A thorough understanding of the molecular regulation of NSC 
quiescence also has implications for the prognosis and treatment of brain cancer, due 
to the existence of cancer stem cells in gliomas, with similar molecular mechanisms 
regulating quiescence and proliferation to endogenous neural stem cells.  
 
Several different extrinsic signals and intrinsic factors have been identified to regulate 
adult neural stem cell activity, however the precise regulation of NSC quiescence is not 
fully understood. Previous work from the Guillemot laboratory has identified the bHLH 
transcription factor Ascl1 as a crucial activation factor for NSCs in the SGZ (Andersen 
et al., 2014), and regulation of Ascl1 at the protein level is required to allow NSCs to 
return to quiescence (Urban et al., 2016). However, the molecular mechanism 
maintaining NSC quiescence is unclear. Therefore, the aim of my PhD research is to 
elucidate the molecular mechanisms regulating adult hippocampal neural stem cell 
(AHNSC) quiescence. Specifically, I aim to investigate AHNSC quiescence in the 
following ways: 
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1. Identify novel ‘quiescence factors’ involved in regulating adult hippocampal 
neural stem cell quiescence downstream of BMP4. 
2. Investigate the mechanism by which these ‘quiescence factors’ regulate neural 
stem cell quiescence, particularly with regards to the regulation of Ascl1. 
3. Determine which hippocampal niche signals regulate the newly-identified 
quiescence factors. 
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Chapter 2. Materials & Methods 
2.1 Experimental model and subject details 
2.1.1 Mouse models 
All procedures involving animals and their care were performed in accordance with the 
guidelines of the Francis Crick Institute, national guidelines and laws. This study was 
approved by the Animal Ethics Committee and by the UK Home Office (PPL 
PB04755CC). Mice were housed in standard cages under a 12h light/dark cycle, with ad 
libitum access to food and water.  
All experimental mice were of a mixed genetic background. Founder mice were bred to 
MF1 mice, and then backcrossed to littermates of the F1 generation. In order to generate 
mice with a hippocampal stem cell-specific, tamoxifen-inducible recombination, plus a 
YFP reporter of recombination, GLAST-CreERT2 (Slc1a3tm1(cre/ERT2)Mgoe ) (Mori et al., 
2006) mice were crossed with Rosa26-floxed-stop-YFP (RYFP; 
Gt(ROSA)26Sortm1(EYFP)Cos) (Srinivas et al., 2001) mice. These mice were then crossed 
with our experimental strains:  
 
Smad4flx (Smad4tm1Rob) mice, originally reported by (Chu et al., 2004).  
RBPJkflx (Rbpjtm1Hon) mice, originally reported by (Han et al., 2002). 
Ascl1Venus (Ascl1tg1(venus)Rik) mice, originally reported by (Imayoshi et al., 2013).   
Ascl1KiGFP (Ascl1tm1Reed) mice, originally reported by (Leung et al., 2007). 
Id4flx mice, originally reported by (Best et al., 2014).  
Glast-CreERT2 mice were crossed with Gt(ROSA)26Sortm9(CAG-tdTomato)Hze (tdTomato), 
originally reported by (Madisen et al., 2010). 
 
Glast-CreERT2;Smad4flx;RYFP mice were crossed with Glast-CreERT2;RBPJk;RYFP 
mice in order to generate the quadruple transgenic Glast-
CreERT2;Smad4flx;RBPJkflx;RYFP line.  
 
Both male and female mice were used for all in vivo genetic studies. Experimental groups 
were a mix of animals from different litters for each particular strain. All mice were 
injected with tamoxifen at postnatal day 60 +/- 2, and brain tissue collected by 
transcardial perfusion at 2, 5, 10 or 30 days after the first injection.  
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2.1.2 Primary Cell Cultures 
For the derivation of adult hippocampal stem cell lines, 7-8-week-old mice were 
sacrificed and the dentate gyrus dissected (previously described by Walker et al., 2013). 
Cultures were amplified as neurospheres for two passages before dissociation to 
adherent cultures. Cells were propagated in basal media (DMEM/F-12 + Glutamax 
(Invitrogen 31331-093) + 1x Neurocult Supplement (Stem Cell Technologies, 05701) + 
1x Penicillin-Streptomycin (ThermoFischer Scientific, 15140)+ 2µg/mL Laminin (Sigma, 
L2020) + 20ng/mL FGF2 (Peprotech, 450-33) + 20ng/mL EGF (Peprotech, 315-09) + 
5µg/mL Heparin (Sigma, H3393-50KU). Cells were incubated at 37°C, 5% CO2.  
 
The control adult hippocampal neural stem cell line (AHNSC line #5) was derived from a 
single male WT/RYFP mouse. AHNSC Ascl1Venus cell line was derived from a single 
male Ascl1wt/Venus mouse. Huwe1 is X-linked, therefore AHNSC Huwe1flx cell line was 
derived from a male Glast-CreERT2wt/wt; Huwefl/Y;RosaYFP/YFP mouse. 
 
2.2 Method Details 
2.2.1 Tamoxifen administration 
To induce activation of CreERT2 recombinase, 2mg (57-67mg/Kg) of 4-
hydroxytamoxifen (Sigma, H6278) was administered intraperitoneally (ip) to mice at 
postnatal day 60 (P60), at the same time each day for 5 consecutive days. For in situ 
hybridization experiments, Glast-CreERT2;tdTomato (Ai19) mice received a single 
injection at postnatal day 60 +/- 2, and brain tissue collected by transcardial perfusion 
48h later. 
 
2.2.2 Tissue preparation and immunofluorescence 
Mice were transcardially perfused with phosphate-buffered saline (PBS) for 3mins, 
followed by 4% paraformaldehyde (PFA) in PBS for 12mins. Brains were post-fixed for 
2hours in 4% PFA at 4°C and washed with PBS. Brains were coronally sectioned at a 
thickness of 40µm using a vibratome (Leica). 
Chapter 2 Materials and Methods 
 
69 
 
For in situ samples, mice were perfused with PBS for 3mins, followed by perfusion with 
10% neutral buffered formalin (NBF) for 12mins. Brains were post-fixed in 10% NBF at 
room temperature for 16-32h, and then washed with and stored in 70% EtOH. Brains 
were paraffin embedded, and coronally sectioned at a thickness of 5µm.  
Cultured cells were fixed with 4%PFA in PBS for 10mins at room temperature, and 
washed with PBS.  
For immunofluorescence of tissue, samples were blocked with 10% normal donkey 
serum (NDS) in 1%Triton-PBS for 2hrs at room temperature with rocking. Fixed cells 
were blocked with 10%NDS in 0.1%Triton-PBS for 1hr at room temperature. Primary 
antibodies were diluted in 10%NDS in 0.1%Triton-PBS, and incubated with samples 
overnight at 4°C with rocking. The following day, samples were washed 3x 0.1%Triton-
PBS, and then incubated with secondary antibodies diluted in 10%NDS in 0.1%Triton-
PBS for 2hrs at room temperature with rocking. Following 3x 0.1%Triton-PBS washes, 
samples were incubated with DAPI 1:10,000 in 1:1 PBS:H2O for 30mins at room 
temperature with rocking. Primary and secondary antibodies are listed Table 2.1  
 
EdU was detected following secondary antibody incubation and 3x 0.1%Triton-PBS 
washes, using Click-iT™ EdU Alexa Fluor 647 Imaging Kit (Invitrogen, C10340), 
following manufacturer’s instructions.  
 
O-propargyl-puromycin (OPP), was detected following secondary antibody incubation 
and 3x 0.1%Triton-PBS washes, using Click-iT™ Plus OPP Alexa Fluor 647 Protein 
Synthesis Assay Kit (Invitrogen, C10458), following manufacturer’s instructions. 
For MitoTracker™ detection, the MitoTracker™ reagent fluoresces in the far-red 
spectrum without the need for detection, therefore samples were processed as normal 
without using far-red secondary antibodies.    
 
For RNA staining with Pyronin Y (PY), following all antibody incubations and DAPI 
staining, cells were washed 1x in 50% PBS-H2O. 10mM PY stock was diluted 1:10,000 
in 50% PBS-H2O and incubated on coverslips for 10mins at room temperature, followed 
by 2x 50%PBS-H2O washes.  
 
To immunostain for BrdU-labelled NSCs, the following steps were taken to prevent false 
detection of EdU by the anti-BrdU antibody (as described in (Liboska et al., 2012)). 
Following detection of EdU labelling with the Click-iT™ detection kit described above, 
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coverslips were washed 3x with PBS, followed by incubated with a non-fluorescent azide 
molecule (azidomethylphenylsulfide) diluted to the same concentration as the azide dye 
used for EdU detection, in the same buffer mix from the EdU Click-iT™ detection kit, for 
30mins at room temperature. This should block any EdU that was not previously stained 
with the fluorescent azide. Coverslips were then incubated in 10mM sodium ascorbate 
plus 4mM copper(ii)sulphate for 10mins at room temperature. This treatment should 
cause oxidative damage to the DNA, generating gaps in which the Anti-BrdU antibody 
can bind its antigen. Next the coverslips were incubated with 20mM EDTA for 30mins at 
room temperature, then washed 3x with PBS. Finally, coverslips were incubated with 
Anti-BrdU antibody diluted in PBS without Triton, in the presence of Exonuclease iii, 
which further elongates the gaps in the DNA enabling the antibody to permeate the DNA 
to better detect BrdU.   
 
To mount the immunostained samples, brain sections were arranged onto a slide in 50% 
PBS-H2O, the PBS-H2O carefully aspirated. Aqua Polymount (Polysciences, 18606) was 
applied to the edge of the samples and a glass coverslip carefully placed over the top in 
a manner to cover the samples with Aqua Polymount medium, and left in the dark to dry 
overnight at room temperature. For mounting fixed cells, a ‘dot’ of Aqua Polymount was 
applied to a glass slide and the coverslip carefully placed on top, cell-side down, and left 
in the dark to dry overnight at room temperature.  
 
2.2.3 RNA in situ hybridization  
For RNA in situ hybridization, the RNAscopeâ Multiplex Fluorescent Reagent Kit V2 
(ACD Bio-Techne, 323110) was used with NBF fixed-paraffin embedded 5µm sections, 
and stained according to the standard company protocol. Target retrieval was 
performed for 15mins, and Protease Plus treatment was carried out for 30mins. For 
dual RNAscopeâ-immunofluorescence, following the development of HRP-C3 signal 
and wash steps, slides were washed in distilled H2O, and washed 3x 5mins in 
0.1%Triton-PBS at room temperature. Slides were then processed for 
immunofluorescence as described above (without “rocking”; reagents were incubated 
in situ on the slides). Probes and fluorophores and their dilutions are listed Table 2.1. 
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2.2.4 Microscopic analysis 
All images were acquired using an SP5 confocal microscope (Leica). For cell culture 
immunofluorescence, 3 random regions of each coverslip were imaged with a z-step of 
1µm. For adult tissue immunofluorescence, both left and right dentate gyri of every 
twelfth 40µm section along the rostrocaudal length of the DG were imaged, with a z-step 
of 1µm through the whole 40µm section. For quantification of %+ RGLs, at least 200 
RGLs in each of at least 3 mice for each genotype were quantified. 
 
RGLs were identified based on their characteristic morphology (nucleus in the 
subgranular zone, radial process projecting through the molecular layer) and positive 
labelling with GFAP and GFP in the case of Glast-CreERT2;RYFP recombined cells, or 
tdTomato positivity in the case of Glast-CreERT2;tdTomato recombined cells. 
 
2.2.5 Cell treatments  
For culturing adult hippocampal NSCs in proliferation conditions, cells were grown in 
basal media (DMEM/F-12 + Glutamax (Invitrogen, 31331-093)) + 1x N2 supplement 
(R&D Systems, AR009) + 1x Penicillin-Streptomycin (ThermoFischer Scientific, 15140) 
+ 2µg/mL Laminin (Sigma, L2020) + 5µg/mL Heparin + 20 ng/mL, and supplemented 
with either 20ng/mL EGF (Peprotech, 315-09) plus 20ng/mL FGF2 (Peprotech, 450-33), 
or 20ng/mL FGF2 alone. NSCs were propagated in supplemented basal media in 
laminin-coated flasks until 80% confluent, at which point they were passaged or frozen 
down. For freezing, NSCs were detached from their flask using Accutase (Sigma, A6964), 
centrifuged and the pellet resuspended in 10% DMSO in fully supplemented basal media, 
and chilled slowly to -80°C before being transferred to liquid nitrogen for long-term 
storage. 
 
In order to transition cells from basal media containing both 20ng/mL EGF and 20ng/mL 
FGF2, to 20ng/mL FGF2 alone, cells were grown in T75 flasks until 80% confluent in the 
presence of both EGF and FGF2, at which point the media was aspirated and replaced 
by fresh supplemented media containing only 20ng/mL FGF2. Cells were incubated at 
37°C, 5% CO2, for 2-3 days before passaging. Cells were passaged in the presence of 
FGF2-alone for at least two passages before being used for experiments, in order to 
allow the cells to adjust to the conditions and to select for the self-renewing stem cells.    
Chapter 2 Materials and Methods 
 
72 
 
 
To induce quiescence, cells were plated onto laminin-coated P6 well plates (200,000 
cells/well) or onto laminin-coated coverslips (40,000 cells/well) in the presence of 
20ng/mL EGF+FGF2 or 20ng/mL FGF2 alone and incubated overnight to allow cells to 
adhere. Media was replaced the next day with basal media plus 20ng/mL recombinant 
mouse BMP4 (R&D Systems, 5020-BP), and cultured for 72h at 37°C, 5% CO2. For 
culturing NSCs long term in a quiescent state, 1x106 cells were seeded into a laminin-
coated T75 flask in the presence of 20ng/mL FGF2. 24hrs later the media was refreshed 
containing 20ng/mL FGF2 + 20ng/mL BMP4. The media was refreshed every 3 days to 
ensure continuous BMP4 signalling, and the cells were passaged 1:3 into a new T75 
flask when necessary (around once per week) to avoid the cells becoming too dense.   
 
To titrate the concentration of FGF2 in NSCs, cells were plated as described for inducing 
quiescence. Following overnight incubation to allow of adherence of cells to the culture 
dish/coverslip, the media was replaced with fresh basal media supplemented with either 
20ng/mL, 10ng/mL, 5ng/mL or 2.5ng/mL FGF2, and cultured for 72h before lysing cells 
for RNA extraction (from P6 wells) or fixing cells on coverslips with 4% PFA for 
immunocytochemistry.  
 
To titrate the concentration of BMP4 in NSCs, cells were plated as described for FGF2 
titration, and then cultured in the presence of 20ng/mL FGF2 plus either 20ng/mL, 
10ng/mL, 5ng/mL or 1ng/mL BMP4, for 72h. After this time cells were lysed from P6 
wells for RNA extraction, and cells on coverslips fixed with 4% PFA for 
immunocytochemistry. 
 
To test that BMP4-induced cells could reactivate and differentiate, NSCs treated with 
20ng/mL BMP4 + 20ng/mL FGF2 for 72h were detached from their flask using Accutase 
(Sigma, A6964) and re-plated into laminin-coated P6 wells (200,000 cells/well) for RNA 
extraction, or onto laminin coated coverslips in P24 wells (40,000 cells/well) in the 
presence of EGF+FGF2 or FGF2 alone. Re-plated cells were cultured for 24h, 48h or 
72h and then fixed with 4% PFA and processed for immunocytochemistry, or the cells 
lysed for RNA extraction.  
 
In order to test the multipotency of NSCs following reactivation, reactivated NSCs were 
cultured on laminin-coated coverslips in P24 well plates at a density of 40,000 cells/well, 
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for 72h in 20ng/mL EGF + 20ng/mL FGF2 or 20ng/mL FGF2 alone, to allow for full 
reactivation. At this point the media was changed to basal media supplemented with 
10ng/mL FGF2 and NSCs cultured for 48h. After 48h the media was changed once again 
to basal media supplemented with 2% foetal bovine serum (Invitrogen, 10270-106) 
without EGF or FGF2. NSCs were cultured for a further 72h, at which point the cells were 
fixed and processed for immunocytochemistry.  
 
In order to label cells in S-phase, 0.5µL of 10mM EdU (Invitrogen, C10340) was added 
to the media of cells on coverslips in 500µL media in P24 wells and dispersed by swirling 
the plate, for a final concentration of 10µM. 10µM EdU was incubated with the cells for 
1hr prior to fixation with 4% PFA, and then cells were processed for antibody staining 
and EdU detection as described in Section 2.2.2. For EdU/BrdU pulse-chase 
experiments described in Section 3.1.2, 10µM EdU or BrdU was added to the media on 
cells in P24 wells and incubated for 24h. To label nascent protein synthesis, cells on 
coverslips were incubated with 50µM O-propargyl-puromycin (OPP) in DMSO, for 1hr 
prior to fixation with 4% PFA, and then processed for antibody staining and OPP 
detection as described in Section 2.2.2. In order to label the mitochondria of NSCs in 
culture, cells on coverslips were incubated with 30nM MitoTracker™ reagent diluted in 
DMSO, for 1hr prior to fixation with 4% PFA. 
 
To inhibit the proteasome, cells were grown on laminin-coated 10cm diameter dishes 
for 72h in supplemented basal media with either just 20ng/mL FGF2 or FGF2 + 
20ng/mL BMP4. Cells were treated with either 10µM MG132 (Sigma, SML1135) or an 
equal volume of DMSO (Sigma), for 30, 60 or 120mins, at which point the cells were 
lysed and processed for Western blot as described in Section 2.2.10.  
 
For experiments in which Notch signalling was inhibited in NSCs, cells were plated 
onto laminin-coated P6 wells at a density of 200,000 cells/well, or onto laminin-coated 
coverslips in P24 well plates at a density of 40,000 cells/well. Media was refreshed 24h 
later to either 20ng/mL FGF2 alone or FGF2 plus 20ng/mL BMP4, and incubated for a 
further 72h to induce quiescence in BMP4-treated NSCs. After this time, 1uM of the 
gamma-secretase inhibitor LY411575 (LY) in DMSO (diluted from a stock of 10mM), or 
an equivalent volume of DMSO without LY was added to the culture medium on the 
cells. NSCs were then incubated for a further 72h before being lysed or fixed for 
analysis.  
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2.2.6 Constructs, plasmid transfection and viral transduction 
For overexpression of Id4, Id1 and GFP in quiescent NSCs, cells were first cultured in 
laminin coated T75 flasks in the basal media supplemented with 20ng/mL FGF2 and 
20ng/mL BMP4, for 72h. At this point, cells were detached using Accutase and counted. 
5x106 cells in suspension were used per construct for nucleofection using the Amaxa 
mouse neural stem cell nucleofector kit (Lonza, VPG-1004) and Amaxa Nucleofector II 
(Lonza), using the program A-033, according to manufacturer’s instructions. For 
overexpression of Id4, the 6µg of pCbeta-Id4-FLAG construct was used, a kind gift from 
M. Israel (Rahme and Israel, 2015), which expresses Id4 from a CMV promoter and also 
expresses an N-terminal FLAG tag. This construct did not contain a fluorescent reporter, 
therefore in order to FAC sort Id4-transfected NSCs, cells were co-transfected with 3µg 
pCAGGS-IRES-GFP construct. These two constructs were nucleofected in a 2:1 
concentration of Id4:GFP in order to increase the likelihood that GFP+ NSCs were also 
Id4+. For Id1 overexpression, quiescent NSCs were nucleofected with 3µg of pcDNA3-
mId1-Venus (Addgene, Item ID #20966; originally reported in Nam et al., 2009) which 
expresses Id1 from a CMV promoter and also expresses a fluorescent Venus tag. To 
generate control quiescent cells overexpressing GFP, BMP4-treated NSCs were 
nucleofected with 2µg pMax-GFP (Lonza, VPG-1004). Following nucleofection, NSCs 
were plated into laminin-coated 1x P6 well (2.5x106 cells/well are plated although many 
cells die following nucleofection) and onto 4x laminin-coated coverslips in P24 wells 
(0.625x106 cells/well), in basal media supplemented with 20ng/mL FGF2 and 20ng/mL 
BMP4 and incubated at 37°C, 5% CO2. The media was refreshed 24hr later in order to 
remove the dead cells, and cells were incubated for a further 24h. At this point cells in 
P6 wells were lysed into 1mL TriZol for RNA extraction, and cells on coverslips were 
fixed in 4% PFA for immunocytochemical analysis. 
 
For overexpression of E47 and GFP in active NSCs, cells were first cultured in laminin 
coated T75 flasks in the basal media supplemented with 20ng/mL FGF2 for 72h. At this 
point, cells were detached using Accutase and counted. 5x106 cells were used per 
construct as described above. For E47 overexpression, an expression construct was 
generated previously in the Guillemot lab by cloning E47 into pCAGGS-IRES-GFP via 
the EcroRV/Xho1 insertion site. 10µg of this construct was used to nucleofect active 
NSCs. To generate control active cells overexpressing GFP, NSCs were nucleofected 
with 2µg pMax-GFP (Lonza, VPG-1004). Following nucleofection, NSCs were plated as 
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described above, in basal media supplemented with 20ng/mL FGF2 and incubated at 
37°C, 5% CO2. The media was refreshed after 24h and cells were collected 48hrs post-
transfection as described above.  
 
To delete Huwe1 in NSCs derived from Huwe1 floxed transgenic mice, Huwe1 floxed 
cells were plated onto laminin coated coverslips in P24 wells at a density of 40,000 
cells/well in the presence of 20ng/mL FGF2. 24hrs after plating, the media was replaced 
with media supplemented with 20ng/mL FGF2, or in 20ng/mL FGF plus 20ng/mL BMP4, 
and cultured for 72h. After this time, either the media was replaced with fresh media 
containing either empty adenovirus (Adeno-empty) or adenovirus expressing Cre 
recombinase (Adeno-Cre) at a concentration of 100 multiplicity of infection (moi) or 
number of virus particles per cell. The media was refreshed 24hrs post-transduction, and 
cells were incubated for a further 6 days to ensure complete degradation of the very 
stable Huwe1 protein, at which point the cells were fixed with 4% PFA for 
immunocytochemical analysis.  
 
In order to overexpress Id4 in active NSCs by adenoviral overexpression, cells were 
plated onto laminin-coated P6 wells (200,000 cells/well), or onto laminin coated 
coverslips in P24 wells (40,000 cells/well) in the presence of 20ng/mL FGF2, and 
cultured for 24h. Media was replaced with FGF2-supplemented basal media containing 
adenovirus expressing mouse Id4 (Ad-m-ID4, Vector Biolabs) which expresses Id4 from 
the CMV promoter, at a concentration of 100 moi. Media was refreshed 24h post-
infection, and cells were cultured for a further 20h in the presence of 20ng/mL FGF2 
before being collected for analysis.  
  
To delete Id4 in NSCs derived from the Id4 floxed transgenic mouse line, Id4 floxed cells 
were plated onto laminin-coated P6 wells (200,000 cells/well), or onto laminin coated 
coverslips in P24 wells (40,000 cells/well) in the presence of 20ng/mL FGF2, or in 
20ng/mL FGF plus 20ng/mL BMP4, and cultured for 72h. After this time, either the media 
was replaced with fresh media (non-transduced control) or with fresh media 
supplemented with FGF2 and/or BMP4 plus 100moi with empty adenovirus (Adeno-
empty) or 100moi adenovirus expressing Cre recombinase (Adeno-Cre), to induce 
recombination of the floxed Id4 locus, thereby genetically deleting Id4. Media was 
refreshed 24h post-transduction, and the cells collected for analysis 24hrs later.  
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2.2.7 FAC sorting  
FACS tubes were pre-coated with 5%BSA-PBS at 37°C for at least 30mins prior to 
sorting. Cells were detached from flasks using Accutase (Sigma) and centrifuged at 
0.3RCF for 5mins. Cell pellets were re-suspended in 750µL recovery media (5%BSA-
PBS + 20 ng/ml FGF + 1µg/mL Heparin). 1µL propidium iodide was added to cell 
suspensions to check for cell viability. Cells were sorted on a FACS Aria III machine, into 
recovery media. Both GFP positive and negative cells were recovered into separate 
tubes. 
 
2.2.8 RNA extraction, cDNA synthesis and QPCR 
For FACS experiments, cells were lysed using Qiagen lysis buffer. For all other 
experiments, cells were lysed by direct addition of 700-1000µL Trizol reagent to the 
culture dish. RNA was extracted using RNeasy® Mini Kit (Qiagen, 74104) or Direct-zol™ 
RNA MiniPrep Kit (Zymo Research, R2052), according to manufacturer’s instructions.  
 
cDNA was synthesised using the High Capacity cDNA Reverse Transcription Kit 
(Applied Biosystems, 4387406) following manufacturer’s instructions. Gene expression 
level was measured using TaqMan Gene expression assays (Applied Biosystems) and 
quantitative real-time PCR carried out on a QuantStudio Real-Time PCR system 
(ThermoFisher). Gene expression was calculated relative to endogenous controls 
Gapdh and ActinB, and normalised to the expression of the control sample in each group, 
to give a ddCt value.  
 
QPCR	probes	
ACTB	QPCR	probe	 Applied	Biosystems	 Cat#	4352933E	
Mm03058063_m1	Ascl1	 Applied	Biosystems	 Cat#	4331182	
Mm01279269_m1	Dll1	 Applied	Biosystems	 Cat#	4331182	
GAPDH	QPCR	probe		 Applied	Biosystems	 Cat#	4352932E	
Mm00775963_g1	Id1	 Applied	Biosystems	 Cat#	4331182	
Mm00711781_m1	Id2	 Applied	Biosystems	 Cat#	4331182	
Mm00492575_m1	Id3	 Applied	Biosystems	 Cat#	4331182	
Mm00499701_m1	Id4	 Applied	Biosystems	 Cat#	4331182	
Table 1. List of probes used for QPCR gene expression analysis 
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2.2.9 RNA sequencing and analysis 
RNA concentration was quantified using the Qubit dsDNA BR/HS Assay Kit. A KAPA 
mRNA HyperPrep Kit (for Illumina) (KAPA Biosystems, Wilmington, MA, USA) was used 
with 1000ng of RNA diluted to a final volume of 50µl. Each RNA sample was captured 
with 50µl of capture beads at 65°C for 2 min and 20°C for 5 min. For the second capture, 
50µl of RNase free water was used at 70°C for 2 min and 20°C for 5 min. Captured RNA 
was subjected to the KAPA Hyper Prep assay: end-repair, A-tailing, and ligation by 
adding 11µl of Fragment, Prime and Elite Buffer (2X). To obtain a distribution of 200-
300bp fragment on the library, the reaction was run for 6 min at 94°C. cDNA synthesis 
was run in 2 steps following manufacturer’s instructions. The ligation step consisted of a 
final volume of 110 μL of the adaptor ligation reaction mixture with 60μL of input cDNA, 
5 μL of diluted adaptor and 45μL of ligation mix (50µL of ligation buffer+ 10 μL of DNA 
ligase). The Kapa Dual-Indexed Adapters (KAPA Biosystems-KK8720) stock was 
diluted to 7µM (1.5mM or 7nM) to get the best adaptor concentration for library 
construction. The ligation cycle was run according to manufacturer’s instructions. To 
remove short fragments such as adapter dimers, 2 AMPure XP bead clean-ups were 
done (0.63 SPRI and 0.7SPRI). To amplify the library, 7 PCR cycles were applied to 
cDNA KAPA HP mix. Amplified libraries were purified using AMPure XP. The quality and 
fragment size distributions of the purified libraries was assessed by a 2200 TapeStation 
Instrument (Agilent Technologies, Santa Clara, CA, USA). 
Libraries were sequenced with Hiseq4000 (Illumina), 50-bp paired-end reads for 
sequencing proliferating vs quiescent NSCs; 75bp single-end reads for Id4/E47 
overexpressing NSCs, with a depth of 30x106 reads.  
The quality of RNA sequence reads was evaluated using FastQC (version 
0.11.2)(Andrews, 2010). Low quality reads and contaminants (e.g. sequence adapters) 
were removed using Trimmomatic (version 0.32) (Bolger et al., 2014). Sequences that 
passed the quality assessment were aligned to the mm10 genome using tophat2 
(version 2.0.14) (Kim et al., 2013), with bowtie2 (version 2.1.0) (Langmead and Salzberg, 
2012) or for the quiescent NSC RNAseq data set, Cufflinks (Trapnell et al., 2010). 
Transcript abundance level (transcript count) was generated using HTSeq (version 
0.5.3p9) (Anders et al., 2015). The transcript counts were further processed using R 
software environment for statistical computing and graphics (version 3.4.0). Data 
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normalization, removal of batch effect and other variant was performed using EDASeq 
R package [(Risso et al., 2011) and RUVseq package (Remove Unwanted Variation from 
RNA-Seq package) (Risso et al., 2014). Differential expression was performed using 
edgeR R package (Robinson et al., 2010), using the negative binomial GLM approach, 
or for the quiescent NSC RNAseq data set, Cuffdiff (version 7) (Trapnell et al., 2013).  
 
To determine genes upregulated by BMP4, Id4, Id1, E47 or GFP, thresholds were set 
for expression level in the treated sample at >=1 (FPKM or CPM), a significant log2 fold 
change of >=1, and a false discovery rate (FDR) of <=0.05 (Benjamini-Hochberg multiple 
testing correction). To determine down-regulated genes, the expression level in control 
samples was set at >=1 (FPKM or CPM); log2 fold change was set at <=-1, and a false 
discovery rate (FDR) of <=0.05 (Benjamini-Hochberg multiple testing correction). The 
BioVenn website (www.biovenn.nl) was used to visualise overlap of gene expression. 
For gene ontology analysis, gene lists were analysed using the online DAVID 
bioinformatics “Functional Annotation” tool (https://david.ncifcrf.gov/).   
 
Processing of the raw RNAseq data for the Id4, Id1 and E47 over-expression data sets 
was performed by D. van den Berg and E. Mulugeta of the Department of Cell Biology, 
Erasmus MC, Rotterdam. Processing of all other RNAseq data sets was performed by 
S. Vaga at the Francis Crick Institute.  
 
The list of cell cycle genes for Figure 5.3L was obtained from Qiagen, at the following 
web address https://www.qiagen.com/gb/resources/resourcedetail?id=0ee18e97-d445-
4fd7-9aa4-0ef4bece124f&lang=en  
 
2.2.10 Protein purification, Western Blot and Co-immunoprecipitation  
For Western blot analysis of NICD, LY- or DMSO-treated NSCs cultured in P6 well plates 
were detached from their culture plastic with Accutase and the cell suspensions 
centrifuged at 2000rpm for 5mins at 4°C. The supernatant was then aspirated and the 
pellet re-suspended in 1x Laemmli sample buffer. Samples were then boiled at 90°C for 
5mins, cooled and then sonicated 1min on/30sec off for 3mins. Samples were then spin 
for 5mins at 13,000rpm at room temperature, after which they were run on 
polyacrylamide gel at 120V, after which they were transferred onto a nitrocellulose 
membrane. Filters were then saturated with 5% BSA in TBS-Tween or 5% milk TBS-
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Tween and incubated with the primary antibody overnight at 4°C under rotation. 
Detection was performed using ECL Western Blotting Reagents (Sigma, GERPN2106) 
according to manufacturer’s instructions. 
 
For Western blot analysis of Id1-4, Ascl1 and E47 in wildtype and Ascl1-Venus NSCs, 
and co-immunoprecipitation experiments, NSCs were cultured in 10cm diameter dishes, 
in either proliferation (20ng/mL FGF2) or quiescent (20ng/mL FGF2 + 20ng/mL BMP4) 
conditions for 72h. Media was refreshed after 40h to ensure constant BMP4 signalling. 
Cells were then washed with ice-cold PBS, and scraped in Lysis Buffer (ThermoFischer 
Scientific, 87788) + 1x Protease inhibitor cocktail (ThermoFischer Scientific, 87786) + 1 
x EDTA (ThermoFischer Scientific, 87788) + 1x Phosphatase inhibitor cocktail 
(ThermoFischer Scientific, 78420). Cells were lysed at 4°C for 20min under rotation and 
then centrifuged at 13,000 RPM at 4°C for 20mins and the pellet discarded. The 
supernatant was analysed either by western blot or subject to immunoprecipitation. For 
western blot analysis, the supernatant was mixed with 1x Laemmli sample buffer (Sigma, 
S3401-10VL) and incubated at 95°C for 5 mins. 
 
For immunoprecipitation experiments, antibodies were added to cell lysate supernatants 
and incubated at 4°C for 2 hours under rotation. As controls, mouse anti-V5-tag or rabbit 
anti-HA-tag antibodies were used under the same conditions. Sepharose coupled to 
protein G (Sigma, P3296) was blocked with 5% BSA-PBS for 2 hours at 4°C under 
rotation. After several washes with PBS, it was then added to the lysate-antibody 
suspension and incubated for 2 hours at 4°C under rotation. After this period, Sepharose 
beads were washed with lysis buffer 5 times, then suspended in an equal volume of 
Laemmli sample buffer and incubated at 95°C for 5 mins. Samples were run in 
polyacrylamide gel at 120V, after which they were transferred onto a nitrocellulose 
membrane. Filters were then saturated with 5% BSA in TBS-Tween or 5% milk TBS-
Tween and incubated with the primary antibody overnight at 4°C under rotation. 
Detection was performed using ECL Western Blotting Reagents (Sigma, GERPN2106) 
according to manufacturer’s instructions.  
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2.3 Quantification and Statistical Analysis 
2.3.1 Quantification of immunofluorescence 
To measure immunofluorescence intensity, the nucleus of each identified RGL was 
manually outlined based on DAPI staining, and the average pixel value of the channel of 
interest was measured using FIJI software. Every value was normalised to the 
background level measured in a negative nucleus in the same z-plane as each RGL. At 
least 200 RGLs in each of at least 3 mice were quantified for each protein. For in vitro 
IHC quantification, average pixel intensity for each channel was measured for the area 
of each nuclei, using FIJI software. For each experiment, at least 100 cells were 
quantified across at least 3 biological replicates. To generate the arbitrary units (A.U.) 
for both in vivo and in vitro IHC, all the values within a sample were made relative to the 
average of the control, and multiplied by 100. For quantification of RNAscope® staining, 
the number of ‘dots’ in each identified RGL nucleus were counted for each probe. In 
addition, the average pixel intensity in and around each RGL nucleus was measured for 
each probe, using FIJI. 100 RGLs were quantified across 5 mice. For analysis of Id4 and 
E47 nucleofected cells, Id4+ or GFP+(E47) cells were identified by immunostaining for 
Id4 or GFP respectively, and positive cells compared to negative, non-transfected cells 
within the same coverslip. Cell counts were done from at least 3 coverslips from 3 
biological replicates.   
 
For quantification of WB and IP assays, films were scanned and, if appropriate, 
subjected to band densitometry and quantification using Image J software. Each band 
value was normalised according to the background of the filter and its loading control.    
 
2.3.2 Statistics  
Statistical analyses were conducted using a two-sample unpaired t test assuming 
Gaussian distribution using Prism software. All error bars represent the mean ± SEM. 
Significance is stated as follows: p>0.05 (ns), p<0.05 (*), p<0.01 (**), p<0.001 (***), 
p<0.0001 (****). Statistical details of each experiment can be found in the figure legend. 
n represents number of independent biological repeats. 
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Target 
Molecule 
Species Procedure Dilution Company Catalogue # 
Actin Rabbit WB 1:1000 Sigma-Aldrich A2066 
Ascl1 Mouse WB 1:500 BD Pharmingen 556604 
Ascl1 Guinea pig IHC 1:10,000 J. Johnson n/a 
Ccnd1 Rabbit IHC 1:400 ThermoScientific RM-9104 
BrdU Rat IHC 1:1000 ABD Serotec OBT0030CX 
E47 Mouse WB 1:200 
Santa Cruz 
Biotechnology 
E2A (Yae): sc-
416X 
E47 Mouse IP 1:225 
Santa Cruz 
Biotechnology 
E2A (Yae): sc-
416X 
GFAP Rat IHC 1:500 Invitrogen 13-0300 
GFP Chicken IHC 1:2000 Abcam ab13970 
GFP Rabbit 
WB 1:1000 
Life Technologies A11122 
IP 1:1000 
Id1 Rabbit 
WB 1:500 
Biocheck BCH-1/#37-2 
IHC 1:1000 
Id2 Rabbit IHC 1:1000 Biocheck BCH-3/#9-2-8 
Id3 Rabbit 
WB 1:500 
Biocheck BCH-4/#17-3 
IHC 1:200 
Id4 Rabbit 
WB 1:2500 
Biocheck BCH-9/#82-12 IP 1:400 
IHC 1:1000 
Ki67 Mouse IHC 1:50 BD Biosciences 550609 
Nestin Mouse IHC 1:100 Biolegend 656802 
NICD Rabbit WB 1:1000 Cell Signaling 4147S 
PDGFRa Rat IHC 1:500 Biosciences 558774 
p-Smad1/5/8 Rabbit IHC 1:500 Cell Signaling 9516 
tdTomato Goat IHC 1:1000 Sicgen ABB181-200 
Tuj1 Rabbit IHC 1:400 Covance PRB-435P-100 
S100β Rabbit IHC 1:500 Dako Z0311 
Sox2 Goat IHC 1:100 Santa Cruz Sc-17320 
V5 Mouse IP 1:1000 
ThermoFisher 
Scientific 
R960-25 
Chicken IgG Donkey IHC-488 1:500 Jackson 703-545-155 
Mouse IgG Donkey IHC-488 1:500 Jackson 715-546-151 
Chapter 2 Materials and Methods 
 
82 
 
Rat IgG Donkey IHC-488 1:500 Jackson 712-546-150 
Rabbit IgG Donkey IHC-Cy3 1:500 Jackson 711-166-152 
Mouse IgG Donkey IHC-Cy3 1:500 Jackson 715-166-151 
Rat IgG Donkey IHC-647 1:500 Jackson 712-606-153 
Goat IgG Donkey IHC-647 1:500 Jackson 705-605-147 
Mouse IgG Donkey IHC-647 1:500 Jackson 715-606-151 
Mouse IgG Rabbit WB-HRP 1:1000 Dako P0161 
Rabbit IgG Goat WB-HRP 1:1000 Dako P0448 
RNAscopeâ Probes Dilution Company Catalogue # 
Mm-Ascl1-C2 
1:50 in probe 
diluent or C1-probe 
ACD (Bio-Techne) 313291-C2 
Mm-Mki67-C1 1:1 ACD (Bio-Techne) 416771 
TSAâ Plus fluorophores    
TSAâ Plus fluorescein 1:1500 Perkin Elmer PN NEL741001KT 
TSAâ Plus Cyanine 3 1:1500 Perkin Elmer PN NEL744001KT 
Table 2. Antibodies and in situ probes. 
 
 
 
 
 
Chapter 3 Results 
 
83 
 
Chapter 3. Results 1 
Due to the high complexity of the adult hippocampal neurogenic niche, and the lack of 
markers specific to the quiescent compartment, delineating the effects of a particular 
signal specifically on the quiescent RGLs is challenging in vivo. In order to overcome 
these challenges, a reductionist approach was required, namely an in vitro model of 
adult NSC quiescence. Such a model had previously been established by the 
Guillemot laboratory and other groups (Martynoga et al., 2013), whereby mouse 
embryonic stem cell-derived neural stem cells (‘NS5’ cells as reported in (Conti et al., 
2005)) were reversibly induced into a quiescent-like state by culturing in the presence 
of BMP4. However, embryonic stem cell-derived and adult hippocampus-derived 
neural stem cells might have fundamental biological differences with regards to their 
response to extrinsic signals, due to their origin. Therefore, in this chapter I will 
describe the generation and characterisation of an in vitro model of adult hippocampus-
derived neural stem cell (AHNSC) quiescence, first validating that the model resembles 
a quiescent NSC state, and comparing the new model using adult hippocampal NSCs 
to the older NS5-NSC quiescence model, by transcriptomic analysis. I will then 
describe how I further refined the mode of AHNSC quiescence by titrating the 
component factors, and analysed more closely the transcriptional signature of BMP4-
induced AHNSC quiescence.  
 
3.1 Development of an in vitro model of adult hippocampal 
stem cell quiescence 
3.1.1 Deriving adult hippocampal neural stem cells 
In order to generate an in vitro model of adult hippocampal NSC quiescence, the 
dentate gyri of adult mice (P50-P60) were dissected, and the cells dissociated and 
grown as neurosphere cultures (as described in (Walker and Kempermann, 2014)). 
Subsequent passaging steps selected for the self-renewing stem cells, while the post-
mitotic neurons and glial cells were diluted out by the proliferating stem cells or simply 
died. Subsequently, the neurospheres were dissociated and plated onto laminin-coated 
flasks, generating adherent cultures of self-renewing NSCs (Figure 3.1). This protocol 
was already in development in the laboratory, and so I took the cultures to develop the 
quiescence model. Initially, the NSCs were cultured in the presence of both EGF and 
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FGF2, in order to maximise proliferation and survival, and replicating the conditions 
used for the maintenance of NS5 cells (Conti et al., 2005; Martynoga et al., 2013; Mira 
et al., 2010). BMP4 was used to induce quiescence of the AHNSCs, as it is described 
to induce quiescence of NS5 cells (Conti et al., 2005; Martynoga et al., 2013) and 
AHNSCs (Mira et al., 2010) (Figure 3.1). 
 
 
Figure 3.1. Scheme of in vitro model of adult-derived hippocampal neural stem 
cell quiescence 
The dentate gyri of adult wildtype mice (P50-P60) were dissected, and the cells dissociated 
and grown as neurosphere cultures. Subsequent passaging steps selected for the self-
renewing stem cells, while the post-mitotic neurons and glial cells were diluted out by the 
proliferating stem cells or simply died. Subsequently, the neurospheres were dissociated 
and plated onto laminin-coated flasks, generating adherent cultures of self-renewing adult 
hippocampal neural stem cells (AHNSCs). Active AHNSCs were cultured in FGF2 and (for 
early experiments) EGF, whilst addition of BMP4 (and removal of EGF) generates 
quiescent AHNSCs.  
 
3.1.2 BMP4-treated AHNSCs can be induced into a reversible quiescent-like 
state  
I first tested whether adult hippocampal NSCs derived in our lab could be induced by 
BMP4 into a quiescent-like state, by immunofluorescence staining for cell cycle 
markers Ki67 and CyclinD1, the activation factor Ascl1, and incorporation of the 
modified thymidine analogue EdU to label S-phase. Treating AHNSCs for 24h with 
Active AHNSCs 
(20ng/mL EGF+) 
20ng/mL FGF2 
20ng/mL FGF2 + 
20ng/mL BMP4
Quiescent AHNSCs
Neurospheres
stem cells
neurons
glial cells
Dentate Gyrus
P50-60 mice
Neurospheres
stem cells
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20ng/mL BMP4 in the presence of 20ng/mL FGF2 and withdrawal of EGF was already 
sufficient to cause a sharp decrease in the number of proliferating NSCs (Figure 3.2A-
E). This initial suppression of proliferation was further decreased by 72h, by which time 
the percentage of proliferating cells had mostly stabilised, and remained at this low 
level throughout 7 days of BMP4 treatment (Figure 3.2A-E). I therefore chose 72h of 
exposure to BMP4 as a standard time to induce quiescence of AHNSCs in future 
experiments. 
 
In addition to cell cycle exit, removal of EGF and addition of BMP4 resulted in the 
increased expression of GFAP, a characteristic marker of RGLs in vivo (Figure 3.2A). 
A true quiescent state should be a reversible cell cycle exit, a feature that distinguishes 
it from senescence or differentiation. To test whether BMP4-induced quiescence was 
reversible, and therefore a true quiescent state, I reactivated the BMP4-treated NSCs 
by plating them back into culture medium containing both EGF and FGF2 (without 
BMP4). Analysis by immunofluorescence shows that the percentage of NSCs positive 
for cell cycle markers Ki67 and EdU, and for activation factor Ascl1, are already back to 
the levels observed pre-BMP4 treatment by 48h after reactivation (Figure 3.2F, H-J). 
Interestingly, the %Ki67+ and %EdU+ NSCs at 48h and 72h post-reactivation exceeds 
those seen prior to BMP4-induced quiescence, which may reflect a synchronicity of the 
cells following coordinated reactivation. CyclinD1 expression was unique in its speed of 
recovery following reactivation, with %CyclinD1+ NSCs back to pre-BMP4 levels 
already by 24h post-reactivation (Figure 3.2K). This could be due to the fact CyclinD1 
plays an important role in the early to mid-G1 phase of the cell cycle, and so its early 
expression may be required for the initial entry into the cell cycle from G0, or 
progressing through early G1.    
 
The protocol used here to reactivate quiescent NSCs involved enzymatic dissociation 
of the cells from the culture plastic, and re-plating into proliferation conditions. This 
process causes disruption of the extracellular matrix and cell-cell contacts which may 
play important roles in regulating quiescence. I therefore tested whether quiescent 
NSC reactivation was solely dependent on BMP4 removal, by reactivating without 
dissociating the cells. Following 72h culture with BMP4, I washed the NSCs with dPBS 
(to ensure sufficient removal of BMP4) and pipetted fresh proliferation medium to the 
cells. 24h post-reactivation, the number of proliferating NSCs was similar to BMP4 
conditions (Figure 3.2L), however by 4d post-reactivation proliferation markers Ki67, 
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CyclinD1 and EdU were expressed in a large proportion of the cells, as well as Ascl1 
protein (Figure 3.2L). The expression of GFAP took longer to decrease in reactivated 
cells that were not dissociated, as can be seen 24h and 4d post-reactivation, although 
levels of GFAP had started to return to pre-BMP4 levels by 7d post-reactivation (Figure 
3.2L). This is in comparison to dissociated cells in which GFAP levels are strongly 
reduced already by 48h post reactivation (Figure 3.2F, second panel). This indicates 
that removal of BMP4 and returning EGF is sufficient to reactivate cells from BMP4-
induced quiescence and does not require disruption of the ECM or cell-cell contacts. 
 
Quiescent NSCs in vivo are maintained in a quiescent state for long periods of time 
while still maintaining their stemness. It was important to investigate how well the in 
vitro system could model longer-term quiescence, in order to see if it could model a 
more physiological, long-term state of quiescence. Moreover, it was useful to test 
whether longer exposure to BMP4 would eventually cause differentiation or 
senescence. To this end, I tested whether the cells could be reactivated following 28 
days in BMP4-induced quiescence. The percentage of NSCs positive for Ascl1, Ki67, 
CyclinD1 and EdU 72h after reactivation from long-term BMP4-induced quiescence 
were highly similar to those seen in reactivated cells after short-term quiescence 
(Figure 3.2.G-K). This suggests that NSCs do not change their identity if exposed to 
BMP4 plus FGF2 for at least 1 month, and therefore the in vitro system would be able 
to model more long-term regulation. 
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Figure 3.2. BMP4 induces reversible cell cycle exit in AHNSCs (legend next page) 
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Figure 3.2. BMP4 induces reversible cell cycle exit in AHNSCs 
(A-E) Immunohistochemistry for cell cycle markers Ki67 and CyclinD1, activation factor 
Ascl1, and S-phase label EdU are decreased in AHNSCs by 72h BMP4 treatment and 
continually supressed for at least 7 days, as quantified in (B-E), whilst the RGL marker 
GFAP is increased upon BMP4 treatment (A). Abbreviations: E, EGF 20ng/mL; F, FGF2 
20ng/mL; B, BMP4 20ng/mL.  
(F-K) The effects of BMP4 are reversible, shown by increased immunofluorescence for 
Ki67, CyclinD1, Ascl1 and EdU incorporation by 48h post-reactivation (F) and quantified in 
(H-J). AHNSCs are able to reactivate from long-term (28 days) BMP4-induced quiescence 
(G, H-K).  
(L) AHNSCs can be reactivated from quiescence without enzymatic dissociation of the cells 
from the culture plastic.  
E, EGF; F, FGF2; B, BMP4. Scale bars, 30µm. Error bars represent the mean ± SEM. n=3 
independent biological repeats for all data shown. 
3.1.3 BMP4-induced quiescent AHNSCs maintain their multipotency 
I next tested whether BMP4-induced quiescent NSCs maintain their multipotency, a 
key aspect of quiescence that distinguishes it from senescence or terminal 
differentiation. In vivo, RGLs are reported to have multipotency, with the capacity to 
differentiate into granule neurons and astrocytes (Bonaguidi et al., 2011), and can also 
generate oligodendrocyte precursor cells (OPCs) under conditions of high Ascl1 
expression (Braun et al., 2015; Jessberger and Gage, 2008). Moreover NSCs in vitro 
have been shown to have trio-potentiality (Oh et al., 2014), therefore I tested for the 
expression of neuronal (Tuj1), astrocytic (GFAP and S100β) and OPC (PDGFRa) 
markers. Following 72h or 28d BMP4 treatment, I reactivated cells for 72h in the 
presence of EGF and FGF2, and subsequently exposed the cells to conditions which 
induce differentiation into glial and neuronal cells (scheme shown in Figure3.1.3A). In 
parallel I also differentiated cells directly from proliferation conditions, to determine if 
there were any differences in multipotency between reactivated NSCs and those that 
had not been exposed to BMP4 (Figure 3.3A). Many Tuj1+ neuronal cells were 
detected by IF following differentiation of all three populations of NSCs, as well as 
immunoreactivity for glial markers GFAP and s100β, and OPC marker PDGFRa 
(Figure 3.3B-D). Overall these initial results suggest that BMP4 can induce a reversible 
cell cycle arrest in adult hippocampal NSCs, without affecting their stemness as 
demonstrated by their ability to generate more differentiated neuronal, glial and 
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oligodendrocyte precursor-like cells. These features are central to defining the BMP4-
induced state as ‘quiescence’ and distinguishing it from differentiation or senescence, 
and therefore indicate this can be a biologically relevant model of adult hippocampal 
NSC quiescence.  
 
Figure 3.3. BMP4-induced quiescent AHNSCs retain their multipotency 
(A) Scheme for the differentiation protocol of AHNSCs reactivated from quiescence. Active 
NSCs are induced to quiescence by either 72h or 28days BMP4 treatment. NSCs are then 
reactivated by culturing back in EGF+FGF2 for 72h, at which point EGF is removed and the 
concentration of FGF2 reduced for 48h, followed by replacement of FGF2 with 2% foetal 
bovine serum for 72h.  
(B-D) Glial cells (S100β+, GFAP+) and Tuj1+ neurons can be generated from active 
AHNSCs as well as AHNSCs previously treated with BMP4 for 72h or 28days. Some cells 
could also be detected to express oligodendrocyte precursor cell marker PDGFRa. n=2 
independent biological replicates. 
3.1.4 BMP4-induced quiescent AHNSCs spontaneously enter the cell cycle 
and can re-enter quiescence 
BMP4 treatment does not completely suppress the cell cycle of NSCs in vitro, as 
observed from the percentage of Ki67+ or EdU+ NSCs in the 7day BMP4-treatment 
time-course (Figure 3.2B-E). This could represent a low-level spontaneous entry of the 
cells into the cell cycle, which is interesting to study in more detail as it could inform on 
the dynamics of cycling NSCs, particularly how many times they divide and if they 
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return to quiescence. Alternatively, this cycling pool could represent a sub-population 
of cells ‘resistant’ to BMP4-induced quiescence, one which never exits the cell cycle. 
This hypothesis, if true, could be extended to suggest that the BMP4-induced NSCs 
are not truly reactivating from quiescence. The ‘BMP4-resistant’ cycling population of 
cells could be selected for upon reactivation, whilst the non-cycling cells never 
reactivate and are quickly out-competed. An immediate argument against this 
hypothesis is the fact I do not see an increase in the percentage of proliferating cells 
over time in BMP4 (Figure 3.2B-E), which would indicate a selective expansion of a 
subpopulation of cycling cells. However, to test this hypothesis more carefully, and also 
to analyse the cell cycle dynamics of NSCs in BMP4 conditions, I carried out an EdU 
pulse-chase paradigm, as shown in Figure 3.4A. I first labelled cells in S-phase by 
incorporation of the thymine analogue EdU for 24h, followed by a chase period of 18h. 
An 18h chase will allow for most cells that had just entered S-phase at the end of the 
24h EdU incubation to progress through the cell cycle. After the chase period, the cells 
were fixed and immunostained for pan-cell cycle marker Ki67, which will label any cell 
currently in the cell cycle at the end of the experiment. This paradigm will tell me three 
things; firstly, how many cells enter S-phase within a 24h period (EdU+); secondly, how 
many of those cells re-enter the cell cycle (EdU+Ki67+), and thirdly how many cells exit 
the cell cycle and return to quiescence (EdU+Ki67-). By the end of the experiment, 
43.77%±4.9 of the cells were EdU+ (Figure 3.4C), indicating just under half of all cells 
had gone through S-phase within a 24h period. Importantly, 16.81%±2.7 of NSCs were 
EdU+Ki67- (“only EdU+”), suggesting that many NSCs return to quiescence (Figure 
3.4B,C). In addition, 7.42%±1.6 of the NSCs were Ki67+EdU- (“only Ki67+”), indicating 
that additional cells had entered the cell cycle after the EdU incorporation (Figure 
3.4B,C). Together these data indicate BMP4-treated NSCs spontaneously and 
dynamically enter and exit the cell cycle, with some cells returning to quiescence and 
new cells, that had not previously cycled, entering the cell cycle. To investigate these 
dynamics in further detail, I extended the pulse-chase paradigm to include a 24h BrdU 
pulse with 18h chase (Figure 3.4D). Using the data generated from these labelling 
experiments, I measured the percentage of NSCs in the cycle states indicated in 
Table3. 
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Cell Cycle Label Interpretation % observed 
Negative Cells did not enter the cell cycle during the experiment 42.6 ± 4.6 
EdU+ only Cells divided, then entered quiescence for (at least) the 
following 60h 
23.11 ± 5.0 
BrdU+ only Cells were quiescent for at least 24h, then divided, then 
entered quiescence for (at least) the following 18h 
21.25 ± 1.5 
Ki67+ only Cells newly entering the cell cycle in the last 18h 2.63 ± 1.2 
EdU+ BrdU- Ki67+ Cells divided, entered quiescence for at least 42h, then re-
entered the cell cycle 
1.96 ± 1.3 
EdU+ BrdU+ Ki67- Cells divided at least twice during the first 66h, then 
entered quiescence 
2.54 ± 0.3 
EdU- BrdU+ Ki67+ Cells did not divide until the BrdU pulse, and continue to 
cycle at the end of the experiment 
4.46 ± 0.7 
EdU+ BrdU+ Ki67+ Cells cycled throughout the experiment and continue to 
cycle at the end of the experiment 
1.21 ± 0.6 
Any combination of 
EdU/BrdU/Ki67 
Represents the overall level of proliferation over 84h 57.4 ± 4.6 
Table 3. Combinations of S-phase markers EdU and BrdU, and pan cell cycle 
marker Ki67 distinguish different cycling behaviours of the cells. 
The percentage frequency with which each cell cycle label combination was 
observed is shown as the mean±SEM, n=3 independent biological replicates. 
 
If the alternative hypothesis is correct and there is a small sub-population of cycling 
cells, then the expectation would be to see only 10% or so cells continuously cycling 
(EdU+BrdU+Ki67+), and none returning to quiescence (as they are insensitive to 
BMP4). In contrast, the results show that by the end of the experiment, nearly 60% of 
cells had entered the cell cycle, with 11.13%±1.7 NSCs actively cycling (Ki67+) at the 
final time-point (Figure 3.4E,F). Table 3 shows the percentage of cells observed for 
each ‘cycle state’. Every combination of EdU, BrdU and Ki67 was observed (Figure 
3.4G; Table 3). These data show that many NSCs dynamically enter and exit the cell 
cycle in BMP4 conditions over time, and importantly argues against a sub-population of 
BMP4-resistant cycling cells, because we see recruitment of previously non-cycling 
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cells into the cell cycle. This shows they had been induced to quiescence by BMP4, 
and subsequently spontaneously divided. Moreover, 48.86±2.0% of these cells then 
returned to quiescence, showing that even the dividing cells are sensitive to the effects 
of BMP4. 
 
 
Figure 3.4. Analysis of cycling cells in BMP4-induced quiescence by EdU-BrdU 
pulse-chase 
 (A) Scheme of 24h EdU pulse followed by an 18h chase in AHNSCs in BMP4+FGF2 
conditions, to label cells that have entered the cell cycle, and either remain cycling 
(EdU+Ki67+) or return to quiescence (EdU+Ki67-).  
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(B-C) 24h EdU labelling shows that around half of cells will cycle in a 42h period, with some 
cells returning to quiescence (EdU+Ki67-; blue arrow in (B)), some continuing to cycle 
(EdU+Ki67+; white arrow), and some cells newly entering the cell cycle at the end of the  
experiment (EdU-Ki67+; green arrow). The grey arrow in (B) shows a cell that remained 
quiescent during the experiment (EdU-Ki67-). n=2 independent biological repeats. 3 
images analysed and at least 300 cells counted per condition. 
(D) Scheme of EdU-BrdU pulse chase paradigm, with 24h pulses and 18h chases, to 
analyse the number of cells that enter and exit the cell cycle in BMP4-induced quiescence. 
(E-G) More than half of the cells were labelled during the course of the experiment (F), with 
each combination of EdU/BrdU/Ki67 double or triple labelling being observed (Yellow arrow 
in E; G). Many cells re-entered quiescence following division (EdU+ only, blue arrow in (E); 
BrdU+ only) (F), and a small percentage of previously quiescent cells enter the cell cycle at 
the end of the experiment (Ki67+ only) (F). Scale bars, 30µm. Error bars represent the 
mean ± SEM. n=3 biological repeats. 
 
3.2 BMP4 induces more quiescence-like features in AHNSCs 
than just cell cycle arrest.  
Quiescence is more than simply cell cycle arrest, but involves the up- and down-
regulation of many hundreds of genes to actively maintain a quiescent state and inhibit 
terminal differentiation (Codega et al., 2014; Coller et al., 2006; Liu et al., 2007; Shin et 
al., 2015). This includes changes in dynamics of RNA transcription, generally 
considered to be at lower levels, at least in quiescent yeast and HeLa cells (Gray et al., 
2004; Kim and Sederstrom, 2015), as well as lower or more tightly regulated protein 
synthesis (Pereira et al., 2015). For example, deletion of Pten in haematopoietic stem 
cells results in stem cell depletion due to overactive protein synthesis (Signer et al., 
2014). Tight regulation of protein synthesis may also be a hallmark of quiescent adult 
hippocampal neural stem cells, as aberrant activation of the mTorc1 pathway via 
deletion of Pten in RGLs also resulted in stem cell depletion (Bonaguidi et al., 2011). 
Similarly, aged hippocampal NSCs show dysfunctional lysosomal activity and 
increased protein aggregates, associated with an inability to activate from quiescence; 
restoration of their lysosomal function restores their ability to activate (Leeman et al., 
2018). In addition to transcriptional and protein synthesis changes, quiescence is also 
accompanied by energetic changes. As described in Section 1.3, quiescent radial glial-
like cells have characteristic mitochondrial distribution, (Beckervordersandforth, 2017), 
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and a predominantly glycolytic metabolism, with functional fatty acid oxidation which 
can directly regulate stem cell activity (Knobloch et al., 2013; Knobloch et al., 2017). 
Therefore, I investigated whether quiescent AHNSCs in vitro demonstrated the 
characteristic changes compared to active NSCs, in RNA and protein synthesis, 
mitochondrial distribution, and gene expression changes associated with the published 
“signature” of quiescence.   
 
3.2.1 BMP4-induced quiescent AHNSCs have different metabolic, 
transcription and translation rates than active AHNSCs 
I first investigated the changes to mitochondria in BMP4-induced quiescent AHNSCs, 
as a read-out of metabolic change. Incorporation of the mitochondrial marker 
MitoTracker™ clearly shows how the mitochondria in proliferating AHNSCs in the 
presence of EGF+FGF2 are abundant and tightly packed around the nucleus (Figure 
3.5A, left panel). In contrast, in BMP4-induced quiescent AHNSCs, the mitochondria 
are spread out into the long processes, becoming elongated and separated (Figure 
3.2.1A, right panel). This may reflect the different energetic demands of the two states; 
active NSCs have high energetic demands near the nucleus for DNA replication and 
mitosis, whereas quiescent NSCs need energy further from the nucleus, perhaps for 
localised transcription of transported RNAs, as occurs in neurons (Riccio, 2018). I also 
analysed the level of transcriptional activity using incorporation of the dye Pyronin Y 
(PY) which labels double-stranded RNA such as mRNA, thereby labelling nascent RNA 
transcription. The levels of PY were qualitatively slightly higher in EGF+FGF2 
conditions then FGF2+BMP4 (Figure 3.5B), suggesting BMP4 treatment suppresses 
transcription in quiescent NSCs. Finally, I measured nascent protein production using 
incorporation of O-propargyl-puromycin (OPP), an alkyne analogue of puromycin which 
gets incorporated into newly synthesised proteins, and which has been shown to be 
enriched in active SVZ NSCs reflecting their high rate of protein translation compared 
to quiescent NSCs (Llorens-Bobadilla et al., 2015). The OPP is then detected using 
fluorescent Click-IT chemistry. The pattern of OPP incorporation in EGF+FGF2 
conditions is mostly around the nucleus, and the overall levels of OPP incorporation is 
higher in active compared to quiescent NSCs (Figure 3.5C). Moreover, quiescent 
NSCs do not display the nuclear OPP staining, instead granules of OPP are dispersed 
throughout the cytoplasm (Figure 3.5C).    
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Figure 3.5. Analysis of mitochondria, RNA transcription and protein translation 
levels in AHNSCs. 
(A) The mitochondria of active (EGF+FGF2) and quiescent (FGF2+BMP4) NSCs were 
labelled by incubation with 30nM MitoTracker™ Deep Red FM in the culture medium for 1 
hour prior to fixation.  
(B) Following fixation, active (EGF+FGF2) and quiescent (FGF2+BMP4) NSCs were 
stained with 1µM Pyronin Y, followed by DAPI staining, in order to visualise double 
stranded RNA.  
Images shown are representatives of n=3 independent biological replicates. 
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(C) Detection of nascent protein synthesis was visualised by incubating active and 
quiescent NSCs with 50µM O-propargyl-puromycin (OPP) in the culture medium for 1 hour 
prior to fixation, followed by Click-IT detection and DAPI staining. Scale bars, 10µm. 
3.2.2 Transcriptome-wide analysis reveals a quiescence “signature” of 
BMP4-treated AHNSCs 
In order to further validate the in vitro model and also gain new insights into the 
transcriptional signature of quiescent AHNSCs, we performed RNA sequencing of 
active and quiescent AHNSCs. AHNSCs were cultured in the presence of either 
20ng/mL EGF+ 20ng/mL FGF2 (active) or 20ng/mL FGF2+ 20ng/mL BMP4 (quiescent) 
for 72h, at which point cells were lysed and the RNA extracted. Samples from 3 
independent biological repeats were collected and processed for RNA sequencing. 
Differential gene expression analysis revealed 1637 genes upregulated and 1456 
genes downregulated in quiescent vs active NSCs. The genes most enriched in the 
quiescent state belonged to ontologies such as “cell adhesion”, “cell-cell signalling”, 
“cation transport” and “lipid catabolic process” (Figure 3.6A). These terms are highly 
characteristic of transcriptional signature associated with quiescent stem cells (Codega 
et al., 2014; Shin et al., 2015). Moreover, these ontologies were highly similar to those 
enriched in the BMP4-treated ES-NSCs (NS5 cells) from (Martynoga et al., 2013), as 
shown in Figure 3.6C. The genes downregulated in quiescent AHNSCs were mostly 
related to the arrest of the cell cycle, such as “cell cycle”, “cell division”, “DNA 
replication” as well as “RNA processing” (Figure 3.6B). Again, these ontologies 
matched closely to those downregulated in BMP4-treated NS5 NSCs (Figure 3.6D).  
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Figure 3.6. RNAseq analysis of active (EGF+FGF2) vs quiescent (BMP4+FGF2) 
AHNSCs and comparison with quiescent NS5-NSCs 
(A,B) Graphs show the top gene ontologies for genes significantly up- or down-regulated in 
BMP4-induced quiescent AHNSCs.  
(C-F) Around half of the genes significantly up- or down-regulated in quiescent AHNSCs 
are common with those genes regulated in quiescent ES-NSCs (“NS5” cells) (C, D), 
despite highly similar gene ontologies between the two quiescent cell types (E, F).  
(G) Overlap of the genes within the “cell adhesion” ontology expressed in FACs isolated 
quiescent SGZ NSCs (Shin et al., 2015), quiescent AHNSCs and quiescent NS5 NSCs. 
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Interestingly, despite the ontologies of genes regulated by BMP4 being highly similar 
between the NS5 NSCs and AHNSCs, the overlap of actual genes was less than half 
for both up- and down-regulated genes (Figure 3.6 E,F), suggesting that specific genes 
within the shared ontology classes are different between the embryonic and adult 
NSCs. I investigated this further by looking at specific genes of the most significantly 
upregulated ontology, “Cell adhesion”, to see if there were adult hippocampal-specific 
genes being expressed in AHNSCs and not in NS5 NSCs. I overlapped the genes 
classified in the “cell adhesion” ontology in BMP4 treated NS5 cells with those for 
BMP4 treated AHNSCs, which again showed less than half of the specific “cell 
adhesion” genes are co-expressed in both types of NSCs (Figure 3.6G). I then 
overlapped these with the “cell adhesion” genes from a single cell RNAseq data set 
from RGLs FAC sorted from the adult SGZ, as a reference for adult hippocampal NSC-
specific genes (Shin et al., 2015). I took the ‘top 1000 enriched genes’ in SGZ FAC 
sorted quiescent NSCs ((Shin et al., 2015) Supplementary Table S4), and ran it 
through gene ontology software to isolate the genes in the “cell adhesion” ontology. 
Out of 50 cell adhesion genes enriched in quiescent SGZ NSCs, 13 were also 
expressed by quiescent NS5 NSCs (26% of SGZ NSC genes), and 22 were expressed 
by quiescent AHNSCs (46% of SGZ NSC genes). Of those 22 genes, 16 were 
exclusively co-expressed in quiescent SGZ NSCs and AHNSCs, and not in NS5 NSCs 
(Figure 3.6G; genes listed in Table 4). These 16 genes were all expressed to some 
degree in adult hippocampal cells including RGLs (according to single cell expression 
data from www.linnarssonlab.org/dentate/). These data show that while there is not an 
exclusive overlap of genes expressed from SGZ NSCs with in vitro AHNSCs, the 
overlap is nearly double the overlap between SGZ NSCs and NS5 NSCs. This might 
reflect a more similar biological identity between the SGZ NSCs and the in vitro 
AHNSCs, which would make them a more reliable cell type for the in vitro quiescence 
model. In further support of the hypothesis that AHNSC have a greater “hippocampal 
stem cell” identity than NS5 NSCs, the ontology “Learning or memory” is specifically 
enriched in BMP4-treated AHNSCs, and not in NS5 NSCs (Figure 3.6A, C). The 
“Learning or memory” ontology includes genes associated with neurodegenerative 
diseases such as PARK2 (Parkinson’s disease); CLN3 (Batten disease); and APP, 
PSEN2 and APBB1 (Alzheimer’s disease), the dysfunction of which are associated 
with hippocampal neuron degeneration. These data could suggest AHNSCs have a 
“hippocampal” identity in addition to their neuronal stem cell properties, and suggest 
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they may model adult hippocampal NSC quiescence in culture more closely than NS5 
NSCs.   
 
Cell adhesion genes 
Expressed in both AHNSCs 
and SGZ RGLs 
Expressed in both NS5 
NSCs and SGZ RGLs 
BCAN CADM1 
MEGF10 ATP1B2 
NRCAM CYR61 
MFGE8 PDPN 
NRXN1 HES1 
NCAM2 NCAN 
HEPACAM ITGB5 
LSAMP CDH2 
CTNND2 NEO1 
DSCAML1 CD9 
VCAM1 IGSF11 
TTYH1 SORBS3 
PCDH10 NLGN1 
OMG  
NTM  
CDH11  
Table 4. Cell adhesion genes exclusively co-expressed in AHNSCs and SGZ 
RGLs, or NS5 NSCs and SGZ RGLs 
 
3.3 Refining the in vitro model of AHNSC quiescence 
3.3.1 Withdrawal of EGF and titration of FGF2 generates a more 
physiological model of AHNSC quiescence without affecting 
stemness.  
A limitation of the model was the presence of EGF in the proliferation conditions, a 
potent mitogen and one which has been shown specifically to regulate SVZ NSCs 
(which express EGF receptor) but not SGZ NSCs (Doetsch et al., 2002; Gonzalez-
Perez et al., 2009; Kuhn et al., 1997), therefore stimulation of AHNSCs with EGF in 
culture is artificial. In addition, the observed effects of BMP4 could in fact be intermixed 
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with effects of withdrawal of EGF, confounding the interpretation of the role of BMP4 in 
NSC quiescence. Therefore, I tested whether NSCs could be maintained in a self-
renewing, proliferative state in FGF2 alone, and whether EGF withdrawal affected their 
stemness or self-renewal capacity. I first measured the proliferation levels of NSCs in 
the presence of both 20ng/mL EGF + 20ng/mL FGF2 compared to 20ng/mL FGF2 
alone (Figure 3.7A-C), which showed that withdrawal of EGF resulted in about a 10% 
drop in the percentage of proliferating RGLs, identified by Ki67 and CyclinD1 
immunoreactivity and incorporation of S-phase marker EdU. mRNA expression of 
CyclinD1 was also decreased 2-fold following EGF withdrawal (Figure 3.7D), however 
this sharp decrease was not completely mirrored in the protein levels (Figure 3.7C), 
indicating the transcriptional change is not translating into a significant biological effect 
on the cell cycle. The sum of the results on NSC proliferation suggest that EGF with 
FGF2 induces the cell cycle more strongly than 20ng/mL FGF2 alone, but FGF2 alone 
is sufficient to keep NSCs self-renewing. To check that cells were not differentiating in 
conditions without EGF, I measured the mRNA levels of Nestin, a stem cell marker, 
which showed a 0.5-fold decrease following EGF withdrawal (Figure 3.7E), however 
Nestin is highly expressed in EGF+FGF2 conditions by RNAseq analysis (FPKM of 
155.11), indicating the small drop in expression may not significantly affect the stem 
cell state. Transcript levels of Dcx (doublecortin), an immature neuron marker, 
measured by QPCR, appear to be strongly induced upon culturing in FGF2 alone 
(Figure 3.7F). However, according to FPKM levels in the RNAseq dataset, Dcx is not 
expressed in EGF+FGF2 conditions, therefore an increase in FGF2 alone still 
represents very low expression levels. Ascl1 mRNA levels also increased 0.5-fold in 
the absence of EGF (Figure 3.7G), but average Ascl1 protein levels were not 
significantly affected by culturing cells in FGF2 without EGF (Figure 3.7H). AHNSCs 
could be passaged in the presence of 20ng/mL FGF2 without EGF for at least 18 
passages, although beyond this point the cells would detach from the culture plastic 
more frequently, which could indicate higher levels of spontaneous differentiation and 
therefore loss of stemness. However, the proliferation of the stem cells was still good 
beyond passage 18, and as demonstrated through immunocytochemistry and gene 
expression analysis (carried out on passage 12-16 AHNSCs), AHNSCs cultured in 
20ng/mL FGF2 without EGF do not demonstrate significant differentiation, supporting 
the decision to remove EGF entirely from the culture conditions in order to produce a 
more physiological culture medium.   
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Like EGF, FGF2 is a mitogen, but unlike EGF, FGF2 has been demonstrated to be 
present in the hippocampal niche in vivo and required for RGL maintenance (Kang and 
Hebert, 2015). FGF2 could not be withdrawn from the cell culture medium completely 
as it is reported to be crucial for hippocampal NSC survival and to prevent 
differentiation towards a neuronal fate, or, in the presence of BMP4 an astrocytic fate 
(Sun et al., 2011). However, RGLs in the hippocampal niche in vivo are likely to be 
exposed to a range of concentrations of FGF2, therefore I decided to titrate the 
concentration of FGF2 in the culture medium, to expose cells to a level that was 
perhaps more physiological. I titrated FGF2 to find the lowest concentration that could 
maintain stemness and self-renewal whilst preventing differentiation or cell death. I 
tested the original 20ng/mL FGF2, along with 10, 5 and 2.5ng/mL (Figure 3.7). The 
percentage of NSCs positive for cell cycle marker Ki67 and S-phase label EdU did not 
significantly vary across the concentrations of FGF2 (Figure 3.7A,B). Cell cycle protein 
CyclinD1 decreases with decreasing concentrations of FGF2 (although stabilises after 
5ng/mL), and this is also reflected in the mRNA expression (Figure 3.7C,D). The 
average levels of Ascl1 protein measured by immunofluorescence intensity does not 
significantly change with decreasing FGF2 concentration (Figure 3.7H), although the 
mRNA levels measured by QPCR start to increase at concentrations lower than 
10ng/mL and become more variable (Figure 3.7G), potentially suggesting the cells are 
moving towards differentiation. Transcript levels of stem cell marker Nestin are also 
decreased at 5 and 2.5ng/mL FGF2 (Figure 3.7E), again suggesting the NSCs may 
lose their stem identity with low levels of FGF2 signalling. Levels of Dcx transcript also 
increase strikingly in the lowest concentrations of FGF2 (Figure 3.7F), although as 
mentioned above, Dcx mRNA levels as measured by RNA sequencing were not 
detected in EGF+FGF2 conditions, and RNA sequencing on NSCs in 10ng/mL FGF2 
alone (described in full detail in Section 3.4) show Dcx has an FPKM of 1.16, therefore 
even in 2.5ng/mL FGF2, Dcx is not expressed at very high levels. Even so, Dcx is 
induced in low concentrations of FGF2, suggesting NSCs may start to differentiate in 
low levels of FGF2 signalling. From a qualitative perspective, when observing the live 
cells in low concentrations of FGF2 in culture under the microscope, their morphology 
changed to become longer and thinner, with smaller, brighter nuclei, and with many 
more cells detaching from the plastic. Together these observations indicate that a 
concentration of FGF2 lower than 10ng/mL starts to induce differentiation of NSCs. 
Despite the observations that 10ng/mL FGF2 seemed sufficient to maintain NSCs in a 
self-renewing stem cell state, long-term passaging of NSCs with 10ng/mL FGF2 
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resulted in more spontaneous differentiation and higher numbers of cells detaching 
from the culture flask already by passage 16 compared to NSCs in 20ng/mL FGF2, 
indicating a faster loss of stemness than with 20ng/mL FGF2. Before making this final 
observation, I performed RNA sequencing of NSCs cultured for a low number of 
passages in 10ng/mL FGF2 (see Section 3.4). However, to ensure I was culturing 
AHNSCs in the best conditions for self-renewal and maintaining stemness over a 
longer period of time in culture, all other future experiments used 20ng/mL FGF2.  
 
 
Figure 3.7. Withdrawal of EGF from active AHNSCs, and titration of FGF2  
(A-C) Quantification of the fraction of EdU+, Ki67+ and CyclinD1+ NSCs following EGF 
withdrawal and titration of FGF2 concentration. NSC proliferation declines slightly following 
withdrawal of EGF, but is not strongly affected by lowering the concentration of FGF2. n=3 
(D-G) QPCR analysis of CyclinD1, Nestin, Dcx (doublecortin) and Ascl1 mRNA in 
EGF+FGF2 conditions, and titration of FGF2 alone. CyclinD1 and Nestin decline following 
EGF withdrawal (D, E), and decrease in a dose-dependent manner in FGF2 titration. Dcx 
and Ascl1 increase following EGF withdrawal (F, G) and are further upregulated in the 
lowest concentrations of FGF2. n=3  
(H) Quantification of Ascl1 immunofluorescence levels (arbitrary units, A.U.) in NSCs in the 
presence of EGF+FGF2, or different concentrations of FGF2 alone. Ascl1 protein levels are 
not strongly affected by withdrawal of EGF or by FGF2 titration. 
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3.3.2 AHNSCs cultured in FGF2 alone can reversibly be induced into 
quiescence 
Having chosen to remove EGF from the culture conditions, I re-tested whether the 
stem cells could be induced into a quiescent state by BMP4, and whether this was 
reversible. NSCs were passaged several times in the presence of FGF2 20ng/mL, and 
then cultured with the addition of 20ng/mL BMP4 for 72h. This resulted in a sharp 
decrease in the percentage of Ki67+ and EdU+ NSCs, along with an increase in GFAP 
immunoreactivity, as observed previously (Figure 3.8A-C). Importantly, NSCs could be 
quickly reactivated from BMP4-induced quiescence by plating cells back into media 
with FGF2 alone, with proliferation rates rebounding by 48h post-reactivation (Figure 
3.8A-C). This reactivation was also not dependent on enzymatic dissociation of the 
cells, as when cells were reactivated without dissociation (as descried in Section 3.1) 
the number of Ki67+ and EdU+ cells were already increased to high levels by 48h post-
reactivation (Figure 3.8D). These data strongly suggest that NSCs maintained in FGF2 
alone can model BMP4-induced quiescence. 
 
Figure 3.8. BMP4 induces reversible quiescence in AHNSCs propagated in FGF2 
only  
(A) Immunofluorescence for GFAP, Ki67, DAPI staining and EdU incorporation for NSCs 
propagated in FGF2 alone shows many proliferating NSCs, which is sharply reduced 
following 72h treatment with BMP4. NSCs are able to be fully reactivated from quiescence 
when BMP4 is withdrawn and cells are propagated in the presence of FGF2 alone, as 
shown by the many Ki67+ EdU+ NSCs.  
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(B, C) Quantification of the fraction of EdU and Ki67 positive NSCs, shown in (A). n=3.  
(D) Immunostaining for Ki67 and EdU incorporation, plus DAPI staining, shows NSCs can 
reactivate without being dissociated from the culture plate, when BMP4 is withdrawn and 
cells are cultured in the presence of FGF2 alone.  
(E) NSCs can be differentiated into neurons and glial cells having been propagated in 
FGF2 alone, induced into quiescence by BMP4 and then reactivated back into FGF2 alone. 
Scale bars, 30µm. 
 
3.3.3 Titrating BMP4 induces different “depths” of quiescence 
One purpose of developing an in vitro model of NSC quiescence is to test the effects of 
niche signals on NSC quiescence and examine their molecular mechanisms in more 
detail. In vivo, RGLs would potentially receive different concentrations of the various 
niche signals at different times, underpinning the dynamic regulation of their activity. It 
was important therefore to further develop the in vitro model to include a dynamic 
range of BMP4 concentrations. This would enable testing of potential activating 
signals, without BMP4 signalling overwhelming their effects. I therefore titrated BMP4 
from 20ng/mL, to 10, 5, and 1ng/mL, and cultured the NSCs for 72h. Overall, the 
results show a dose curve for BMP4. Firstly, the expression of RGL marker Gfap 
shows a very clear dose-dependent upregulation with increasing concentration of 
BMP4, as does direct BMP4 target gene (and quiescence marker, discussed further in 
Section 3.4), Id4 (Figure 3.9A,B). In contrast, cell cycle gene CyclinD1 shows a BMP4 
dose-dependent suppression (Figure 3.9C), as does the percentage of cells positive for 
the protein, as identified by IF (Figure 3.9E,Jiii). The percentage of Ki67+ NSCs is 
already strongly suppressed by 1ng/mL BMP4 compared to FGF2 alone, however 
there is still a dose-dependent decrease as BMP4 concentration increases (Figure 
3.9F,Jiii). The percentage of cells incorporating EdU however is suppressed by 1ng/mL 
BMP4 and not further suppressed by higher concentrations (Figure 3.9G,Jiii). 
Interestingly, activation gene Ascl1 expression is not significantly affected by BMP4 at 
any concentration (Figure 3.9D), but Ascl1 protein levels are suppressed in a dose-
dependent manner (Figure 3.9H,Ji), an observation I will explore further in Chapter 4. 
Id4 protein level is also increased with increasing concentrations of BMP4 (Figure 
3.9I,Ji). The morphology of cells in 1ng/mL BMP4 starts to resemble that of 20ng/mL 
BMP4 (Figure 3.9Jii) however the expression of GFAP protein is visibly lower in 
1ng/mL BMP4 as compared to 20ng/mL (Figure 3.9Jii), reflecting the mRNA 
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expression levels (Figure 3.9B). These results show that 1ng/mL BMP4 is sufficient to 
induce cell cycle arrest in the majority of NSCs and morphological changes associated 
with BMP4-induced quiescence including slightly increased expression of GFAP 
protein, without strongly inducing or suppressing other genes. Therefore, 1ng/mL 
BMP4 could be used to model a “shallow” quiescence, in order to test the effects of 
activating signals on the cell cycle arrest aspect of quiescence, whilst 20ng/mL BMP4 
induces a “deep” quiescence. Moreover, the other doses of BMP4 could be tested in 
concert with different concentrations of activating signal, to examine the relative 
strength of opposing signals on regulating NSC quiescence.   
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Figure 3.9. Titrating BMP4 induces quiescence in a dose-dependent manner 
(legend next page) 
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Figure 3.9. Titrating BMP4 induces quiescence in a dose-dependent manner 
(A-D) QPCR analysis of the expression of Id4, Gfap, CyclinD1 and Ascl1 in NSCs treated 
with 20ng/mL EGF and 20ng/mL FGF2, FGF2 alone, or FGF2 plus BMP4 at 1ng, 5ng, 
10ng or 20ng/mL (E: EGF, F: FGF2, B: BMP4). Id4 and Gfap are induced and CyclinD1 
repressed by BMP4 in a dose-dependent manner (A-C). Ascl1 mRNA expression is 
unaffected by BMP4 at any concentration (D). n=3, statistical analyses made using paired 
t-test (mean±SEM). p>0.05 (ns), p<0.05 (*), p<0.005(**), p<0.0005(***). 
(E-G) Quantification of immunostaining for cell cycle markers CyclinD1, Ki67 and EdU 
incorporation in EGF+FGF2, FGF2 alone and FGF2+ 1-20ng/mL BMP4 (immunostaining 
shown in (Jiii)). The percentage of NSCs positive for CyclinD1 and Ki67 are reduced with 
increasing concentrations of BMP4. The percentage of EdU+ NSCs is suppressed by 
1ng/mL BMP4 and is not further reduced by increasing concentrations. n=3  
(H) Quantification of Ascl1 protein level, measured by immunofluorescence intensity 
(arbitrary units, A.U.) (immunostaining shown in (Ji)) shows Ascl1 is suppressed BMP4 in a 
dose-dependent manner.  
(I) Quantification of Id4 protein level, measured by immunofluorescence intensity (arbitrary 
units, A.U.) (immunostaining shown in (Ji)). Id4 protein is induced by EGF withdrawal 
(FGF2 alone), and further induced by BMP4 in a dose-dependent manner.  
(J) (i) Immunostaining for Ascl1 and Id4 in NSCs in EGF+FGF2, FGF2 alone, FGF2+BMP4 
1ng/mL and FGF2+BMP4 20ng/mL (ii) Immunostaining for Sox2 and Nestin shows strong 
expression in NSCs in all conditions, suggesting they maintain their stemness in all 
conditions. GFAP is expressed at low levels in BMP4 1ng/mL and at high levels in BMP4 
20ng/mL (iii) Immunostaining for Ki67, CyclinD1, EdU incorporation and DAPI shows 
proliferation decreases between EGF+FGF2 and FGF2, and with increasing concentration 
of BMP4. Scale bars, 30µm.    
 
3.4 Transcriptome-wide analysis of the refined in vitro model 
shows BMP4-treated AHNSCs are quiescent 
3.4.1 BMP4 treatment (and not EGF withdrawal) induces a quiescence 
transcriptional “signature” similar to in vivo quiescent NSCs 
Having refined the in vitro model of NSC quiescence, I wanted to further investigate 
how well BMP4-induced NSCs modelled the transcriptional prolife of quiescent stem 
cells, both to validate the refined model and also to gain more knowledge about the 
genes specifically expressed in quiescent AHNSCs. We performed RNA sequencing 
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on AHNSCs treated with 10ng/mL FGF2, either alone or in the presence of either 
1ng/mL or 20ng/mL BMP4 for 72h. At high concentrations, BMP4 regulates many 
hundreds of genes (1364 upregulated in 20ng/mL BMP4 vs FGF2; 933 downregulated) 
(Figure 3.10A,B). Gene ontology analysis showed that BMP4 strongly induces the 
expression of genes involved in “Cell adhesion”, “lipid metabolic process”, “Ion 
transport” and signalling pathways (such as Notch and Pi3k/Akt) (Figure 3.10A,B). 
These ontologies are highly associated with quiescence in stem cells (Shin et al., 
2015) and reflect those found in quiescent NS5 cells (Figure 3.6C). The ontology 
“learning or memory” was also enriched in BMP4 treated AHNSCs, once again 
suggesting these NSCs may retain a transcriptional similarity to their in vivo origins in 
the dentate gyrus. The genes most downregulated by 20ng/mL BMP4 were mostly 
involved in “Cell cycle” and “Cell division” (Figure 3.10B), mirroring the results seen by 
IF and QPCR for cell cycle genes (Figure 3.9). An interesting difference between the 
ontologies enriched in the genes downregulated from FGF2 alone to BMP4, as 
compared to those downregulated from EGF+FGF2 to BMP4 (Figure 3.6B), is that 
there is a bigger variety of terms in the former, such as “Protein phosphorylation”, 
“Sterol biosynthetic process” and “Nervous system development”. This could indicate 
that the effect of removing EGF has a strong independent effect on cell cycle genes, 
which when combined with the effect of BMP4, enriches for cell cycle ontologies at the 
expense of the other BMP4-specific ontologies, further strengthening the reasoning for 
removing EGF from the in vitro system. I next compared the list of BMP4-upregulated 
genes with genes reported to be enriched in stem cells sorted directly from adult 
neurogenic niches. Specifically, I compared the 1364 genes in my dataset to the top 
1000 genes enriched in FAC-sorted quiescent RGLs from the adult mouse dentate 
gyrus, identified by single-cell RNAseq, from the work of Shin and colleagues (Shin et 
al., 2015), and the genes enriched in FACS isolated quiescent SVZ NSCs by Codega 
and colleagues (Codega et al., 2014). Of the genes significantly upregulated by BMP4 
in NSCs, 12.5% were also enriched in quiescent RGLs from the SGZ, and 23.7% were 
shared with quiescent SVZ NSCs (Figure 3.10C). Considering this analysis is 
comparing data gathered from stem cells isolated directly from the adult mouse brain 
versus stem cell cultures, from two different neurogenic niches, by different 
laboratories, and the raw data processed in different ways, it is striking that more than 
a third (36.3%) of the BMP4-induced genes are common with quiescent in vivo NSCs. 
Figure 3.10D shows the top 20 genes with the biggest fold-increase in BMP4-induced 
quiescent AHNSCs; genes that were also found to be enriched in quiescent RGLs in 
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vivo (Shin et al., 2015) are coloured green. Two of the other top “quiescence” genes 
identified by Shin et al., Id4 and Id3, were also strongly induced by BMP4 treatment 
(Figure 3.10C). Together these data strongly support the hypothesis that BMP4-
induced AHNSCs model a state of quiescence with a high degree of similarity to 
quiescent RGLs of the adult dentate gyrus, and therefore is a biologically relevant 
system to further explore the regulation of SGZ NSC quiescence. 
 
Figure 3.10. RNAseq analysis of active (FGF2 only) and quiescent (FGF2+BMP4) 
AHNSCs (legend next page) 
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Figure 3.10. RNAseq analysis of active (FGF2 only) and quiescent (FGF2+BMP4) 
AHNSCs 
A list of genes differentially expressed between NSCs in FGF2 vs FGF2+BMP4 was 
generated, and split into significantly upregulated (FPKM expression in FGF2+BMP4 >=1, 
Log2 fold change >=1) and significantly downregulated (FPKM expression in FGF2 >=1, 
Log2 fold change <=-1). n=3 independent biological replicates.  
(A-B) Gene Ontology terms associated with up- or down-regulated genes in FGF2+BMP4 
20ng/mL 72h compared to NSCs in FGF2 alone. Shown for each term are the number of 
genes associated with the ontology, and its significance (p value). Dots are coloured based 
on their ontology terms - light blue: cell cycle/division; dark blue: DNA repair/replication; 
light green: Protein phosphorylation/modification; dark green: signalling, transcription; 
orange: adhesion/cytoskeleton; yellow: ion-related; pink: brain/nervous system related; 
purple: metabolism.  
(C) Overlap of genes enriched (upregulated) in AHNSCs in FGF2+BMP4 conditions, with 
genes enriched in quiescent SGZ NSCs from Shin et al., 2015 (Supplementary Table S4, 
Top 1000 DOWN genes), and genes enriched in quiescent SVZ NSCs from (Codega et al., 
2014) (Supplementary Table S1, “qNSC signature”). Numbers correspond to number of 
genes.  
(D) The top 20 genes most enriched in FGF2+BMP4-treated NSCs compared to FGF2 
alone are listed in order of fold change (FPKM expression in FGF2 >=1, Log2 fold change 
>=1). Green bars highlight genes also identified to be enriched in quiescent NSCs from 
(Shin et al., 2015) and (Codega et al., 2014). Also shown are Id4, Id3 and Id2 which are the 
84th, 94th and 177th most expressed genes in BMP4, respectively.  
 
3.4.2  “Shallow” and “deep” quiescent NSCs have specific transcriptional 
differences 
As mentioned above, RGLs in vivo likely receive different concentrations of the various 
niche signals such as BMP. The level of BMP signalling they receive could dictate their 
response to other regulating signals, therefore it is useful to understand more about the 
biology of the stem cells in different concentrations of BMP4. To this end, I explored 
the dose-dependent transcriptional effects of BMP4 on NSCs by comparing RNAseq 
data generated from NSCs treated with 1ng/mL (“shallow” quiescence) vs 20ng/mL 
BMP4 (“deep” quiescence). Firstly, 20ng/mL BMP4 regulates far more genes than 
1ng/mL BMP4 (1839 vs 254; Figure 3.11). There are some shared ontologies of genes 
upregulated in 1ng/mL and 20ng/mL BMP4, such as “Ion transport”, “Lipid metabolic 
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process”, “Pi3K signalling” and “Memory” (Figure 3.11A), and most of the upregulated 
genes overlap with those upregulated by 20ng/mL BMP4 (Figure 3.11C). However, the 
top enriched ontology in 20ng/mL BMP4 (and published NSC quiescent signatures 
(Codega et al., 2014; Shin et al., 2015)) “Cell adhesion” is not enriched in 1ng/mL 
BMP4 conditions, suggesting high doses of BMP4 are required to induce a full 
transcriptional “quiescence” profile. The downregulated genes however are more 
similar in ontology between the two concentrations of BMP4, mostly concerning “Cell 
cycle”, and again most of the downregulated genes overlap with those downregulated 
by 20ng/mL BMP4 (Figure 3.11D), suggesting low dose of BMP4 mostly affects the cell 
cycle, which was also seen by analysis of proliferation markers (Figure 3.9). Overall, 
these results show that 1ng/mL BMP4 can partially induce the quiescence 
transcriptional programme, mostly regulating cell cycle genes, but it is not sufficient to 
induce the wide-scale transcriptomic changes seen with 20ng/mL BMP4, which more 
strongly correspond with the published data on quiescent NSCs (Codega et al., 2014; 
Shin et al., 2015). Lower concentrations of BMP4 may be useful in modelling a shallow 
state of quiescence from which the stem cells are more easily reactivated, as well as to 
determine the interaction of BMP with other niche signals such as Notch, which I will 
explore further in Chapter 5. The higher concentration of BMP4 induces a “deeper” 
state of quiescence and based on the analysis here may model more closely the 
quiescent state of adult RGLs in vivo. 
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Figure 3.11. Comparison of 1ng/mL vs 20ng/mL BMP4 in quiescent AHNSCs by 
RNAseq  
 (A-B) Gene Ontology terms associated with up- or down-regulated genes in FGF2+BMP4 
1ng/mL 72h compared to NSCs in FGF2 alone. Shown for each term are the number of  
genes associated with the ontology, and its significance (p-value). Dots are coloured based 
on their ontology terms - light blue: cell cycle/division; dark blue: DNA repair/replication; 
light green: Protein phosphorylation/modification; dark green: signalling, transcription; 
orange: adhesion/cytoskeleton; yellow: ion-related; pink: brain/nervous system related; 
purple: metabolism.  
(C,D) Overlap of genes up- or down-regulated in 20ng/mL or 1ng/mL BMP4. Numbers 
correspond to number of genes. 
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Chapter 4. Results 2 
Having developed an in vitro model of AHNSC quiescence that closely resembles 
many features of quiescent RGLs in the SGZ, as described in Chapter 3, I next sought 
to use this model to further investigate the molecular mechanisms downstream of 
BMP4-induced quiescence, by combining the in vitro model with investigating RGL 
quiescence in vivo. Previous work from our laboratory has identified Ascl1 protein to be 
expressed in a subset of active RGLs and a crucial activation factor for RGLs 
(Andersen et al., 2014), as well as being tightly regulated at the protein level by the E3-
ubiquitin ligase Huwe1 (Urban et al., 2016). Moreover, in Chapter 3 I presented the 
interesting observation that BMP4 suppresses the levels of Ascl1 protein, but not Ascl1 
mRNA in quiescent NSCs (Figure 3.9D,H). These results raised the possibility that 
Ascl1 may be transcriptionally active in quiescent NSCs, but suppressed at the protein 
level. In light of these findings, I began my investigation of the regulation of RGL 
quiescence by further characterising Ascl1 expression in quiescent vs active RGLs. In 
this chapter, I will begin by presenting the unexpected findings of Ascl1 mRNA 
expression in quiescent RGLs in vivo, focussing on the differences between the mRNA 
and protein expression, and confirming the in vitro model recapitulates these 
observations. I will then describe the identification of Id4 as a candidate regulator of 
Ascl1 protein stability downstream of BMP4 signalling, characterising its expression in 
RGLs in vitro and NSCs in vivo. Next, I will present the functional analysis of Id4 in 
NSCs in vitro, and the effects of Id4 conditional deletion in vivo on RGL quiescence. 
Finally, I will investigate whether Id4 expression is downstream of BMP/Smad 
signalling in vivo.  
4.1 Ascl1 is expressed at the transcriptional level, but inhibited 
at the protein level, in quiescent NSCs in vivo and in vitro  
4.1.1 Many more RGLs in vivo express Ascl1 mRNA than Ascl1 protein  
Ascl1 has been shown to be a crucial transcription factor for RGL activation, integrating 
niche signals to drive a transcriptional program to activate RGLs (Andersen et al., 
2014). It has also been shown that negative regulation of Ascl1 stability by the E3 
ubiquitin ligase Huwe1 is required to enable active RGLs to return to quiescence, by 
promoting the degradation of Ascl1 (Urban et al., 2016). However, considering Ascl1 
levels are central to regulating RGL activation from quiescence, it had not been 
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examined whether Ascl1 protein is also regulated in quiescent RGLs, nor has the 
transcriptional expression of Ascl1 in RGLs been examined. Therefore, I investigated 
Ascl1 transcriptional levels in RGLs in adult mice, by examining the expression of GFP 
in P70 Ascl1KiGFP mice in which the coding region of one allele of Ascl1 is replaced by 
the coding sequence for nuclear-localised GFP, downstream of the Ascl1 promoter. 
This means GFP+ RGLs report Ascl1 transcriptional expression. RGLs were identified 
by their expression of Glial Fibrillary Acidic Protein (GFAP), localisation of their nucleus 
in the subgranular zone of the DG, and the presence of a radial process extending 
towards the molecular layer. By monoclonal antibody immunostaining, Ascl1 protein is 
detected in a very small percentage of RGLs, representing the “active” fraction (Figure 
4.1A; (Andersen et al., 2014)). Strikingly, Ascl1 mRNA as reported by GFP 
immunoreactivity was found in the majority (82.3±3.8%) of RGLs, in stark contrast to 
the 1.9±0.3% RGLs positive for Ascl1 protein (Figure 4.1A,C) (IF and quantifications 
performed by N. Urban). I also used an independent readout of Ascl1 protein, the 
Ascl1Venus mouse line, which expresses an Ascl1-Venus fusion protein and allows 
detection of lower levels of Ascl1 by GFP immunostaining (Figure 4.1B), levels which 
we were not able to detect using the monoclonal antibody (I will discuss further the 
issues of Ascl1 antibody staining in Section 4.4.3). Many more Ascl1+ RGLs were 
detected using Ascl1Venus fluorescence (50.5±10.5%) than monoclonal Ascl1 
antibody immunoreactivity (Figure 4.1C), although quantification of the actual 
fluorescence levels showed many of the positive RGLs had very low levels of Venus 
(Figure 4.1D). Specifically, 72.4% of the RGLs measured had a Venus intensity less 
than the mean, indicating the majority of RGLs had low Ascl1Venus levels. Also, 
despite the higher percentage of Ascl1Venus+ RGLs than Ascl1KiGFP+ RGLs, still 
around 30% more RGLs expressed Ascl1 mRNA (GFP) than Ascl1Venus (Figure 
4.1C). Overall these data show many more RGLs express Ascl1 mRNA than Ascl1 
protein.  
 
The levels of Ascl1 transcription in Ascl1KiGFP mice (GFP immunostaining) were 
variable (Figure 4.1A,E,G), with some RGLs expressing high levels of GFP and others 
low levels. This could reflect an oscillatory expression of Ascl1 transcription, similar to 
what has been observed for Ascl1 in embryonic NSCs (Imayoshi et al., 2013). A 
dynamic expression pattern of this kind could regulate the activation of RGLs, with 
higher Ascl1kiGFP levels representing RGLs that are closer to activation. To determine 
whether Ascl1 transcription (GFP) levels correlated with other markers of activation, I 
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double-labelled RGLs for GFP and Ki67 (Figure 4.1E). Every Ki67+ RGL identified was 
also GFP+ (Figure 4.1F). However, 83.8±4.1% of Ki67- quiescent RGLs were also 
GFP+ (Figure 4.1F), indicating Ascl1 mRNA is expressed in most quiescent RGLs. I 
next measured the GFP fluorescence intensity in Ki67+ (active) and Ki67- (quiescent) 
RGLs to see whether Ascl1 is expressed at a higher level in active RGLs and at a 
lower level in quiescent RGLs. Figure 4.1G shows average GFP levels were not 
significantly different in active and quiescent RGLs. This shows that both active and 
quiescent RGLs express Ascl1 mRNA, suggesting there is a negative regulatory 
mechanism functioning in most RGLs to suppress Ascl1 protein expression. 
Interestingly, the range of GFP intensity values was greater in quiescent compared to 
active RGLs. The dynamics of Ascl1 transcription in RGLs in vivo has not been 
investigated, and it would be interesting to explore whether there is a functional 
significance to this expression pattern with regards to neural stem cell activity. 
 
A caveat of using Ascl1KIGFP mice to readout Ascl1 transcript levels is the stability of the 
GFP is not necessarily equivalent to the stability of Ascl1 protein, therefore GFP 
positivity may reflect a cell that had been transcribing Ascl1 in the past, but had shut it 
down by the time of analysis. In other words, Ascl1KiGFP could be giving false positive 
results. Therefore, to more specifically examine Ascl1 mRNA expression in RGLs in 
vivo, I performed fluorescent RNA in situ hybridization using the RNAscope® system 
(ACD/Biotechne) on brain sections from P60 mice, for both Ascl1 and Ki67, followed by 
immunocytochemistry for GFAP. GFAP IHC allowed me to identify RGLs based on 
their immunoreactivity and morphology, and Ki67 RNA staining enabled me to 
distinguish between active and quiescent RGLs. In addition, I also analysed Ascl1 and 
Ki67 in situ in GlastCreERT2;tdTomato (Ai9) mice 48h after a single tamoxifen injection. 
These mice have a Cre reporter allele with a loxP-flanked STOP cassette, which allows 
for tdTomato expression following tamoxifen-induced Cre-mediated recombination. 
tdTomato clearly marks the morphology of recombined RGLs, allowing for more 
reliable identification of RGLs than GFAP IHC. Giving a single injection of tamoxifen 
induces sparse recombination in GLAST-expressing stem cells, allowing for the 
identification of individual recombined RGLs. I identified 93 RGLs across 5 mice, based 
on GFAP or tdTomato immunoreactivity and morphology, of which 20 were Ki67+, and 
72 were Ascl1+. mRNA was detected as fluorescent ‘dots’ of varying sizes (Figure 
4.1H,I). Every RGL positive for Ki67 mRNA had at least 1 ‘dot’ of Ascl1 mRNA (Figure 
4.1H-J). Out of the Ki67- RGLs identified, 27.39% were negative for Ascl1 mRNA, 
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however two thirds had at least one ‘dot’ of Ascl1 mRNA, with many having far more, 
some with up to 17 detectable ‘dots’ (Figure 4.1J). This shows that Ascl1 is transcribed 
in quiescent RGLs in vivo, reflecting the results from quiescent NSCs in vitro. The 
average number of Ascl1 mRNA ‘dots’ in Ki67- RGLs was 2.58±0.3, and was not 
significantly different from the average number in Ki67+ RGLs (3.95±0.8). mRNA ‘dots’ 
varied in size, with some having a stronger fluorescence signal than others, which 
could reflect differing amounts of RNA. Therefore, to determine whether there was a 
difference in Ascl1 mRNA levels between active and quiescent RGLs that could be 
seen by differences in Ascl1 fluorescence, I measured the fluorescence intensity of 
Ascl1 in situ, in the area within and around the nucleus of identified RGLs, following the 
boundary of GFAP or tdTomato immunofluorescence. Average fluorescence intensity 
of Ascl1 in situ was not significantly different between quiescent (Ki67-) and active 
(Ki67+) RGLs (86.51±3.6 vs 100±8.8 arbitrary units; Figure 4.1K), indicating Ascl1 is 
transcribed at similar levels in both active and quiescent RGLs. This strongly suggests 
there is a mechanism regulating Ascl1 protein levels in RGLs in vivo.  
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Figure 4.1. Ascl1 mRNA and protein expression in hippocampal RGLs (legend 
next page) 
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Figure 4.1. Ascl1 mRNA and protein expression in hippocampal RGLs 
(A) Immunolabelling for Ascl1, GFAP and GFP in the subgranular zone (SGZ) of the 
dentate gyrus (DG) of Ascl1KiGFP mice. White arrows indicate GFP+Ascl1- RGLs; yellow 
arrows indicate GFP+Ascl1+ RGLs. Scale bar, 30µm. 
(B) Immunolabelling for GFAP and GFP(Ascl1-Venus) in adult Ascl1Venus mice. Scale bar, 
30µm. 
(C) Quantification of percentage of GFP+ RGLs in Ascl1KiGFP mice; Ascl1+ RGLs detected 
by monoclonal antibody staining; and Ascl1Venus+ RGLs in Ascl1Venus mice. The 
widespread GFP expression in Ascl1KiGFP mice indicates Ascl1 is transcribed in most 
GFAP+ RGLs. Venus immunostaining in Ascl1Venus mice is detected in more RGLs than 
monoclonal antibody staining for Ascl1, likely due to the more sensitive and robust GFP 
antibody. n=3 mice. 
(D) Quantification of the fluorescence levels of Ascl1Venus in Ascl1Venus mice (detected by 
GFP immunostaining) shows a range of expression levels with the vast majority showing 
low levels of expression. n=1 representative mouse.  
(E) Immunolabelling for GFP, Ki67 and GFAP in the SGZ of the DG of Ascl1KIGFP reporter 
mice. White arrows indicate GFP+Ki67- RGLs; yellow arrows indicate GFP+Ki67+ RGLs. 
Scale bar, 30µm. 
(F, G) Quantification of the data in (E). Most quiescent (Ki67-) RGLs express GFP and 
therefore transcribe Ascl1 (F) and the average levels of GFP are not significantly different 
in quiescent and proliferating RGLs (G), indicating that Ascl1 is transcribed in both RGL 
populations. The range of GFP fluorescence levels is much higher in quiescent RGLs, 
suggesting they have a higher dynamic range of Ascl1 transcriptional activity, possibly 
reflecting an oscillatory expression. n=3 mice.  
(H, I) RNA in situ hybridization by RNAscope® with an Ascl1 probe (magenta) and a Ki67 
probe (green) and Immunolabelling for GFAP in wildtype mice, or tdTomato in Glast-
CreERT2;tdTomato mice, to mark RGLs in the SGZ of the DG. To label RGLs with 
tdTomato, Glast-CreERT2;tdTomato mice were injected once at P60 with 4-
hydroxytamoxifen, and analysed 48h later. White arrows indicate RGLs positive for Ascl1 
RNA staining; yellow arrows show RGLs positive for both Ascl1 and Ki67 RNA. 
Magnifications of the RGLs marked by white boxes are shown on the right, highlighting an 
RGL positive for both Ascl1 and Ki67 RNA, and an RGL positive for only Ascl1 RNA. 
Dotted lines show the outline of the GFAP or tdTomato signal. Scale bar, 10µm. n=5 mice.  
(J, K) Quantification of the data in (H, I). Ascl1 RNA levels were quantified either by 
counting the number of RNA ‘dots’ per nucleus (J) and the intensity of the fluorescence 
signal per RGL nucleus (K). Ascl1 transcripts are found at a similar level in quiescent 
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(Ki67-) and proliferating (Ki67+) RGLs. 100 RGLs were quantified across n=5 mice. All 
statistical analyses were made using unpaired t-test (mean±SEM). p>0.05 (ns), p<0.05 (*). 
4.1.2 Ascl1 protein, but not mRNA, is inhibited by BMP4-induced 
quiescence in AHNSCs in vitro 
I next looked to see how Ascl1 mRNA and protein were expressed in active and 
quiescent AHNSCs in vitro, to see whether the observations in vivo could be 
recapitulated by the in vitro model. I repeated QPCR analysis of Ascl1 mRNA levels in 
active (FGF2 20ng/mL) and quiescent NSCs (FGF2 20ng/mL +BMP4 20ng/mL, 72h), 
from cells that had been cultured for several passages in FGF2 alone (rather than 
immediately following EGF withdrawal, as for results shown in Chapter 1), which again 
showed no change between the two conditions (Figure 4.2A). I also analysed AHNSCs 
derived from adult Ascl1KiGFP mice. GFP expression acts as a readout for Ascl1 
transcriptional levels, so I performed immunocytochemistry for GFP in active and 
quiescent Ascl1KiGFP AHNSCs in culture, which revealed many GFP+ cells in both 
active and quiescent conditions in a ‘salt and pepper’ pattern (Figure 4.2B), which 
could indicate an oscillatory expression dynamic, similar to the observation of 
Ascl1KiGFP staining in vivo and live imaging of Ascl1 transcription in embryonic NSCs 
(Imayoshi et al., 2013). Analysis of nuclear GFP fluorescence intensity in every cell 
revealed no significant difference in average intensity between active and quiescent 
AHNSCs (Figure 4.2C), further supporting the notion that BMP4 does not affect Ascl1 
mRNA expression. I next repeated immunofluorescence staining of Ascl1 protein in 
active and quiescent non-transgenic AHSNCs (Figure 4.2D), and measured the 
nuclear fluorescence intensity (Figure 4.2E), which showed BMP4 significantly 
supressed Ascl1 protein levels. This observation was confirmed by measuring Ascl1 
protein levels in AHNSC lysates by Western blot (Figure 4.2F; Western blot performed 
by M. Masdeu), which showed a significant decrease in Ascl1 protein in quiescent 
AHNSCs. These results indicate Ascl1 is actively transcribed but repressed at the 
protein level in quiescent NSCs.  
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Figure 4.2. Ascl1 mRNA and protein expression in AHNSCs in vitro 
(A) QPCR analysis of transcript levels of Ascl1 in hippocampal-derived NSCs in active 
(FGF2) or quiescent (FGF2+BMP4 20ng/mL) conditions. Ascl1 mRNA levels are not 
changed between active and quiescent conditions. 
(B) Immunocytochemistry for GFP and DAPI staining in active and quiescent NSCs derived 
from Ascl1KIGFP mice. Scale bar, 30µm.  
(C) Quantification of GFP levels shown in (B). The average fluorescence level (arbitrary 
units, A.U.) for GFP, which reports Ascl1 transcriptional activity, is not significantly different 
between active and quiescent NSCs. Data shown is from one representative experiment of 
n=3 independent biological replicates.   
(D) Immunocytochemistry for Ascl1 and DAPI staining in FGF2- and FGF2+BMP4-treated 
NSCs. Scale bar, 30µm. 
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(E) Quantification of the data in (D). The levels of Ascl1 protein, measured by fluorescence 
intensity (A.U.) is expressed in a salt-and-pepper pattern in active NSCs, possibly reflecting 
an oscillatory expression, with many expressing high levels of Ascl1. Ascl1 protein is mostly 
undetectable in quiescent NSCs. Data shown is from one representative experiment of n=3 
independent biological replicates. 
(F) Western blot analysis and quantification of Ascl1, relative to Actin, in FGF2- and 
FGF2+BMP4-treated NSCs. BMP4 suppresses Ascl1 protein expression. n=3 
All statistical analyses were made using unpaired t-test (mean±SEM). p>0.05 (ns), p<0.05 
(*), p<0.0001(****).  
 
4.1.3 Ascl1 protein is actively translated in NSCs in vitro 
One hypothesis for why Ascl1 mRNA but not protein is expressed in quiescent RGLs, 
is that Ascl1 mRNA is transcribed into protein in quiescent RGLs, but is subsequently 
very rapidly degraded by the proteasome. This could be possible, due to the short 30-
minute half-life of Ascl1 protein in active NSCs (Urban et al., 2016). An alternative 
hypothesis is that the mRNA is being transcribed but prevented from being translated, 
for example by microRNA-mediated translation inhibition (without mRNA 
destabilisation), or via the various other forms of translational regulation that exist in 
eukaryotic cells (reviewed by (Sonenberg and Hinnebusch, 2009)). Therefore, I tested 
whether Ascl1 protein was being actively translated in quiescent NSCs using the in 
vitro quiescence model, by inhibiting the proteasome and measuring Ascl1 protein 
levels by Western Blot. To inhibit the proteasome, I used MG132 which inhibits the 
function of the proteasome by covalently binding to the active proteolytic sites inside 
the proteolytic ß-ring domain, thereby inhibiting proteasomal degradation of 
ubiquitinated proteins. I induced quiescence in NSCs with BMP4, and then treated 
them with 10µm of the MG132 for 30, 60 and 120 minutes. Control quiescent NSCs 
were treated with an equal volume of DMSO for 30mins. Ascl1 protein is barely 
detectable in BMP4-induced quiescent NSCs (Figure 4.1F; Figure 4.3A DMSO control) 
however following MG132 treatment the protein is clearly detected and strongly 
increased compared to control (Figure 4.3A), indicating Ascl1 protein is actively 
transcribed in quiescent NSCs but rapidly degraded in a proteasome-dependent 
manner. Increased levels of Ascl1 protein were also observed in active NSCs treated 
with the proteasome inhibitor (Figure 4.3B), reflecting the dynamic regulation of Ascl1 
and its short half-life (Urbán et al., 2016).  
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Figure 4.3. Ascl1 protein levels increase in AHNSCs following proteasomal 
inhibition  
(A, B) Western blot analysis of Ascl1 in quiescent (FGF2+BMP4 10ng/mL) or active (FGF2) 
NSCs, after treatment with 10uM of the proteasome inhibitor MG132 for 30, 60 or 120 
minutes. Ascl1 levels are undetectable in quiescent NSCs relative to Actin, however a clear 
band is observed following proteasomal inhibition (A). Ascl1 levels are also increased 
following proteasomal inhibition of active NSCs (B). n=1. 
 
4.1.4 Proteasomal degradation of Ascl1 in quiescent NSCs is independent of 
Huwe1 
As previously mentioned at the beginning of this chapter, our lab has shown that Ascl1 
protein is targeted for degradation in active RGLs by the E3-ubiquitin ligase Huwe1 
(Urban et al., 2016). I therefore tested whether Huwe1 was mediating the proteasomal 
degradation of Ascl1 in quiescent NSCs. I used AHNSCs derived from Cre-mediated 
Huwe1 knock-out mice (Huwe1fl/Y; Urban et al., 2016) in order to conditionally delete 
Huwe1 (Huwe1cKO) in AHNSCs in vitro. I transduced active and quiescent AHNSCs 
with either empty Adenovirus or Adenovirus expressing Cre-recombinase, to induce 
recombination of the floxed Huwe1 allele. I measured Ascl1 protein levels in Huwe1cKO 
NSCs by immunofluorescence and found BMP4 was able to significantly suppress the 
levels of Ascl1 protein in the absence of Huwe1 (Figure  4.4A,B), indicating there is a 
Huwe1-independent mechanism acting in quiescent AHNSCs to promote the 
proteasomal degradation of Ascl1. This result agrees with the observation that Huwe1 
is required in vivo to facilitate the return of proliferating RGLs to quiescence, but not 
required to maintain RGL quiescence itself (Urban et al., 2016).  
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Figure 4.4. Inhibition of Ascl1 protein in quiescent AHNSCs is Huwe1-
independent 
(A) Immunostaining for Ascl1 and DAPI staining in NSCs derived from Huwe1-floxed mice, 
infected with either Adeno-empty or Adeno-Cre to induce recombination of the floxed 
alleles and delete Huwe1. Cells were fixed 6 days following adenoviral infection, in order to 
allow sufficient time for the very stable Huwe1 protein to degrade. Treatment with 72h 
BMP4 20ng/mL was able to suppress Ascl1 protein levels in both control and Huwe1cKO 
cells. Scale bar, 30µm. 
(B) Quantification of Ascl1 immunofluorescence shown in (A). Ascl1 levels (arbitrary units, 
A.U.) are significantly suppressed by BMP4 treatment even in the absence of Huwe1. n=1. 
Unpaired t-test (mean±SEM), p<0.0001(****).  
 
4.2 Inhibitor of Differentiation 4 (Id4) is highly expressed in 
quiescent RGLs and NSCs, and anti-correlates with Ascl1 
protein 
4.2.1 Expression of the Id proteins in vivo  
I next explored the potential mechanism regulating Ascl1 protein in quiescent RGLs. Id 
proteins have been described to negatively regulate bHLH transcription factors like 
Ascl1, by sequestering E-proteins, which are dimerization partners of Ascl1 and are 
required for the stabilisation of Ascl1 protein and DNA binding of its target genes (Shou 
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et al., 1999; Vinals et al., 2004). The RNAseq analysis of BMP4-induced quiescent 
NSCs showed the four Id genes Id1-4 were strongly enriched in the quiescent state 
(Figure 3.10D). Id4 was also shown to be the most enriched gene in quiescent RGLs in 
the single cell RNAseq data generated from FAC sorted RGLs in adult mice (Shin et 
al., 2015). Therefore, I examined the expression of the four Id proteins in the SGZ of 
adult mice. Id1 is expressed in around half of all RGLs (52.2±4.4%; Figure 4.5A,B), 
whereas Id4 was found in 89.57±2.3% of all RGLs (Figure 4.5D,E). Id3 expression was 
found in a very small number of RGLs, and Id2 was expressed by granule neurons and 
not in RGLs (Figure 4.5I,J). Based on these expression patterns, Id1 and Id4 are the 
more likely candidates to be negatively regulating Ascl1 in quiescent RGLs. 
Interestingly, analysis of the protein level of Id1 or Id4 in quiescent (Ki67-) vs active 
(Ki67+) RGLs, quantified by fluorescence intensity of the immunostaining, showed that 
Id1 was enriched in active RGLs (Figure 4.5C), whereas Id4 was highly enriched in 
quiescent RGLs (Figure 4.5F). Moreover, immunostaining for Id4 in Ascl1Venus mice 
showed Ascl1Venus+ RGLs had lower levels of Id4 than Venus- RGLs (Figure 4.5G,H) 
suggesting an anti-correlation between Id4 and Ascl1. These data implicate Id4 as a 
key candidate for regulating Ascl1 protein in quiescent RGLs in vivo.  
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Figure 4.5. Protein expression of Id1, 2, 3 and 4 in the dentate gyrus 
(A) Immunolabelling for Id1, Ki67 and GFAP in the dentate gyrus of adult mice. White 
arrows indicate GFAP+RGLs positive for both Id1 and Ki67. Scale bar, 30µm.  
(B) Quantification of the percentage of Id1+ GFAP+ RGLs. n=4 mice. 
(C) Quantification of Id1 protein levels, measured by immunofluorescence intensity (A.U.) 
in active (Ki67+) or quiescent (Ki67-) RGLs. Id1 levels are significantly higher in active 
RGLs.  n=4 mice. 
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(D) Immunolabelling for Id4, Ki67 and GFAP in the dentate gyrus of adult mice. The white 
arrow indicates a GFAP+RGL positive for Ki67 and negative for Id4. Scale bar, 30µm.  
(E) Quantification of the percentage of Id4+ GFAP+ RGLs. n=4 mice. 
(F) Quantification of Id4 protein levels, measured by immunofluorescence intensity (A.U.) in 
active (Ki67+) or quiescent (Ki67-) RGLs. Id4 protein is strongly enriched in quiescent 
RGLs.  n=4 mice. 
(G) Immunolabelling for Id4, Ascl1Venus (GFP) and GFAP in the dentate gyrus of adult 
Ascl1Venus mice. The white arrow indicates a GFAP+RGL positive for Ascl1Venus and 
negative for Id4. Scale bar, 30µm.  
(H) Quantification of the immunofluorescence levels of Ascl1Venus in RGLs with high or 
low levels of Id4. Ascl1Venus levels are much higher in Id4 low RGLs, compared to Id4 
high. The dotted line indicates the threshold for Ascl1Venus positivity. n=1 representative 
mouse.  
(I, J) Immunofluorescence for GFAP and Id2 (I) or Id3 (J) plus DAPI staining in the DG of 
adult mice. Id2 is expressed in granule neurons, while Id3 is expressed in astrocytes and 
very small number of RGLs. White arrows indicate Id3+ GFAP+ RGLs. Scale bar, 30µm. 
 
4.2.2 Id4 is the most enriched Id protein in quiescent AHNSCs in vitro, and 
anti-correlates with Ascl1 
I returned to the in vitro model of AHNSC quiescence to see whether Id4 was enriched 
in BMP4-induced quiescence. I had already observed that Id4 was upregulated upon 
BMP4 treatment compared to EGF+FGF2 conditions (Figure 3.9A,I). I repeated the 
QPCR for Id4, along with Id1-3, in cells cultured in FGF2 alone and FGF2+BMP4, 
which showed all four Id genes were upregulated upon 72h BMP4 treatment, with Id4 
showing the biggest fold-change (Figure 4.6A). I next analysed the protein levels of the 
four Ids by immunocytochemistry (Figure 4.6E-H). Each Id protein had some degree of 
expression in active NSCs, and quantification of the fluorescence intensity showed Id2 
and Id3 were not changed following BMP4 addition, whereas Id1 and Id4 were strongly 
upregulated at the protein level in quiescent NSCs (Figure 4.6B). Moreover, the pattern 
of Id2 and Id3 in quiescent NSCs was fairly uniform, whereas Id1 and Id4 had a salt 
and pepper expression pattern (Figure 4.6E-H), much like Ascl1, which could indicate a 
dynamic regulation and allow for the expression of Ascl1 protein in those cells where 
Id1/4 is lower expressed. Western blotting for Id1, Id3 and Id4 confirmed the 
upregulation of Id1 and Id4 by BMP4 (Figure 4.6C) (the antibody for Id2 did not work 
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for Western blot; Western blots performed by M. Masdeu). The fold increase for Id4 
protein is quantified in Figure 4.6D, showing significant upregulation by BMP4. Id1 and 
Id4 therefore presented as promising candidates for regulating Ascl1 protein in 
quiescent NSCs, with Id4 being the top candidate based on its expression in vivo. I 
next analysed the co-expression of Ascl1 and the Id proteins by immunofluorescence 
(Figure 4.6E-L). Ascl1 is expressed at low levels in a small percent of quiescent NSCs, 
and so I measured the fluorescence intensity of Ascl1 and each Id protein, and plotted 
the values against each other. Pearson correlation coefficient analysis showed a 
positive correlation between Ascl1 and Id1, Id2 and Id3 (Figure 4.6I-K), whereas for Id4 
the correlation coefficient was close to 0. When I inputted the thresholds for Id4 and 
Ascl1 positivity (determined by background fluorescence, marked by dotted lines on 
graph 4.6L), I saw that no quiescent NSC was positive for both Ascl1 and Id4; where 
Id4 levels were higher, Ascl1 was low or negative, and in the few cells that express 
detectable Ascl1, Id4 levels were below the threshold to be considered positive. This 
mutually exclusive expression pattern reflects the pattern of Id4 and Ascl1Venus in 
vivo, and may be indicative of Id4 functioning to suppress Ascl1 levels. 
Chapter 4 Results 
 
128 
 
 
Figure 4.6. Expression of Id1-4 in AHNSCs in vitro 
(A) QPCR analysis of the expression levels of Id1-4 in active (FGF2) and quiescent 
(FGF2+BMP4 20ng/mL) NSCs in vitro. n=3 for Id1,3 and 4. n=2 for Id2. 
(B) Quantification of immunofluorescence levels (A.U.) of Id1-4 in active (FGF2) and 
quiescent (FGF2+BMP4 20ng/mL) NSCs in vitro. n=3. At least 100 cells were quantified.  
(C) Western blot analysis of Id1, Id3 and Id4 in active (FGF2) and quiescent (FGF2+BMP4 
20ng/mL) NSCs in vitro. Id2 antibody was unable to detect any signal, with high 
background.  
(D) Quantification of Id4 protein levels as determined by Western blot. n=3. 
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(E-H) Immunolabelling of Id1, Id2, Id3 or Id4 with Ascl1 and DAPI staining in active and 
quiescent NSCs. Scale bar, 30µm. 
(I-L) Plots of Ascl1 immunofluorescence vs Id1,2,3 or 4 immunofluorescence per nuclei, 
measured from the immunostainings shown in (E-H). Shown are the correlation coefficients 
(r) and coefficient of determination (R2) for Ascl1 with each Id protein. Ascl1 is positively 
correlated with each Id protein except for Id4.  
4.2.3 E-proteins are expressed in hippocampal NSCs and interact with Ascl1 
and Id4 in vitro 
Before further investigating the function of Id4 in relation to Ascl1 in quiescence, I 
needed to examine the expression of the third player in the Id-bHLH dynamic, the E-
proteins, which in mammals are E47, E12, E2-2 and HEB. The inhibitor of 
differentiation proteins are well known to regulate bHLH transcription factors by 
sequestering the bHLH dimerization partners, E-proteins, rendering the bHLH factor 
unable to bind DNA and activate its target genes. When Ascl1 is monomeric, it is highly 
unstable and rapidly targeted for degradation (Vinals et al., 2004). At this stage, we 
hypothesised that the degradation of Ascl1 protein in quiescent RGLs was caused by 
the high levels of Id4 sequestering the E-protein dimerization partners of Ascl1. I 
therefore examined the expression of the genes encoding the E-proteins, Tcf3 (the 
mRNA of which is alternately spliced to produce E47 or E12 protein), Tcf4 (encoding 
E2-2) and Tcf12 (encoding HEB) from the RNAseq data of active vs quiescent NSCs 
described in Chapter 3. FPKM values for the three Tcf genes show all three are 
expressed in NSCs in vitro, with slightly lower expression in quiescent NSCs (Figure 
4.7A). I also examined their expression in the database of single cell RNAseq gene 
expression generated by the Linnarsson lab from FAC sorted adult DG cells, which 
show all three Tcf genes are expressed in RGLs, with Tcf4 being the most highly 
expressed (http://linnarssonlab.org/dentate/), although none are expressed at high 
levels, especially when compared to Id4 expression, suggesting that expression of the 
E-proteins is a limiting factor in the stability of Ascl1 protein. I next examined whether 
the protein product of these genes was detectable in NSCs in vitro. E47 protein is 
expressed in both active and quiescent NSCs in vitro, shown by Western blot (Figure 
4.7B; Western blots performed by M. Masdeu). Attempts were made to measure the 
levels of the other E-proteins, but commercial antibodies tested were unable to detect 
any protein. I next investigated whether E47 binds to Ascl1 and Id4 in NSCs in vitro. 
The Ascl1Venus cell line was used here, as the mouse monoclonal antibody against 
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Ascl1 does not work well for Western blot, in contrast to the very strong and consistent 
signal for GFP (Ascl1Venus). The Ascl1Venus fusion protein is reported to have similar 
expression as endogenous Ascl1 and Ascl1Venus transgenic mice show normal 
development (Imayoshi et al., 2013), suggesting the fusion protein functions 
comparably to endogenous Ascl1. In active NSCs, immunoprecipitation for E47 was 
able to pull down GFP (Ascl1), whereas no Id4 co-immunoprecipitated with E47 or 
Ascl1 (GFP) in this condition (Figure 4.7C, lanes 1 and 5), although this may reflect the 
low expression of Id4 in FGF2 conditions. In contrast, in quiescent NSCs, E47 was 
able to pull down Id4 (lane 5), and Id4 could pull down E47 (lane 8), whereas no Id4-
Ascl1 co-IP was detected, although again this may simply reflect the low levels of Ascl1 
in quiescent NSCs, meaning there is no protein to IP in the first place. However, when 
Ascl1Venus (GFP) was immunoprecipitated in quiescent NSCs, a band was detected 
using the GFP antibody (Lane 7), suggesting there is still some Ascl1 in quiescent 
conditions to IP, which would suggest Id4 and Ascl1 do not dimerise. We would expect 
that in conditions of high Id4 (quiescence), E47 and Ascl1 do not dimerise, as Id4 is 
sequestering all the E-protein. However, Ascl1-E47 co-IP is also observed in quiescent 
NSCs (lane 7) (Figure 4.7C). This could reflect that Id4 is not able sequester all the E-
protein away, leaving some to bind with Ascl1, but not enough to stabilise high levels of 
Ascl1 protein. This makes sense with regards to the immunostaining of Ascl1 in BMP4-
treated NSCs; even though there is a very strong suppression, some cells do have 
detectable Ascl1. A mouse anti-V5 tag antibody was used as the negative control; V5 
is never expressed in cells unless genetically modified, therefore the antibody will only 
detect background for mouse species of antibody. The negative control showed no co-
IP of any of the proteins, and each protein was able to be detected by Western blot for 
its own IP (Figure 4.7C, lanes 3,4,7,8) (Co-IPs and Western blots performed by M. 
Masdeu). Overall, these results confirm that Ascl1-E47 heterodimers exist in active 
NSCs, and Id4-E47 dimers are present in quiescent NSCs. It could therefore be 
inferred that Id4 is sequestering E47 from Ascl1 in quiescent conditions, promoting 
unstable monomeric Ascl1.  
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Figure 4.7. E-protein expression and co-immunoprecipitation of E47, Id4 and 
Ascl1 in AHNSCs in vitro 
(A) The expression of the Tcf3, 4 and 12 are shown as Fragments per Kilobase per Million 
reads (FPKM) from RNA sequencing of active and quiescent NSCs. All three Tcf genes are 
expressed in both conditions, slightly higher in active than quiescent NSCs.  
(B) Western blot analysis for Tcf3 gene product E47, which shows it is expressed at the 
protein levels in both active and quiescent NSCs.  
(C) Immunoprecipitation of the Ascl1 dimerisation partner E47 from FGF2- and 
FGF2+BMP4-treated NSCs, followed by western blot analysis of GFP(Ascl1Venus) and 
Id4. E47 co-immunoprecipitates with GFP in FGF2 conditions but with Id4 in FGF2+BMP4 
conditions. Mouse anti-V5 antibody was used for the negative control.  
 
4.3 Functional analysis of Id4 in vitro reveals its role in 
maintaining quiescence of NSCs 
4.3.1 Over-expression of Id4 in active NSCs in vitro suppresses Ascl1 
protein, and induces cell cycle arrest 
The results so far suggest Id4 may function to maintain quiescence by inhibiting 
and downregulating Ascl1 protein, via sequestration of its E-protein binding 
partners. To test this functionally, I nucleofected active AHNSCs with Id4 
expressed from a pcBeta plasmid, with a CMV promoter and an N-terminal FLAG 
tag (pcBeta-Id4-nFLAG) (Figure 4.8A). Nucleofected NSCs were then incubated for 
a further 48h in the presence of FGF2, and then analysed. The hypothesis is that in 
active NSCs, Ascl1 is heterodimerised with the E-protein E47, and able to bind the 
E-box sites in its target genes to activate transcription. However, over-expression 
of Id4 will cause E47 to be preferentially dimerised to Id4, leaving Ascl1 monomeric 
and therefore 1) unable to bind DNA to activate transcription of its target genes, 
and 2) rapidly targeted for degradation (Figure 4.8B). After 48h transfection, the 
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efficiency of transfection was 33.75±4.2%, measured by the very strong 
immunoreactivity for overexpressed Id4; endogenous Id4 was undetectable due to 
the very high levels of exogenously expressed Id4 (Figure 4.8C,D). By measuring 
the fluorescence intensity of Ascl1 immunostaining in Id4+ vs Id4- NSCs, I 
observed a highly significant reduction in Ascl1 protein level in Id4 over-expressing 
NSCs (Figure 4.8C,E). This suggests Id4 may be mediating the BMP4-induced 
suppression of Ascl1 protein in AHNSCs, although Id4 is expressed at a higher 
level by overexpression, compared with BMP4-induced Id4, and so the effect 
observed here could also be a result of artificially high levels of Id4. I confirmed that 
Id4 overexpression was not affecting Ascl1 mRNA expression by QPCR (Figure 
4.8F) from RNA extracted from FAC sorted, nucleofected NSCs (described below 
in Section 4.3.2). Id4 overexpression also partially induced cell cycle arrest in 
NSCs; the percentage of Ki67+ NSCs was significantly reduced from 50.81±5.7% 
in Id4- NSCs to 29.7±2.9% in Id4+ NSCs (Figure 4.8G,H), and the percentage of 
NSCs in S-phase marked by EdU incorporation during a 1 hour pulse prior to 
fixation, was also decreased, although not significantly (22.03±4.6% in control 
NSCs, 13.19±2.7% in Id4+ NSCs; Figure 4.8I,J). I independently validated these 
findings by over-expressing Id4 in active NSCs via transduction of an Id4-
expressing Adenovirus. I transduced cells in FGF2 with either 100moi (multiplicity 
of infection; number of viral particles per cell) Adeno-empty virus, as a control, or 
Adeno-Id4 at 100moi, and analysed the cells after 20h. After this time, Ascl1 
protein levels were decreased in Id4-overexpressing NSCs compared to control 
NSCs, quantified by immunofluorescence intensity (Figure 4.8K-M). The 
percentage of cells positive for EdU following a 1 hour pulse prior to fixation, was 
also decreased in Adeno-Id4 transduced cells compared to Adeno-empty 
transduced. Together these results support the hypothesis that Id4 contributes to 
the reduced levels of Ascl1 protein and to the reduced levels of proliferation in 
quiescent NSCs. However, the Adenovirus over-expression experiment was n=1, 
and therefore must be repeated before strong conclusions can be drawn.  
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Figure 4.8. Over-expression of Id4 in active AHNSCs in vitro 
(A) Experimental design for the overexpression of Id4 in active NSCs, via nucleofection of a 
pCbeta-Id4-NFLAG expression construct. NSCs were analysed 48h after nucleofection. 
(B) Scheme showing the hypothesis for the effect of Id4 overexpression. In control active 
NSCs, Ascl1 is heterodimerised to E47, and able to bind DNA and activate transcription of 
its target genes. When Id4 is overexpressed, it sequesters E47, leaving Ascl1 undimerised.  
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In its monomeric form, Ascl1 is unable to bind DNA and activate transcription, and is also 
highly unstable and quickly targeted for degradation (red star).  
(C) Immunostaining for Ascl1 and Id4 and DAPI in active NSCs 48h-post Id4 nucleofection. 
The high levels of Id4 overexpression can be seen from the strong green immunolabelled 
cells. White arrows show the low or absent levels of Ascl1 in Id4-overexpressing NSCs. 
Scale bar, 30µm. 
(D) The percentage of Id4+ NSCs amongst all NSCs was quantified to give a transfection 
efficiency. n=8 from 4 independent biological repeats.  
(E) Quantification of the data shown in (C). Ascl1 protein levels are significantly reduced in 
active NSCs over-expressing Id4. n=4 
(F) Ascl1 mRNA levels are unaffected by Id4 overexpression, measured by QPCR. n=3  
(G, I) Immunostaining for Ki67 (G) or EdU (I) with Id4 and DAPI staining in active NSCs 
48h-post Id4 nucleofection. White arrows indicate Id4+ NSCs negative for Ki67 or EdU. 
Scale bar, 30µm. 
(H, J) Quantification of the data shown in (G, I). The percentage of NSCs positive for Ki67 
or EdU is reduced when Id4 is overexpressed. n=4 for H, n=3 for J.  
(K, L) Immunolabelling of Ascl1, Id4 and DAPI staining in active NSCs transduced with 
either control adenovirus (Adeno-empty, upper panel) or adenovirus expressing Id4 
(Adeno-Id4, lower panel). A concentration of 100 multiplicity of infection (moi) i.e. 100 viral 
particles per cell, was used and NSCs were analysed 20h post-infection. White arrows 
indicate Id4-overexpressing NSCs with undetectable levels of Ascl1. Scale bar, 30µm. n=1 
(M) Quantification of the data shown in (K,L). Ascl1 protein levels were significantly 
suppressed in Adeno-Id4 infected NSCs. n=1 
(N) The percentage of EdU+ NSCs was reduced in NSCs infected with Adeno-Id4 vs 
control adenovirus. n=1 
 
4.3.2 Over-expression of Id4 in active NSCs in vitro induces transcriptional 
changes associated with quiescence 
To determine how much of the BMP4-induced quiescence programme was mediated 
by Id4, I examined the global transcriptional effect of Id4-overexpression in active 
NSCs, by RNAseq of Id4-transfected NSCs. In order to isolate transfected cells, I 
needed to co-transfect a GFP-expressing plasmid (pCAGGS-IRES-GFP) alongside 
pCbeta-Id4-nFLAG, which does not express a fluorescent protein. Active NSCs were 
nucleofected with either pCAGGS-IRES-GFP alone or in combination with pCbeta-Id4-
FLAG in a ratio of 1:2 (GFP:ID4) to ensure GFP+ NSCs were likely to also be Id4+ in 
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co-transfected cells. NSCs were incubated in FGF2 for 48h following nucleofection, 
FAC sorted for GFP+ NSCs, and RNA extracted for RNAseq analysis (Figure 4.9A). In 
order to confirm the transfected NSCs received both the GFP and Id4 plasmids 
together, I immunostained co-transfected cells for both GFP and Id4, and analysed 
their co-localisation (Figure 4.9B), which showed a high degree of co-expression. I 
quantified this by plotting the A.U. fluorescence value for GFP and ID4 in each cell 
against each other, which showed a positive correlation (Figure 4.9C) suggesting FAC 
sorted GFP+ NSCs are highly likely to also be transfected with Id4, and therefore will 
provide a clean population of transfected NSCs for RNAseq analysis. To control for the 
overexpression of GFP, active NSCs were transfected with the same GFP-expressing 
construct in parallel to those transfected with Id4 (Figure 4.9A), and FAC sorted and 
processed for RNAseq. Differential gene expression analysis was performed on mRNA 
sequenced from GFP+ (control) versus Id4+(GFP+) NSCs. This analysis revealed Id4 
regulates a large number of genes; over-expression induced the expression of 806 
genes, and inhibited the expression of 823 (Figure 4.9D). The ontology of genes 
upregulated by Id4 include “Cell adhesion”, “Metabolic process”, and “Anion transport” 
(Figure 4.9E), ontologies also seen enriched in BMP4-induced quiescence (Figure 
3.6A), suggesting Id4 may contribute to regulating a large subset of “quiescence” 
genes. Much like with BMP4-induced quiescence, the ontologies of genes 
downregulated by Id4-overexpression centre mostly on cell cycle processes (Figure 
4.9F), reflecting the effect of Id4-overexpression on cell cycle arrest (Figure 4.8G-J), 
and again suggesting Id4 may mediate part of BMP4-induced cell cycle arrest. Direct 
comparison of the genes regulated by Id4 and BMP4 showed a large overlap (Figure 
4.9G) with 44.2% of BMP4-regulated genes also regulated by Id4. The ontologies of 
the commonly up- and down-regulated genes unsurprisingly show the common 
quiescence signature ontologies, including “cell adhesion”, signalling pathways and cell 
cycle regulation (Figure 4.9H,I). Together these results show Id4 can regulate a large 
part of BMP4-indcued quiescence, although the majority of the BMP4-induced genes 
are induced by other factors downstream of BMP4.  
 
Finally, I examined the effect of Id4 overexpression on specific Ascl1 target genes, to 
see whether the suppression of Ascl1 protein levels by Id4 corresponds to a 
suppression of Ascl1 activity. Indeed, the Counts Per Million of all 10 Ascl1-target 
genes examined, including Dll1, Skp2, Birc5, Egfr, and Rrm2 (identified by ChIP-chip 
for Ascl1, in embryonic mouse telencephalon (Castro et al., 2011)) showed significant 
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downregulation in Id4-overexpressing active NSCs compared to GFP-expressing 
active NSCs (Figure 4.9J; grey bars control, green bars Id4). Moreover, Id4-
overexpression was sufficient to downregulate these genes to very similar levels as 
BMP4+GFP-treatment alone (Figure 4.9J, blue bars). The only Ascl1 target gene that 
was not regulated in the same way by Id4 as BMP4, was Fbl, which was significantly 
downregulated by Id4 but not BMP4. Id4 also regulated many cell cycle genes to a 
similar extent as BMP4, such as CyclinB1 and CyclinE1 (Ccnb1, Ccne1; Figure 4.9K). 
Even CyclinD2, which is in fact significantly upregulated by BMP4 treatment, is also 
trending towards upregulation by Id4. Overall, these data indicate Id4 is responsible for 
regulating a significant proportion of the transcriptional programme induced by BMP4 in 
quiescent NSCs, specifically the suppression of Ascl1 target genes. This is likely an 
indirect result of the suppression of Ascl1 protein by Id4. Moreover, Id4 appears to 
regulate more than just the cell cycle status of NSCs, as evidenced by the upregulation 
of genes involved in cell adhesion, phosphorylation and signalling pathways. These 
data suggest Id4 is central to the regulation of adult NSC quiescence.  
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Figure 4.9. RNAseq analysis of Id4 over-expression in active AHNSCs in vitro 
(legend next page) 
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Figure 4.9. RNAseq analysis of Id4 over-expression in active AHNSCs in vitro 
(A) Experimental design for overexpressing Id4 in active NSCs followed by Fluorescence 
Activated Cell Sorting (FACS). Active NSCs were nucleofected with either pCAGGS-IRES-
GFP alone or in combination with pCbeta-Id4-FLAG in a ratio of 1:2 (GFP:ID4) to ensure 
GFP+ NSCs are likely to also be Id4+ in co-transfected cells. NSCs were incubated in 
FGF2 for 48h following nucleofection, FAC sorted for GFP+ NSCs, and RNA extracted for 
RNAseq analysis.  
(B) Immunostaining for GFP and Id4, and DAPI staining in NSCs nucleofected with both 
GFP and Id4 constructs, showing a high level of co-transfection.  
(C) Quantification of data shown in (B). The immunofluorescence level of GFP is highly 
correlated with Id4 in co-transfected cells, with a correlation coefficient of 0.9037. The 
coefficient of determination (0.8167) shows the data closely fit the regression line. n=360 
cells from one biological repeat. 
(D) Volcano plot of genes regulated by Id4 overexpression in active NSCs.  
(E,F) Gene ontology terms associated with up- or down-regulated genes in active NSCs 
overexpressing Id4 compared to GFP-nucleofected NSCs. Shown for each term are the 
number of genes associated with the ontology, and its significance (Log10 p-value). Dots 
are coloured based on their ontology terms - light blue: cell cycle/division; dark blue: DNA 
repair/replication; light green: Protein phosphorylation/modification; dark green: signalling, 
transcription; orange: adhesion/cytoskeleton; yellow: ion-related; pink: brain/nervous 
system related; purple: metabolism; navy blue: organism-wide process. 
(G) Overlap of Id4-regulated and BMP4-regulated genes.  
(H, I) Gene ontology terms associated with up- or down-regulated genes in both Id4-
overexpressing and BMP4-treated NSCs. Ontologies are coloured based on categories 
described above. 
(J) Expression of Ascl1 target genes, shown as counts per million (CPM) from RNAseq 
analysis of active NSCs nucleofected with GFP or Id4, and quiescent NSCs nucleofected 
with GFP. Every Ascl1 target is significantly suppressed by Id4 overexpression, and to a 
very similar extent to BMP4 treatment. n=3 independent biological replicates. 
(K) Expression of cell cycle genes, shown as counts per million (CPM) from RNAseq 
analysis of active NSCs nucleofected with GFP or Id4, and quiescent NSCs nucleofected 
with GFP. Id4 regulates cell cycle genes to the same extent as BMP4, strongly 
downregulated several genes. n=3 independent biological replicates.  
Unpaired t-test was used for all statistical analyses (mean±SEM), p>0.05 (ns), 
p<0.001(***), p<0.0001(****).  
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4.3.3 Over-expression of Id1 can induce cell-cycle arrest but does not 
suppress Ascl1 protein 
The effect of Id4 on NSCs is highly suggestive of a specific role for Id4 in regulating 
quiescence, however it could also be an effect of high expression levels of any Id 
protein, and the over-expression of another Id protein could have the same effects. Id1 
is expressed in quiescent NSCs in vitro and RGLs in vivo, and even though it is 
observed to be enriched in active RGLs in vivo, this correlation cannot rule out a role in 
regulating quiescence. Therefore, to both test whether Id4 is unique in its regulation of 
quiescence, and whether Id1 specifically plays a role in quiescence, I over-expressed a 
pCDNA-mId1-Venus construct, which drives Id1 and a Venus tag from a CMV 
promoter, in active NSCs via nucleofection, and analysed the effects 48h later (Figure 
4.10A). I first analysed Ascl1 protein levels in Id1-overexpressing cells (Venus+). 
Quantification of Ascl1 fluorescence intensity in Id1Venus- and Id1Venus+ NSCs 
showed a very small decrease of Ascl1 in Id1-overexpressing cells (Figure 4.10B), with 
the average levels only declining from 98.54±3.2 A.U. to 88.9±2.8 A.U (Figure 4.10C), 
with many more Ascl1 strong positive NSCs than observed when Id4 is overexpressed 
(Figure 4.8E). This suggests the effect of Id4-overexpression on Ascl1 protein levels is 
a specific function of Id4, rather than a general effect of high Id protein levels. Id1 over-
expression suppressed the cell cycle of NSCs to a similar degree as Id4 
overexpression (Figure 4.10G-J). The percentage of Ki67+ NSCs decreased from 
56.49±6.0% in Venus- cells to 33.97±2.2% in Venus+ cells (Figure 4.10D,E), while the 
percentage of EdU+ NSCs decreased from 27.09±5.3% to 18.5±4.6% (Figure 
4.10F,G). Id1-overexpression in active NSCs induces cell cycle arrest to a similar 
degree as Id4-overexpression suggesting it could contribute to BMP4-induced 
quiescence when expressed at high levels.   
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Figure 4.10. Over-expression of Id1 in active AHNSCs in vitro 
(A) Experimental design for overexpressing Id1 in active NSCs. NSCs cultured in FGF2 
were nucleofected with pCNDA3-Id1-Venus, cultured for a further 48h, at which time they 
were analysed.  
(B) Immunostaining for GFP (Venus) and Ascl1, and DAPI staining, shows a reduction of 
Ascl1 in some Id1-expressing NSCs. Scale bar, 30µm. 
(C) Quantification of the data in (B). Immunofluorescence levels of Ascl1 protein (arbitrary 
units, A.U.) are mildly suppressed in Id1-overexpressing NSCs compared to non-
transfected NSCs. n=3 independent biological replicates. 
(D, E) Immunostaining for Ki67 in Id1-transfected NSCs is reduced relative to non-
transfected NSCs, quantified in (E). n=3. Scale bar, 30µm. 
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(F, G) Detection of EdU incorporation (1-hour pulse) shows fewer EdU+ Id1-transfected 
NSCs compared to non-transfected NSCs, quantified in (F). n=3 independent biological 
replicates. Scale bar, 30µm. 
4.3.4 Id1 only induces a small subset of the quiescence transcriptional 
signature, and does not regulate Ascl1 target genes 
To further compare the effect of Id1 vs Id4 over-expression, I FAC sorted Venus+ 
NSCs, and performed RNA sequencing, comparing the gene expression to FGF2+GFP 
nucleofected NSCs (Figure 4.11A). Id1 was only able to regulate the expression of a 
relatively small number of genes, with 359 upregulated and 83 downregulated by Id1-
overexpression (Figure 4.11B), which is far fewer genes than either BMP4 or Id4-
overexpression (Figure 4.11C). This suggests Id4 is specific in its induction of a large 
proportion of the BMP4-induced quiescence ‘programme’. Despite the difference in 
number of genes regulated, most of the genes regulated by Id1 are common with 
BMP4-regulated and/or Id4-regulated genes (Figure 4.11C). Moreover, the ontologies 
of genes up- or down-regulated by Id1 are highly similar to those seen for BMP4 and 
Id4, such as “Cell adhesion” ion-related and signalling-related for upregulated genes, 
and “Cell cycle” for downregulated genes (Figure 4.11D,E). However, when I looked 
specifically at direct Ascl1 target genes, none were regulated by Id1 overexpression 
(Figure 4.11F), nor were most specific cell cycle genes that were previously shown to 
be strongly downregulated by BMP4 and Id4 (Figure 4.9K), apart from CyclinB1 (Figure 
4.11G). These results show that Id1 has a very minor contribution to the quiescent 
state induced by BMP4, and the effects of Id4 over-expression demonstrate the 
specific function of Id4. Moreover, unlike Id4, Id1 does not strongly negatively regulate 
Ascl1 protein and as a result, does not repress activation or cell cycle genes 
associated with Ascl1 transcriptional activity. Overall these results suggest Id4 has a 
specific function in the BMP4-induced quiescent state in NSCs due to a unique role (at 
least in comparison to Id1) of inhibiting and downregulating Ascl1 protein.  
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Figure 4.11. RNAseq analysis of Id1 over-expression in active AHNSCs in vitro 
(legend next page) 
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Figure 4.11. RNAseq analysis of Id1 over-expression in active AHNSCs in vitro 
(A) Experimental design for overexpressing Id1 in active NSCs followed by Fluorescence 
Activated Cell Sorting (FACS). Active NSCs were nucleofected with either pCAGGS-IRES-
GFP or pCDNA3-Id1-Venus. NSCs were incubated in FGF2 for 48h following 
nucleofection, FAC sorted for GFP+ NSCs, and RNA extracted for RNAseq analysis.  
(B) Volcano plot showing genes regulated by Id1 overexpression in active NSCs.  
(C) Overlap of genes regulated by Id4-overexpression, Id1-overexpression or BMP4-
treatment.  
(D, E) Gene ontology terms associated with up- or down-regulated genes in Id1-
overexpressing NSCs compared to GFP-transfected NSCs. Ontologies are coloured based 
on categories described above. 
(F) Expression of Ascl1 target genes, shown as counts per million (CPM) from RNAseq 
analysis of active NSCs nucleofected with GFP or Id1. None of the Ascl1 target genes were 
significantly regulated by Id1. n=3 independent biological replicates. 
(G) Expression of cell cycle genes, shown as counts per million (CPM) from RNAseq 
analysis of active NSCs nucleofected with GFP or Id1. Id1 only regulates CyclinB1 
(Ccnb1), and does not affect the expression of any other cell cycle gene analysed. n=3  
 
4.3.5 Inactivating Id4 in quiescent NSCs stabilises Ascl1 
Expression of Id4 is sufficient to inhibit Ascl1 protein levels and induce a quiescent-
like state in active NSCs. To determine whether it is also required to maintain 
quiescence in BMP4-induced NSCs, I re-reintroduced the binding partner of Ascl1 
via nucleofection of an E47-expression plasmid, into BMP4-induced quiescent 
NSCs (Figure 4.12A). In this way, Id4 (and the other Id proteins) were inhibited as 
high levels of E47 “mops up” the Ids, and the remaining E47 that is not bound to 
Id4 would be able to dimerize with Ascl1, stabilising Ascl1 and enabling it to bind to 
its target DNA (Figure 4.12B). 48h after transfection of quiescent NSCs with 
pCAGGS-E47-GFP, many cells were GFP+, with a transfection efficiency of 
31.05±5.2 (Figure 4.12C). Comparison of Ascl1 protein levels in GFP+ and GFP- 
NSCs showed an increase in the mean fluorescence intensity as well as more 
Ascl1 bright NSCs, in E47 over-expressing cells (Figure 4.12D,E). This increase 
occurred without affecting Ascl1 mRNA levels (Figure 4.12F); in fact, Ascl1 mRNA 
trended towards downregulation in E47-overexpressing NSCs. The mRNA here 
was obtained through FAC sorting nucleofected cells, discussed in more detail 
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below in Section 4.3.6. This observation suggests E47 is able to re-stabilise Ascl1 
protein in conditions where BMP4 is high. In addition to the effect on Ascl1, E47-
overexpression also resulted in an increase in the fraction of Ki67+ and EdU+ cells 
in the GFP+ population compared to the GFP- (Figure 4.12G-I), suggesting E47 is 
counteracting the cell cycle arrest induced by BMP4/Id4, potentially as a direct 
result of re-stabilisation of Ascl1 protein.  
 
 
Figure 4.12. Over-expression of E47 in quiescent AHNSCs in vitro 
(A) Experimental design for overexpressing E47 in quiescent NSCs. NSCs cultured in 
FGF2+ 20ng/mL BMP4 for 72h, were nucleofected with pCAGGS-E47-IRES-GFP, cultured 
for a further 48h in the presence of FGF2+BMP4 20ng/mL, after which point they were 
analysed.  
(B) Scheme showing the hypothesis for the effects of E47 overexpression in quiescent 
NSCs. In control cells, in the presence of FGF2 and 20ng/mL BMP4, Id4 expression is high 
and sequesters the E-protein binding partner of Ascl1, resulting in its inactivity and  
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degradation. Following E47 overexpression, Id4 is mopped up, and excess E47 is free to 
dimerise with newly transcribed Ascl1, stabilising it and enabling its transcriptional activity.  
(C) Immunostaining for Ascl1, GFP and DAPI staining in quiescent NSCs transfected with 
E47 for 48h. Scale bar, 30µm. 
(D) The percentage of GFP(E47)+ NSCs within each sample was quantified to determine 
the transfection efficiency. n=5 images from 4 independent biological repeats. 
(E) Quantification of Ascl1 immunofluorescence levels (A.U.) shows Ascl1 is significantly 
increased in E47-overexpressing quiescent NSCs. n=1 representative of 4 biological 
repeats.   
(F) QPCR analysis of Ascl1 mRNA levels in control and E47-transfected NSCs. n=3 
independent biological replicates. 
(G-I) Immunostaining and quantification of %Ki67+ and %EdU+ NSCs in control and E47-
transfected NSCs. Both Ki67 and EdU are increased in E47-overexpressing quiescent 
NSCs. Control cells are non-transfected (GFP-) NSCs within the transfected sample. n=3 
independent biological replicates. Scale bar, 30µm. 
 
4.3.6 Inactivating Id4 in quiescent NSCs restores the function of Ascl1  
E47 overexpression should induce gene expression changes associated more with the 
active state, than quiescent, due to the fact it should block Id4-mediated inhibition of 
Ascl1. Moreover, if E47 is able to re-stabilise Ascl1 protein in BMP4 conditions and 
restore its function as a transcription factor, we should also see an upregulation of 
Ascl1 target genes. To test both of these hypotheses, I FAC sorted GFP+ NSCs from 
BMP4-induced E47:GFP transfected NSCs, or as a control, quiescent NSCs 
transfected with just GFP, and performed RNA sequencing on the GFP+ sorted cells 
(Figure 4.13A). E47 overexpression significantly induced the expression of 1768 
genes, and downregulated 619 genes (Figure 4.13B), as compared to the gene 
expression in BMP4+GFP NSCs. Comparison of the genes induced by E47 with those 
downregulated by BMP4 (i.e. genes enriched in the active state), showed a large 
overlap, with 40.65% the genes downregulated by BMP4 also induced by E47 (Figure 
4.13C). Gene ontology analysis showed these commonly regulated genes are mostly 
involved in the cell cycle, as well as “negative regulation of Notch signalling”, which is 
interesting considering the reported role for Notch signalling in maintaining quiescence 
of hippocampal RGLs, as described in Section 1.5.2.2. I looked specifically at the 
subset of known Ascl1 target genes (previously discussed in Section 4.3.1), to see 
Chapter 4 Results 
 
146 
 
whether stabilisation of Ascl1 protein by E47 overexpression results in restoration of its 
function. Indeed, every gene had a trend towards upregulation, with significant 
upregulation observed for Dll1, Dll3, Birc5 and Rrm2 (Figure 4.13E). This shows that 
replenishing the binding partner of Ascl1 in conditions of high Id4 expression is 
sufficient to re-stabilise Ascl1 protein and restore its function, whilst also resulting in a 
reversal of the quiescent-like state (specifically cell cycle arrest), potentially as a direct 
result of Ascl1 transcriptional activity. 
 
 
Figure 4.13. RNAseq analysis of E47 over-expression in quiescent AHNSCs in 
vitro 
(A) Experimental design for overexpressing E47 in quiescent NSCs followed by 
Fluorescence Activated Cell Sorting (FACS). Quiescent (FGF2+BMP4 20ng/mL) NSCs 
were nucleofected with either pCAGGS-IRES-GFP or pCAGGS-E47-IRES-GFP. NSCs 
were incubated in FGF2+BMP4 for 48h following nucleofection, FAC sorted for GFP+ 
NSCs, and RNA extracted for RNAseq analysis.  
(B) Volcano plot showing the genes significantly regulated by E47 overexpression. 
(C) Overlap of genes up-regulated by E47 overexpression, and genes downregulated by 
BMP4 treatment (i.e. genes associated with the active state). 
(D) Gene ontology terms associated with genes down-regulated by BMP4 and up-regulated 
by E47 overexpression. Ontologies are coloured based on categories described above. 
(E) Expression of Ascl1 target genes, shown as counts per million (CPM) from RNAseq 
analysis of quiescent NSCs nucleofected with GFP (Control) or E47. Several Ascl1 target  
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genes were significantly upregulated following 48h E47-overexpression, and several 
trended towards upregulation. n=3 independent biological replicates. 
4.3.7 Loss of Id4 in NSCs results in increased Ascl1 protein levels but does 
not prevent cell cycle arrest in BMP4-induced quiescence  
To inactivate Id4 via an alternative method, NSCs were derived from the Cre-inducible 
Id4flx mouse line, whereby adenovirus-mediated expression of Cre recombinase in 
these NSCs induces recombination of loxP sites flanking exons 1 and 2 of the Id4 
gene, which represents the entire coding region (exon 3 represents a 3’ untranslated 
region) (Figure 4.14A). However, immunostaining for Id4 in both non-transfected NSCs 
in FGF2 and FGF2+BMP4 conditions showed no Id4 signal (Figure 4.14B,C), and 
unsurprisingly no signal was detected in quiescent NSCs transduced with Adeno-
empty or Adeno-Cre virus (Figure 4.14D,E). QPCR for Id4 mRNA extracted from these 
cells also suggested that these cells had lost expression of Id4 sometime during the 
derivation process (Figure 4.14F), although the probe used to detect Id4 spanned exon 
boundary 2-3, and so the ability of the taqman QPCR probe to detect its target mRNA 
may have been impaired by the loxP sites. Nevertheless, the immunocytochemistry 
was highly suggestive that Id4 expression was very low or gone in these cells and 
concurrently the levels of Ascl1 were much higher in BMP4-treated Id4flx NSCs (Figure 
4.14C) than observed previously for non-transgenic AHNSCs (Figure 4.6H). This 
further supports the idea that Id4 can mediate the BMP4-induced suppression of Ascl1 
protein. The loss of Id4 did not affect the ability of BMP4 to induce cell cycle arrest, 
shown by a reduction in the number of Ki67+ and EdU+ NSCs (Figure 4.14G) 72h after 
BMP4. One possible explanation for this is compensation by the other Id proteins 
which are still highly expressed in Id4KO NSCs (Figure 4.14I). Moreover, I have shown 
Id1 can induce cell cycle-related quiescence without affecting Ascl1 protein levels 
(Section 4.3.4). Id1 mRNA expression was increased 2-fold in Id4KO NSCs compared 
to wildtype NSCs (Figure 4.14H), in both FGF2 and FGF2+BMP4 conditions. Id1 
protein levels were not significantly increased compared with wildtype NSCs, but these 
data suggest that the high expression of Id1-3 may mediate a part of BMP4-induced 
cell cycle arrest.   
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Figure 4.14. Expression of Id-4 and Ascl1 in AHNSCs derived from Id4flx mice 
(A) Structure of the Id4 floxed allele in the Id4cKO mice, from which the Id4cKO NSC line was 
derived.  
(B, C) Immunostaining for Id4 and Ascl1 and DAPI staining in Id4cKO NSCs cultures in 
FGF2 or FGF2+BMP4. Id4 is undetectable in either condition. Ascl1 protein levels are high 
even in quiescent Id4cKO NSCs. Scale bar, 30µm. 
(D, E) Immunostaining for Id4 and Ascl1 and DAPI staining in quiescent Id4cKO NSCs 
cultures transduced with either control adenovirus (Adeno-null) or adenovirus expressing 
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 Cre-recombinase (Adeno-Cre), in order to delete the floxed exons of Id4. Id4 protein levels 
are undetectable in both conditions, and Ascl1 levels are unaffected by transduction with 
Adeno-Cre virus. Scale bar, 30µm. 
(F) QPCR analysis of Id4 mRNA levels in active and quiescent wildtype and Id4cKO NSCs. 
Id4 mRNA is undetectable in Id4cKO NSCs. n=1. 
(G) Immunostaining for Ki67 and EdU incorporation in active and BMP4-treated Id4cKO 
NSCs. Scale bar, 30µm. 
(H) QPCR analysis of Id1 mRNA levels in active and quiescent wildtype and Id4cKO NSCs. 
Id1 mRNA is upregulated in Id4cKO NSCs compared to wildtype NSCs. n=1. 
(I) Immunostaining for Id1, Id2 and Id3 in active and BMP4-treated Id4cKO NSCs. Scale bar, 
30µm. 
 
4.4  Id4 maintains quiescence of RGLs in vivo 
4.4.1 Acute conditional deletion of Id4 in vivo activates RGLs from 
quiescence 
Overall the functional analysis of Id4 in vitro strongly indicates Id4 can 1) suppress 
Ascl1 protein levels and 2) induce a quiescent-like state. I therefore investigated 
whether Id4 is important for maintaining quiescence of RGLs in vivo. I utilised the Id4flx 
transgenic mouse line described in Section 4.3.7, crossed to GLASTCreERT2;Rosa26-
EYFP mice, in order to conditionally delete Id4 in GLAST-expressing stem cells via 
tamoxifen-induced Cre-mediated recombination. The Cre is fused to mutated hormone-
binding domains of the estrogen receptor, and is activated by binding of the ligand 
OHT (4-hydroxytamoxifen) which results in translocation to the nucleus where it 
recombines the loxP-flanked Id4 exons. These mice also carry the Rosa26-EYFP 
allele, in which a floxed PGK-neo cassette containing a tpA stop sequence, and an 
enhanced yellow fluorescent protein gene, are inserted in the Gt(ROSA)26Sor locus. 
Upon tamoxifen-induced recombination, the STOP sequence is floxed out, enabling 
expression of YFP and identification of recombined cells by YFP fluorescence. Adult 
P60 mice, either homozygous for the floxed Id4 locus (Id4cKO mice), or wildtype for Id4 
(control mice), were injected with tamoxifen once a day for 5 days, and analysed on the 
5th day (Figure 4.15A). These mice were housed in the animal facility of collaborators 
E. Huillard and B. Rocamonde at the Institute du Cerveau et de la Moelle Epinière 
(ICM) in Paris, and required travelling to their institute in order to perfuse mice for 
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analysis, which meant the number of mice were very limiting for these experiments 
(discussed further in Section 4.4.3 below). Immunostaining for Id4 showed the protein 
was completely lost in every YFP+ cell after 5 days of tamoxifen (Figure 4.15B). As a 
result of Id4 deletion, the number of Ascl1+YFP+GFAP+ RGLs was increased almost 
3-fold, from 6.0±0.6% in control mice to 15.0±2.1% in Id4cKO mice, in mice analysed 
immediately after 5 days of tamoxifen treatment (Figure 4.15D). Ascl1 protein levels, 
measured by fluorescence intensity, were also significantly increased in Id4cKO mice 
(Figure 4.15E). This indicates Id4 normally functions to suppress Ascl1 protein in 
RGLs. To test whether this had an effect on the proliferation of RGLs, I measured the 
fraction of Ki67+ YFP+GFAP+ RGLs, which increased from 5.1±1.1% in control mice to 
12.3±1.9% in Id4cKO mice (Figure 4.15F, G). Overall, these results show Id4 is required 
to maintain quiescence of RGLs, potentially via suppression of Ascl1 protein. It is 
interesting that despite the fact Id4 is expressed in the majority of RGLs, and the 
deletion is complete in Id4cKO mice, only a fraction of RGLs activate following Id4 
deletion, potentially indicating compensatory mechanisms. 
Chapter 4 Results 
 
151 
 
 
Figure 4.15. Effects of acute conditional deletion of Id4 from RGLs in the adult 
hippocampus (legend next page) 
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Figure 4.15. Effects of acute conditional deletion of Id4 from RGLs in the adult 
hippocampus  
(A) Experimental design for the deletion of Id4 from RGLs in adult (P60) Id4cKO mice. Mice 
either wildtype (control) or homozygous floxed (Id4cKO) for the Id4 locus were treated with 
tamoxifen for 5 days, and analysed immediately after.  
(B) Immunolabelling of YFP, GFAP and Id4 shows complete elimination of Id4 protein from 
YFP+GFAP+ RGLS in Id4cKO mice after 5 days of tamoxifen. Scale bar, 30µm. 
(C) Immunolabelling of YFP, GFAP and Ascl1 in control and Id4cKO mice following 
tamoxifen-induced deletion of Id4. White arrows indicate Ascl1-positive RGLs. Scale bar, 
30µm. 
(D) Quantification of percentage Ascl1+ RGLs, from the data shown in (C). Loss of Id4 in 
RGLs results in increased numbers of Ascl1+ RGLs. n=5 
(E) Quantification of Ascl1 protein immunofluorescence levels (A.U.) in YFP+GFAP+ RGLS 
in control or Id4cKO. n=5 mice.  
(F) Immunostaining of YFP, GFAP and Ki67 Ascl1 in control and Id4cKO following 5days of 
tamoxifen treatment. White arrows indicate Ki67-positive RGLs. Scale bar, 30µm. 
(G) Quantification of the data shown in (F).	Loss	of	Id4	results	in	an	increase	in	the	fraction	of	
proliferating	RGLs.	n=5	for	both	control	and	Id4cKO 
Unpaired t-test was used for all statistical analyses (mean±SEM), p<0.05 (*), 
p<0.0001(****).  
 
4.4.2 The effects of conditional Id4 deletion from RGLs are lost after 30 days 
In accordance with the hypothesis that compensatory mechanisms may be supressing 
the effects of acute Id4 deletion, one month after Id4 deletion (Figure 4.16A), the effect 
on Ascl1 and proliferation is lost, with no difference observed in %Ascl1+ or %Ki67+ 
RGLs between control and Id4cKO mice (Figure 4.16B-E). I first analysed Ascl1 
expression by immunofluorescence and found no strong difference in the percentage 
of Ascl1+ YFP+GFAP+RGLs between cKO (4.39%) and control* mice (3.14±0.8%) 
(Figure 4.16B,C). However strong conclusions cannot yet be drawn from this data, due 
to a lack of P90 Id4cKO mice and lack of the same kind of control mouse used for acute 
Id4 deletion; control (control*) mice in this case are homozygous Id4 floxed mice which 
were not treated with tamoxifen, as opposed to mice wildtype for Id4 with tamoxifen 
treatment (Figure 4.15A). The reason for the lack of data here is due to differences in 
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perfusion technique and issues with antibodies against Ascl1 for immuno-detection, 
which I will discuss further in the Section 4.4.3 below. In addition, I also analysed levels 
of RGL proliferation of control (Id4 wildtype plus tamoxifen), control* (Id4 floxed without 
tamoxifen) and Id4cKO mice treated with tamoxifen for 5 days and analysed 30 days 
later (Figure 4.16D,E). Quantification of Ki67+ YFP+GFAP+RGLs in the three 
conditions showed no significant difference between %Ki67+ RGLs in control 
(3.63±0.89%) and Id4cKO mice (5.49±0.8%), and only a small significant increase 
between control* mice (2.80±0.3%) and Id4cKO mice. Moreover, there was no difference 
in %Ki67+ RGLs between the two sets of control mice, indicating both are suitable as 
controls.  
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Figure 4.16. Long-term effects of Id4 deletion on RGL activity and Ascl1 protein 
level 
(A) Experimental design for analysis of RGLs 1 month after Id4 deletion in adult (P60) 
Id4cKO mice. Mice either wildtype (control) or homozygous floxed (Id4cKO) for the Id4 locus 
were treated with tamoxifen for 5 days, and 30 days later (P90).  
Control: Glast-CreERT2; Id4wt/wt; RYFP + TAM
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(B) Immunolabelling of YFP, GFAP and Ascl1 in control and Id4cKO mice 30 days after 
tamoxifen administration. Control mice in this case are mice homozygous for the floxed Id4 
allele, without tamoxifen treatment. Scale bar, 30µm. 
(C) Quantification of the percentage of Ascl1+ YFP+GFAP+RGLs in control and Id4cKO 
mice 30 days after Id4 deletion. Control mice in this case are mice homozygous for the 
floxed Id4 allele, without tamoxifen treatment. n=3 for control and n=1 for Id4cKO. 
(D) Immunolabelling of YFP, GFAP and Ki67 in control and Id4cKO mice 30 days after 
tamoxifen administration. Scale bar, 30µm. 
(E) Quantification of the percentage of Ki67+ YFP+GFAP+RGLs in control and Id4cKO mice 
30 days after Id4 deletion. n=6 for both control Id4cKO mice. 
Unpaired t-test was used for all statistical analyses (mean±SEM), p>0.05 (ns). 
 
4.4.3 Perfusion technique and Ascl1 antibody species affects Ascl1 protein 
detection 
Despite showing data for Ascl1 immunostaining for just three control* mice and one 
Id4cKO mouse at P90, many control and further Id4cKO P90 mice were perfused and 
stained. These samples were perfused by collaborators who were already analysing 
the Id4 floxed mouse line and kindly sent samples to our lab. However, they used a 
different perfusion technique to that of the Guillemot lab, resulting in very difficult 
antibody detection of Ascl1, the detection of which is very sensitive to fixation. 
Moreover, they had routinely used the Guinea pig anti-Ascl1 antibody, produced by the 
lab of Jane Johnson, whereas the Guillemot lab used a monoclonal mouse anti-Ascl1 
antibody generated in-house (also available commercially, BD Pharmingen, #556604). 
All P65 samples analysed and presented in Section 4.4.1 were from mice perfused by 
myself of N. Urbán, and stained with mouse-anti Ascl1. Shown in Figure 4.17Ai are 
examples of staining with the Guinea pig anti-Ascl1 antibody in control P90 mice 
perfused by collaborators, which gave very high levels of background in these 
samples, particularly in the granule neurons indicating non-specific staining, rendering 
it very difficult to identify Ascl1 positive cells. However, the detection of Ascl1 was 
challenging in these samples also when using the mouse anti-Ascl1 antibody, 
producing high non-specific background staining (Figure 4.17Aii). We therefore 
decided to perfuse mice ourselves to avoid differences in Ascl1 detection. This greatly 
improved the sensitivity of Ascl1 detection for both Guinea pig- and mouse-anti Ascl1 
antibodies, as show in Figure 4.17B. However, there were not enough mice to perfuse 
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and analyse at P90 and generate a full data set. This is why we used some Id4 
homozygous floxed mice without tamoxifen treatment as controls (control*), as we 
lacked Id4 wildtype mice the most. Despite the high levels of background observed 
when using the Guinea pig anti-Ascl1 antibody, in some samples the detection was 
very clear, and I tended to detect more Ascl1+ cells, which raised the question of 
whether the Guinea pig antibody was more sensitive than the mouse anti-Ascl1, when 
used on samples perfused in the appropriate manner. Moreover, I have demonstrated 
that there are many RGLs expressing Ascl1 mRNA via Ascl1KiGFP reporter mice and 
Ascl1 RNA in situ (Section 4.1.2), and more Ascl1+ RGLs can be detected using the 
Ascl1Venus mouse line than with monoclonal antibody staining (Section 4.1.2), 
suggesting there may be significant issues with sensitivity of the mouse anti-Ascl1 
antibody and raising the requirement for a better antibody. Therefore, I investigated 
whether there was a significant difference between the sensitivity of the Guinea pig- 
and mouse-anti Ascl1 antibodies in control and Id4cKO samples perfused by myself or 
N. Urbán. I first quantified the fraction of Ascl1+ YFP+GFAP+RGLs in P65 control and 
Id4cKO mice, which showed significantly more Ascl1+ RGLs were detected with the 
Guinea pig antibody in control samples (Figure 4.17C), however there was no 
difference in Id4cKO mice between the detection of Ascl1 using the mouse or Guinea pig 
antibody. This meant the increase in the percent of Ascl1+ RGLs between control and 
Id4cKO  was significant when using the mouse antibody, but not when using the Guinea 
pig antibody. A similar pattern emerged when analysing P90 samples with both 
antibodies, with a trend (although not significant) towards a higher percentage of 
Ascl1+ RGLs in control* samples stained with the Guinea pig antibody (Figure 4.17D). 
Again, this higher sensitivity of the Guinea pig antibody was not seen in Id4cKO P90 
samples, although only 1 mouse was available to analyse here (Figure 4.17D). Direct 
comparison of the percentage of Ascl1+ RGLs in every mouse that had been stained 
with both Ascl1 antibodies highlighted some instances where the values were very 
different, although on average the difference between the two antibodies was not 
significant (Figure 4.17E). As a final investigation into the sensitivity of each Ascl1 
antibody, I compared the percentage of Ascl1+ RGLs with the percentage of Ki67+ 
RGLs quantified within each mouse. Ki67 is expressed in activated RGLs, following 
Ascl1 expression, therefore Ki67 and Ascl1 immunostaining should correlate fairly 
closely. In this way, I can identify if one of the Ascl1 antibodies is detecting more or 
less positive RGLs than expected. Plotting the data from control and Id4cKO P65 and 
P90 mice against each other shows a very strong positive correlation 
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between %Ascl1+ and %Ki67+ RGLs, with an r value of 0.8708 (Figure 4.17F). No 
sample stained with either antibody deviates strongly from the regression line. Overall 
these data suggest that while there are issues with low sensitivity of the mouse anti-
Ascl1 antibody, the Guinea pig anti-Ascl1 has only a marginally higher sensitivity, and it 
also potentially gives greater non-specific background staining, such as in the granule 
neurons (Figure 4.17A). It is worth using both antibodies in the future to confirm 
quantifications of Ascl1 immunostaining, however these data indicate that the use of 
mouse anti-Ascl1 in data presented here is reliable.  
 
Figure 4.17. Analysis of perfusion method and antibody on Ascl1 
immunodetection 
(A) P90 control Id4 floxed mice, perfused by collaborator B. Rocamonde, were 
immunostained for GFAP and Ascl1 using either the guinea-pig (i) or mouse (ii) anti-Ascl1 
antibody. Scale bars, 30µm. 
(B) Immunostaining for GFAP and Ascl1, using either the mouse or Guinea pig anti-Ascl1 
antibody, in a P65 Id4cKO mouse perfused by N. Urbán. Scale bars, 30µm. 
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(C) Quantification of the %Ascl1+ YFP+GFAP+RGLs detected with either the mouse or 
Guinea pig anti-Ascl1 antibody, in P65 control and Id4cKO mice perfused by myself or N. 
Urbán. Data points are coloured to identify the same mouse stained with each antibody.  
(D)  Quantification of the %Ascl1+ YFP+GFAP+RGLs detected with either the mouse or 
Guinea pig anti-Ascl1 antibody, in P90 control* (Id4 homozygous floxed, without tamoxifen) 
and Id4cKO mice perfused by myself or N. Urbán. Data points are coloured to identify the 
same mouse stained with each antibody. 
(E) Direct comparison of the %Ascl1+ RGLs detected with either mouse or Guinea pig anti-
Ascl1 antibody within each sample.  
(F) Correlation of the %Ascl1+ RGLs with the %Ki67+RGLs within each sample, from all 
P65 and P90 control and Id4cKO mice, stained with either Guinea pig or mouse anti-Ascl1. 
Linear regression and correlation analysis show a strong positive correlation between Ki67 
and Ascl1 immunoreactivity.  
Unpaired t-test was used for all statistical analyses (mean±SEM), p>0.05 (ns), p<0.01 (**). 
 
4.4.4 Id1 and Id3 are upregulated in response to Id4 deletion 
Returning to the effect of Id4 deletion, I investigated further the loss of phenotype 30 
days post-tamoxifen. Compensation by the other Id proteins could explain the loss of 
effect on proliferation. In line with this hypothesis, I observed a dramatic increase in the 
expression of Id1 and Id3 in the DG of Id4cKO mice, both 5 days and 30 days post-
tamoxifen. The percentage of Id1+ RGLs in Id4cKO mice increased 5 days after 
tamoxifen, from 51.82±10.3 in control to 88.02±3.1 in Id4cKO (Figure 4.18A,B). This 
increase was maintained at 30 days post-tamoxifen (42.79±1.9 in control, 74.16±1.0 in 
Id4cKO; Figure 4.18C, D). Id1 is normally found to be enriched in active, rather than 
quiescent RGLs (Section 4.2.2), so might not be expected to be able to compensate for 
Id4, a quiescence factor. However, we have seen that overexpression of Id1 in active 
NSCs in vitro can induce partial quiescence (Section 4.3.3), so its higher-than-normal 
expression levels following Id4 deletion in vivo may facilitate compensation for the 
suppression of proliferation. Id3+ RGLs increased very highly following Id4 deletion, 
both 5 days and 30 days post-tamoxifen (Figure 4.18E,F). I have not investigated the 
molecular function of Id3 in NSCs, nor have I quantified its levels in active vs quiescent 
RGLs, however it is reasonable to hypothesise that upregulation of Id3 in Id4cKO RGLs 
could also potentially mediate the compensatory effect observed. It would be highly 
Chapter 4 Results 
 
159 
 
interesting to investigate the role of Id1 and Id3 in RGL quiescence and activation 
further.  
 
Figure 4.18. Effects on Id1 and Id3 expression following acute and long-term 
conditional deletion of Id4 from RGLs (legend next page) 
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Figure 4.18. Effects on Id1 and Id3 expression following acute and long-term 
conditional deletion of Id4 from RGLs 
(A) Immunostaining of YFP, GFAP and Id1 in control and Id4cKO following 5 days of 
tamoxifen treatment (P65). Scale bar, 30µm. 
(B) Quantification of percentage Id1+ YFP+GFAP+RGLs, from the data shown in (A). Loss 
of Id4 in RGLs results in increased numbers of Id1+ RGLs. n=2 for control and n=3 for 
Id4cKO.  
(C) Immunostaining of YFP, GFAP and Id1 in control and Id4cKO 30 days after tamoxifen 
treatment (P90). Scale bar, 30µm. 
(D) Quantification of percentage Id1+ YFP+GFAP+RGLs, from the data shown in (C). The 
percentage of Id1+ RGLs is increased 30days post-Id4 deletion. n=2 for control and n=3 for 
Id4cKO.  
(E) Immunostaining of GFAP and Id3 in control and Id4cKO following 5 days of tamoxifen 
treatment (P65). The number of Id3+ RGLs is visibly increased in Id4cKO mice compared to 
control mice. Scale bar, 30µm. 
(F) Immunostaining of YFP, GFAP and Id3 in control and Id4cKO 30 days after tamoxifen 
treatment (P90). The increased number of Id3+ RGLs in Id4cKO mice is sustained even 30 
days after Id4 deletion. Scale bar, 30µm. 
Unpaired t-test was used for all statistical analyses (mean±SEM), p<0.05 (*), p<0.001(***).  
 
4.5 Id4 expression is independent of Smad4 in vivo 
Having identified Id4 as a key regulator of RGL quiescence, I next asked what 
signalling pathways regulate Id4 in vivo. Due to the strong regulation of Id4 by BMP4 in 
AHNSCs in vitro, and due to the fact that Ids are induced by BMP in embryonic neural 
progenitor cells (Samanta and Kessler, 2004), I began by investigating the effect of 
BMP/Smad signalling on Id4 in RGLs in vivo. I utilised a transgenic mouse line 
containing floxed Smad4 alleles, which when crossed with GlastCreERT2; Rosa26-EYFP 
mice, would allow me to conditionally delete Smad4 in adult RGLs. Smad4 deletion 
should block BMP signalling, as it is a common effector of the pathway, integrating 
signalling via phosphorylated Smads1/5/8 as well as phosphoSmad2/3.   
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4.5.1 Smad signalling is active in a small number RGLs in vivo, in the 
presence or absence of Smad4 
BMP-Smad signalling has previously been reported to be active in many cells in the 
DG, including stem cells (Bonaguidi et al., 2008; Colak et al., 2008; Mira et al., 2010), 
so I confirmed this by performing immunostaining for pospho-Smad1/5/8 in adult brain 
sections from either control or Smad4cKO mice (Figure 4.19A). I was able to identify a 
small number of pSmad1/5/8+ RGLs in both control and Smad4cKO mice (Figure 
4.19B), suggesting both that BMP/Smad signalling is active in some adult RGLs and 
that Smad4 deletion in RGLs does not affect signalling upstream. However, the 
number of pSmad1/5/8 RGLs detected was far less than the number of Id4+ (or Id1+) 
RGLs, suggesting pSmad detection here is not sensitive enough, or that Id4 
expression can be independent of pSmad1/5/8 signalling. Poor detection of 
pSmad1/5/8 may be the more likely case, as detection using a different pSmad-1 
antibody by Mira et al., 2010 show high levels of pSmad-1 staining in the DG, including 
in Sox2+ RGLs; the results I obtained closely reflected the staining seen by Colak et 
al., 2008, who used the same pSmad1/5/8 antibody I used. It is therefore likely that 
BMP-Smad signalling is active in RGLs in the adult DG, and could induce Id4 
expression.  
 
 
Figure 4.19. Expression of phospho-Smad1/5/8 in the dentate gyri of control and 
Smad4cKO mice (legend next page) 
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Figure 4.19. Expression of phospho-Smad1/5/8 in the dentate gyri of control and 
Smad4cKO mice 
(A) Experimental design for the deletion of Smad4 from RGLs in adult (P60) Smad4cKO 
mice. Mice either wildtype (control) or homozygous floxed (Smad4cKO) for the Smad4 locus 
were treated with tamoxifen for 5 days, and analysed 30 days later (P90).  
(B) Immunostaining for GFAP and phospho-Smad1/5/8 in the dentate gyrus of control and 
Smad4cKO 30days post-tamoxifen treatment. pSmad1/5/8 staining is found in hilar (H) 
astrocytes, as well as some GFAP+ RGLs. The subgranular zone (SGZ) is identified by the 
white dotted lines. GCL: granule cell layer. Scale bar, 30µm. 
 
4.5.2 Conditional deletion of Smad4 in vivo does not affect Id4 expression or 
RGL activation 
I next asked whether Id4 expression in RGLs is dependent upon BMP/Smad4 
signalling. I conditionally deleted Smad4 in RGLs of adult mice, and analysed brain 
sections of control and Smad4cKO mice (Figure 4.20A) either 5 days (Figure 4.20Ai) or 
30 days (Figure 4.20Aii) following tamoxifen administration. Surprisingly, 5 days after 
Smad4 deletion, the percentage of YFP+GFAP+ RGLs expressing Id4 was not 
significantly changed (97.11±0.9% in control vs 99.48±0.5% in Smad4cKO) (Figure 
4.20B,C), and in fact the level of Id4 protein was increased, measured by fluorescence 
intensity (average of 100.7± 4.1 A.U. in control vs 129.8± 4.5 A.U. in Smad4cKO) (Figure 
4.20C). The percentage of Id4+ RGLs was also not significantly changed 30 days 
following Smad4 deletion (89.85±4.5% in control vs 79.92±2.7% in Smad4cKO) (Figure 
4.20D). Smad4 deletion did however strongly suppress the levels of Id1 protein in 
YFP+GFAP+ RGLs, both 5 days post-tamoxifen (17.73±3.6% in control vs 6.86±0.7% 
in Smad4cKO) and 30 days post-tamoxifen (52.59±3.4 in control vs 5.96±1.4% in 
Smad4cKO) (Figure 4.20E-G). This shows that the deletion of Smad4 was functional, 
and highlights yet again the difference between Id4 and the other Ids. The increase in 
Id4 expression may reflect the reduction of Id1, which may negatively regulate Id4 to a 
small degree. Further to the effect on Id protein expression, I examined whether 
Smad4 deletion affected RGL activation, by quantifying the percentage of Ascl1+ or 
Ki67+ YFP+GFAP+ RGLs. 5 days post-tamoxifen neither Ascl1 nor Ki67 were 
significantly changed (Figure 4.20H-K). This again indicates Id1 does not strongly 
regulate RGL quiescence when Id4 expression is high. More surprisingly these results 
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show that Id4 expression is independent of Smad4-mediated BMP signalling in RGLs 
in vivo. 
 
Figure 4.20. Effects of acute and long-term conditional deletion of Smad4 from 
RGLs (legend next page) 
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Figure 4.20. Effects of acute and long-term conditional deletion of Smad4 from 
RGLs 
(A) Experimental design for the deletion of Smad4 from RGLs in adult (P60) Smad4cKO 
mice. Mice either wildtype (control) or homozygous floxed (Smad4cKO) for the Smad4 locus 
were treated with tamoxifen for 5 days, and (i) analysed immediately or (ii) 30 days later 
(P90).  
(B) Immunolabelling of YFP, GFAP and Id4 shows Id4 protein is still expressed in 
YFP+GFAP+ RGLS in Smad4cKO mice after 5 days of tamoxifen, at similar levels to control 
mice. Scale bar, 30µm. 
(C) Quantification of Id4 levels shown in (B). The percentage of YFP+GFAP+ RGLs 
positive for Id4 was unchanged between control and Smad4cKO mice after 5 days of 
tamoxifen. Id4 protein levels as measured by immunofluorescence intensity (A.U.) was 
significantly increased in Smad4cKO mice compared to control, and the average 
fluorescence levels were also increased in Smad4cKO mice. n=3 for control and n=4 for 
Smad4cKO.  
(D) The percentage of Id4+ YFP+GFAP+ RGLs was not changed between control and 
Smad4cKO mice 30 days after tamoxifen treatment (P90). n=2 for control and n=6 for 
Smad4cKO. 
(E) Immunolabelling of YFP, GFAP and Id1 shows Id1 protein is reduced in YFP+GFAP+ 
RGLS in Smad4cKO mice after 5 days of tamoxifen, compared with control mice. Scale bar, 
30µm. 
(F) Quantification of Id1 levels shown in (B). The percentage of YFP+GFAP+ RGLs positive 
for Id1 was strongly reduced in Smad4cKO mice after 5 days of tamoxifen treatment. n=3 for 
control and n=4 for Smad4cKO. 
(G) The percentage of YFP+GFAP+ RGLs positive for Id1 was also strongly reduced in 
Smad4cKO mice 30 days after tamoxifen administration. n=2 for control and n=6 for 
Smad4cKO. 
(H) Immunolabelling of YFP, GFAP and Ascl1 shows little difference in Ascl1 
immunostaining between control and Smad4cKO mice after 5 days of tamoxifen treatment. 
Scale bar, 30µm. 
(I) Quantification of the data shown in (H). The percentage of YFP+GFAP+ RGLs positive 
for Ascl1 was 2.05±0.4% in control mice and 2.64±0.6% in Smad4cKO mice after 5 days of 
tamoxifen treatment, and therefore not significantly changed. n=3 for both control and 
mutant mice.  
(J) Immunolabelling of YFP, GFAP and Ki67 shows similar numbers of Ki67+ RGLs 
between control and Smad4cKO mice after 5 days of tamoxifen treatment. Scale bar, 30µm. 
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(K) Quantification of the data shown in (J). The percentage of YFP+GFAP+ RGLs positive 
for Ki67 was unchanged between control (3.96±0.8%) and Smad4cKO (3.71±0.3%) mice 
after 5 days of tamoxifen treatment. n=3 control mice and n=4 for Smad4cKO mice.  
Unpaired t-test was used for all statistical analyses (mean±SEM), p>0.05 (ns), p<0.05 (*), 
p<0.01 (**), p<0.0001(****).  
4.5.3 Conditional deletion of Smad4 in AHNSCs in vitro does not affect Id4 
protein level, but does lead to a loss of Id1 and Id3 
The following experiment shows only a single repeat, and is therefore preliminary data. 
However, the results suggest an interesting divergence between the different Id 
proteins and their regulation by Smad4 signalling, therefore I present them here as an 
insight for the results obtained in vivo in the Smad4cKO mice. In order to examine the 
effects on all Id proteins following Smad4 deletion in AHNSCs, I utilised an adult 
hippocampal neural stem cell line derived from the Smad4flx mice described in Section 
4.5.2 (line derived by N. Urbán). Normal AHNSCs in active and quiescent conditions 
have the capacity to signal via the BMP/Smad pathway, due to the expression of 
Smad1-5 seen in the RNA sequencing data, as well as the expression of the BMP 
receptors Bmpr1a, Bmpr1b and Bmpr2, and the expression of BMP ligands such as 
Bmp1. Therefore, deletion of Smad4 in these cells could have a functional 
consequence, particularly in light of the report that hippocampal NSCs exposed to the 
BMP agonist Noggin in vitro show increased proliferation (Mira et al., 2010). Smad4flx 
AHNSCs were cultured in either proliferation conditions (20ng/mL FGF2 plus 20ng/mL 
EGF; these cells were derived directly into FGF2+EGF conditions and utilised for 
experiments prior to being transitioned into FGF2-alone) or quiescent conditions 
(20ng/mL BMP4 + 20ng/mL FGF2, 72h). Cells were then transduced with 100moi 
adenovirus expressing either GFP or Cre-recombinase to induce recombination of the 
floxed Smad4 alleles, and the cells cultured for 4 days to allow time for the remaining 
Smad4 protein to be degraded. At this point, cells were collected and either fixed for 
immunocytochemistry, or RNA extracted. I first checked the expression of targets of 
BMP/Smad signalling Id1, Id3 and Id4 by QPCR (ddCT are shown relative to the 
expression in proliferating AHNSCs transduced with Adeno-GFP, to show the change 
in expression upon BMP4 treatment). In quiescent conditions, Id1, Id3 and Id4 were all 
downregulated at the mRNA level following Smad4 deletion, with a fold-change of 2.0, 
9.8 and 2.6 respectively (Figure 4.21A-C), indicating BMP4-induced expression of 
these three Id genes is mediated in part by Smad4, and Id3 is the most strongly 
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regulated Id gene by Smad4 signalling. It also suggests there is another signal present 
in the in vitro culture system capable of inducing Id gene expression. I next examined 
the protein levels of Id1-4, to determine how Id protein levels were affected following 
Smad4 deletion. I immunostained for all four Id proteins in quiescent Smad4flx NSCs, 
transduced with either Adeno-GFP or Adeno-Cre, and quantified the fluorescence 
intensity of each protein per nucleus. Smad4 deletion in proliferating AHNSCs results 
in a strong decrease in the protein levels of Id1 (Figure 4.21D, I) and Id3 (Figure 4.21F, 
K), whereas Id2 protein levels are very slightly increased in Smad4cKO cells (Figure 
4.21E, J), and Id4 protein levels are unchanged (Figure 4.21G, L). These results 
highlight a differential induction of the four Ids by BMP/Smad4 signalling, particularly 
for Id4, for which the protein level is sustained despite a decrease in mRNA expression 
following Smad4 deletion. These data also corroborate the observations that Smad4 
deletion in RGLs in vivo results in a loss of Id1 protein but not Id4. Finally, I also 
checked Ascl1 protein levels, to see whether a reduction in Id1-3 protein affected Ascl1 
levels. Ascl1 protein levels were significantly increased in Smad4cKO AHNSCs (Figure 
4.21H, M) suggesting either that Id proteins other than Id4 contribute to the negative 
regulation of Ascl1 protein levels, or that Smad4 signalling can directly suppress Ascl1 
expression.  
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Figure 4.21. Analysis of Id levels in AHNSCs derived from Smad4flx mice 
(A-C) QPCR analysis of Id1, Id3 and Id4 mRNA levels in Smad4flx AHNSCs, in BMP4-
induced quiescent conditions (20ng/mL BMP4 + 20ng/mL FGF2, 72h), transduced with 
either 100moi Adeno-GFP or Adeno-Cre virus for 4 days. ddCt shown are relative to the  
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relative expression of each gene in Smad4flx AHNSCs in proliferation conditions (20ng/mL 
EGF + 20ng/mL FGF2) transduced with 100moi Adeno-GFP for 4 days. n=1. 
(D-G) Immunostaining for Id1, Id2 Id3 and Id4 in BMP4-induced quiescent Smad4flx 
AHNSCs, transduced either 100moi Adeno-GFP or Adeno-Cre virus for 4 days. Scale bar, 
30 µm.  
(I-L) Quantification of the immunofluorescence intensity (arbitrary units, A.U.) of the 
staining shown in (D-G). Error bars shown mean±SEM, p>0.05 (ns), p<0.05 (*), 
p<0.0001(****).  
(H) Immunostaining for Ascl1 in BMP4-induced quiescent Smad4flx AHNSCs, transduced 
either 100moi Adeno-GFP or Adeno-Cre virus for 4 days. Scale bar, 30 µm.  
(M) Quantification of the immunofluorescence intensity (arbitrary units, A.U.) of Ascl1 
staining shown in (H).  
Error bars shown mean±SEM, p<0.0001(****). E, EGF; F, FGF2; B, BMP4. 
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Chapter 5. Results 3 
The neurogenic niche in the adult dentate gyrus provides a source of multiple different 
signals that have the potential to regulate adult neural stem cell quiescence and 
activation. Delineating the effects of these signals specifically on stem cell activity is 
important for linking together the changes in the niche which often occur as a result of 
a change in behaviour or global biology of the organism, to the behaviour of the stem 
cells. BMP signalling has been reported to be active in the dentate gyrus, and acts to 
maintain quiescence of adult RGLs. As I have shown it also induces quiescence of 
NSCs in vitro. Notch signalling has also been shown to be required to maintain RGL 
quiescence (Ables et al., 2010; Basak et al., 2012; Ehm et al., 2010). However, it is yet 
to be examined how these two niche factors interact to regulate quiescence. Therefore, 
in the following chapter I will examine the interplay of Notch and BMP signalling on the 
quiescent state. Moreover, having identified Id4 as an important factor for maintaining 
quiescence of adult RGLs, I will investigate whether Notch signalling regulates Id4 
expression in vivo.  
  
5.1 Modulating Notch signalling has different effects in 
different concentrations of BMP4  
5.1.1 Notch signalling is active in NSCs in vitro 
I first turned to the in vitro model of quiescence in order to investigate the role of Notch 
signalling specifically in the regulation of stem cell quiescence and Id4 expression, and 
how Notch interplays with BMP4 signalling. Notch signalling can have different effects 
in different contexts, and the different Notch receptors are reported to differently 
regulate RGL quiescence. It therefore may regulate active and quiescent NSCs 
differently. Moreover, RGLs in vivo are likely to receive differing concentrations of the 
various niche signals; it is plausible that the balance of BMP, Notch and other niche 
signals is highly relevant for stem cell regulation. Therefore, I tested the role of Notch in 
three different concentrations of BMP4; the “active” proliferating state with AHNSCs in 
the presence of FGF2 (and EGF for experiments done early in my PhD) with no BMP4; 
“shallow” quiescence with 1ng/mL BMP4; and “deep” quiescence with 20ng/mL BMP4 
(scheme shown in Figure 5.1.1A). I blocked Notch signalling in the three NSC states by 
treating AHNSCs with either DMSO as a vehicle control, or a gamma-secretase 
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inhibitor (GSI) LY411575 (hereafter referred to as LY) which blocks the cleavage of the 
intracellular domain (NICD) of Notch receptors1, 2 and 3, preventing NICD-mediated 
Notch-target gene activation ((Alunni et al., 2013); Figure 5.1B). I first checked the 
endogenous level of Notch signalling in the three NSC states, to check whether 
blocking Notch would have a functional effect. The three Notch receptors Notch1, 2 
and 3 were all expressed in the three NSC states, as shown by FPKM values from 
RNAseq (Figure 5.1C) and QPCR relative expression (Figure 5.1D). All three receptors 
were expressed at similar levels in all three states, indicating Notch signalling could 
potentially be induced in NSCs in each state. I next measured the expression levels of 
the Notch target genes Hes1, Hes5 and Hey1, by both FPKM from the RNAseq data 
set and by QPCR relative expression levels. All three targets were expressed in all 
three states, with Hes5 having the highest expression of the three genes, indicating 
Notch signalling is active in active and quiescent NSCs. Interestingly, Hes5 expression 
was increasingly suppressed by increasing BMP4 concentration (Figure 5.1E,F), 
suggesting BMP4 may inhibit Notch signalling at high concentrations. Overall these 
results suggest Notch signalling may be functional in active and quiescent NSCs in 
vitro, and this model can therefore be used to test its function in regulating quiescence.  
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Figure 5.1. Scheme for inhibiting Notch signalling and expression of Notch 
components in AHNSCs in vitro 
(A) Scheme showing the treatment of NSCs to induce three different states of activity or 
quiescence. “Active” NSCs are propagated in the presence of 20ng/mL FGF2 (plus 
20ng/mL EGF for a small number of earlier experiments). “Shallow” quiescence is induced 
by treating active NSCs with 1ng/mL BMP4 for 72h, and “Deep” quiescence is induced with 
20ng/mL BMP4 for 72h.  
(B) Scheme of Notch signalling, inhibited by the y-secretase inhibitor (GSI) LY411575. 
Notch receptors 1, 2 and 3 are activated via binding of their ligands Dll1 or Jagged 
presented on neighbouring cells, promoting a conformational change of the receptor. This  
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allows for cleavage by ADAM metalloproteases, followed by proteolytic cleavage of the 
Notch intracellular domain (NICD) via the y-secretase enzyme. NICD then enters the 
nucleus and binds to the DNA of its gene targets in a complex with DNA-binding protein 
CSL, thus activating transcription. The GSI LY411575 inhibits y-secretase mediated 
cleavage of NICD, thus preventing activation of Notch target genes.  
(C) The expression of the Notch receptors 1,2 and 3 are shown as Fragments per Kilobase 
per Million reads (FPKM) from RNA sequencing of active, shallow and deep quiescent 
NSCs. All three receptors are expressed in all three conditions at similar levels, with Notch1 
showing the highest expression. Notch3 is slightly suppressed in “deep” quiescence.  
(D) Quantitative PCR for Notch1,2 and 3, from mRNA extracted from active, shallow and 
deep quiescent NSCs, confirms the expression levels observed in the RNAseq data, 
although here suggests the expression levels for all three receptors are similar in all 
conditions, in contrast to the higher levels of Notch1 observed in the RNAseq data. The 
ddCt values shown are relative to the expression of internal control genes GAPDH and 
ActinB, and then relative to the expression of Notch1 in active NSCs.  
(E) The expression of the Notch target genes Hes1, Hes5 and Hey1 are shown as 
Fragments per Kilobase per Million reads (FPKM) from RNA sequencing of active, shallow 
and deep quiescent NSCs. All three genes are expressed in all three conditions. Hes5 has 
the highest expression of the three, however is downregulated in “deep” quiescence.  
(F) Quantitative PCR for Hes1, Hes5 and Hey1, from mRNA extracted from active, shallow 
and deep quiescent NSCs, confirms the expression levels observed in the RNAseq data. 
The ddCt values shown are relative to the expression of internal control genes GAPDH and 
ActinB, and then relative to the expression of Hes1 in active NSCs.  
 
5.1.2 Active Notch signalling is required for low-level proliferation of 
quiescent NSCs, independent of Id4 and Ascl1 
I next tested whether treatment with LY could block Notch signalling in NSCs. “Active” 
AHNSCs (in the presence of EGF and FGF2) and “deep” quiescent AHNSCs were 
treated with either 1uM, 10uM or 20uM LY, or an equal volume of DMSO as a control, 
for 72h after which cell lysates were extracted to perform Western blot for the Notch1 
intracellular domain (N1ICD). 72hr was chosen in order to allow time for any cleaved 
NICD to be recycled, and to give time for the cells to enter/exit the cell cycle, as with 
BMP4 treatment. N1ICD was strongly detected in both active and quiescent NSCs, 
further demonstrating that Notch signalling is active in these conditions. Treatment with 
LY, even at the lowest concentration (1uM), was sufficient to completely block the 
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cleavage of the Notch1 receptor and the production of NICD (Figure 5.2A), as 
compared to the control samples, in both active and “deep” quiescent AHNSCs. I 
therefore chose 1uM LY to inhibit Notch in AHNSCs for future experiments. I next 
checked the expression level of Notch target gene Hes5 in active, “shallow” and “deep” 
quiescent NSCs treated with either 1uM LY or an equal volume of DMSO. QPCR for 
Hes5 in LY treated NSCs showed that Notch inhibition in active or “shallow”-quiescent 
NSCs could strongly suppress Notch signalling (Figure 5.2B). Interestingly, LY could 
not suppress Hes5 expression in the “deep” quiescent NSCs, suggesting high levels of 
BMP4 signalling may be able to induce Hes5 expression. This is paradoxical to the 
observation in Section 5.1.1 that increasing concentration of BMP4 suppresses Hes5 
expression (also seen in Figure 5.1B). It could be that BMP4 simultaneously inhibits 
endogenous Notch signalling whilst also inducing some Notch target genes such as 
Hes5, albeit less strongly than Notch can induce them. I will explore this further in 
Section 5.1.3. Concurrent to the suppression of Hes5, LY treatment led to the 
upregulation of Ascl1 mRNA (Figure 5.2C). This would be expected, because Ascl1 is 
suppressed at the transcriptional level by Hes1/5 (Imayoshi and Kageyama, 2014b) 
Moreover, the upregulation of Ascl1 was less marked in “deep” quiescence compared 
to “shallow” quiescence (Figure 5.2C), which could reflect the sustained expression of 
Hes5 in the presence of high levels of BMP4 plus GSI (Figure 5.2B). Notch1 signalling 
is reported to be important for maintaining quiescence of RGLs in vivo, therefore I 
measured the proliferation rate of LY-treated cells by immunostaining for cell cycle 
markers Ki67 and CyclinD1, and incorporation of S-phase marker EdU. Notch inhibition 
did not affect the proliferation of active NSCs (Figure 5.2D-F, green bars; Gi), likely 
reflecting the fact they are already proliferating at a high rate. Notch inhibition also did 
not significantly affect the proliferation of shallow quiescent NSCs, although there was 
a trend towards lower proliferation rates (Figure 5.2D-F, light blue bars; Gii). Most 
surprisingly, LY treatment of deeply quiescent NSCs induced an even deeper state of 
quiescence as shown by significant reduction of the fraction of EdU+, Ki67+ and 
CyclinD1+ NSCs (Figure 5.2D-F, dark blue bars; Giii). I checked whether this was due 
to changes in the levels of Ascl1 and Id4. Id4 expression was not significantly affected 
by LY in deeply quiescent NSCs, although was upregulated in active and shallow-
quiescent NSCs (Figure 5.2H). Id4 protein was mildly increased in active and shallow-
quiescent NSCs following Notch inhibition, as measured by fluorescence intensity from 
immunostaining (Figure 5.2J), corresponding with the observed increase in mRNA 
expression (Figure 5.2H). Id4 levels were mildly decreased in LY-treated deep-
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quiescent NSCs (Figure 5.2J,N) and the shift to lower fluorescence levels with LY 
treatment can be seen when plotted as a histogram of intensity (Figure 5.2K). 
Therefore, Notch appears to suppress Id4 expression in the presence of low BMP4, but 
higher concentrations of BMP4 can overcome this suppression to induce Id4. This 
shows the decrease in proliferation of “deep” quiescent NSCs following Notch inhibition 
cannot be explained by changes in Id4 levels in vitro. Moreover, despite the higher or 
normal levels of Id4 protein (Figure 5.2 J), Ascl1 protein levels were increased in all 
three conditions treated with LY (Figure 5.2L) and the shift towards higher Ascl1 levels 
in LY-treated deeply-quiescent NSCs can be seen clearly in a histogram of Ascl1 
fluorescence intensity (Figure 5.2M). This is likely a result of increased Ascl1 
transcription following Notch inhibition (Figure 5.2C). Increased Ascl1 protein levels 
would be expected to lead to increased proliferation, however the opposite is observed, 
suggesting Notch may regulate other pathways that induce proliferation in the 
presence of BMP4, independent of Ascl1. There may potentially be a compensatory 
effect by other Id proteins, as Id1 expression is upregulated following LY-treatment, 
only in quiescent NSCs (Figure 5.2I). However, I have not quantified whether Id1 
protein is significantly upregulated in LY-treated quiescent NSCs. Overall these results 
suggest an interesting dynamic between Notch and BMP4 signalling at different levels 
in NSCs in vitro, whereby Notch is able to modulate the levels of Hes5, Ascl1, and Id4 
when BMP4 is absent or low. In contrast, in high concentrations of BMP4, Notch has 
less of an effect on the transcription of these factors, but more strongly affects the low 
level of proliferation. These results may be explained by a potential effect of Notch on 
the oscillations of Ascl1, Id4 and Hes5 protein, which I will discuss further in Section 6.  
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Figure 5.2. Effects of inhibiting Notch signalling in active and quiescent AHNSCs 
in vitro (legend next page) 
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Figure 5.2. Effects of inhibiting Notch signalling in active and quiescent AHNSCs 
in vitro 
(A) Western Blot analysis of Notch1 intracellular domain (N1ICD) and Actin in NSCs in 
EGF+FGF2 (“active”) or FGF2+BMP4 20ng/mL (“deep” quiescent) conditions, treated for 
72h with either DMSO or 1uM, 10uM or 20uM of the y-secretase inhibitor LY411575. 
N1ICD can be strongly detected in both active and deep quiescent NSCs, and is 
completely lost upon treatment with all concentrations of LY.  
(B) QPCR analysis of Hes5 expression in active, shallow and deep quiescent NSCs, 
treated for 72h with either 1uM LY or an equivalent volume of DMSO (control). n=3. 
(C) QPCR analysis of Ascl1 expression in active, shallow and deep quiescent NSCs, 
treated for 72h with either 1uM LY or an equivalent volume of DMSO (control). n=3. 
(D) Quantification of the percentage of NSCs that have incorporated the S-phase marker 
EdU during a 1hour pulse, in control (DMSO) or Notch-inhibited (1uM LY) active, shallow 
and deep quiescent NSCs. n=3. 
(E) Quantification of the percentage of NSCs positive for Ki67 immunostaining, in control or 
(1uM LY) Notch-inhibited active, shallow and deep quiescent NSCs. n=3. 
(F) Quantification of the percentage of NSCs positive for CyclinD1 immunostaining, in 
control (DMSO) or Notch-inhibited (1uM LY) active, shallow and deep quiescent NSCs. 
n=3. 
(G) Immunostaining for Ki67, CyclinD1, and EdU in deep quiescent NSCs treated with 
either DMSO (control) or 1uM LY. Scale bar, 30µm. 
(H) QPCR analysis of Id4 expression in active, shallow and deep quiescent NSCs, treated 
for 72h with either 1uM LY or an equivalent volume of DMSO. n=3. 
(I) QPCR analysis of Id4 expression in NSCs in EGF+FGF2 (“active”) or FGF2+BMP4 
20ng/mL (“deep” quiescent) conditions, treated for 72h with either 1uM LY or an equivalent 
volume of DMSO (control). n=3. 
(J) Immunofluorescence intensity (arbitrary units, A.U.) of Id4 in the nuclei of NSCs are 
plotted for active, shallow and deep quiescent NSCs, treated for 72h with either 1uM LY or 
an equivalent volume of DMSO (control). n=3. 
(K) Histogram plot of the immunofluorescence intensity values for Id4 in deep quiescent 
NSCs in DMSO (control) or 1uM LY, shown in (J). LY-treated NSCs have a lower 
percentage of nuclei with Id4 A.U. values above 80.  
(L) Immunofluorescence intensity (A.U.) of Ascl1 in the nuclei of NSCs are plotted for 
active, shallow and deep quiescent NSCs, treated for 72h with either 1uM LY or an 
equivalent volume of DMSO (control). n=3. 
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(M) Histogram plot of the immunofluorescence intensity values for Ascl1 in deep quiescent 
NSCs in DMSO (control) or 1uM LY, shown in (J). LY-treated NSCs have a higher 
percentage of nuclei with Ascl1 A.U. values above 40.  
(N) Immunohistochemistry for Ascl1 and Id4 in deep quiescent NSCs treated with DMSO or 
1uM LY for 72h. Scale bar, 30µm. 
Unpaired t-test was used for all statistical analyses (mean±SEM), p>0.05 (ns), p<0.05 (*), 
p<0.01(**), p<0.001(***), p<0.0001(****). All repeats were independent biological replicates. 
 
5.1.3 Notch regulates different genes depending on the level of BMP4 
signalling  
To further understand the interaction of Notch and BMP signalling in regulating NSC 
quiescence, I performed RNA sequencing of active (20ng/mL FGF2), “shallow” 
quiescent (20ng/mL FGF2 + 1ng/mL BMP4) and “deep” quiescent (20ng/mL FGF2 + 
20ng/mL BMP4) NSCs treated for 72h with DMSO or 1uM LY. A transcriptome-wide 
analysis allowed me to identify potential pathways that Notch regulates in the presence 
of no, low or high BMP4, to help explain the effects seen on proliferation. The first 
striking observation was that Notch regulates far more genes in active and shallow 
quiescent NSCs (1722 and 1738 genes, respectively), than in deep quiescence (427 
genes) (Figure 5.3A,B). This could suggest that high concentrations of BMP4 can 
induce Notch target genes, or that high levels of BMP signalling suppress Notch and 
therefore Notch inhibition would have little effect in this condition. This ties in with the 
observation made in Figure 5.2B, that 20ng/mL BMP4 inhibits the QPCR expression of 
Hes5 compared to active and shallow quiescent NSCs, but also induces Hes5, as 
Notch inhibition does not affect Hes5 in this condition. I looked further into this by 
analysing the FPKM expression of Notch target genes Hes1, Hes5 and Hey1 in active, 
shallow quiescent and deep quiescent NSCs treated with DMSO or LY (Figure 5.3C-
D). I found consistently for all three notch target genes that 20ng/mL BMP4 suppressed 
their expression compared to active and shallow quiescent NSCs in control conditions 
(Figure 5.3C-D, grey bars). LY treatment strongly suppressed all three Notch targets in 
active and shallow quiescent NSCs. However, LY did not affect the expression of 
Hes1, Hes5 or Hey1 in the presence of 20ng/mL BMP4, indicating BMP4 actually 
induces these genes. Overall it appears that in high concentrations, BMP4 acts 
redundantly with Notch signalling, suppressing its signalling and inducing its target 
genes (at least in the case of Hes1, Hes5 and Hey1) albeit less strongly than Notch. In 
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further support of this notion, the genes regulated by Notch in deep quiescence are 
mostly unique to that state, whereas the majority of genes regulated by Notch in active 
NSCs are also regulated in shallow quiescent NSCs (Figure 5.3A,B). This implies that 
BMP signalling is regulating Notch target genes in deep quiescence but not in shallow 
quiescence or active NSCs, therefore Notch inhibition affects more genes in the latter 
two conditions. To see more broadly the categories of genes that were regulated by 
Notch, I analysed the ontologies of genes significantly up- or down-regulated by LY 
treatment in active, shallow and deep quiescent NSCs. Interestingly, cell cycle genes 
were strongly upregulated by Notch inhibition in active and shallow quiescence (Figure 
5.3F,H). This concurs with the reported role for Notch in maintaining quiescence in vivo 
(Ables et al., 2010; Ehm et al., 2010; Kawaguchi et al., 2013; Ottone et al., 2014), 
however it does not translate to an actual increase in proliferation in the in vitro system 
(Figure 5.2D-G). Genes downregulated following Notch inhibition in active and shallow 
quiescent NSCs are highly enriched for “Lipid metabolic process”, “Cell adhesion”, and 
“Oxidation-reduction process” (Figure 5.3G,I), indicating Notch may regulate 
quiescence by modulating metabolism or adhesion of NSCs to the niche, both of which 
have been reported to regulate NSC quiescence in vivo ((Knobloch et al., 2013); 
adhesion shown to regulate SVZ NSCs, but not for SGZ NSCs yet, i.e. (Kazanis et al., 
2010; Ottone et al., 2014)). “Protein phosphorylation” ontologies are found in both up- 
and down-regulated samples in all conditions, suggesting Notch may dynamically 
regulate phosphorylation (Figure 5.3F-K). In contrast, inhibiting Notch signalling in 
deep quiescent NSCs does not significantly regulate any cell cycle genes (Figure 
5.1.3L) perhaps due to the fact BMP4 already strongly suppresses cell cycle genes. 
Instead, genes associated with “Negative regulation of Wnt signalling” are upregulated, 
whilst “Erk1/2 cascade” and “NFkB activity” are downregulated following Notch 
inhibition, suggesting it may be regulating various mitogenic signalling pathways in high 
levels of BMP4. As for active and shallow quiescent NSCs, “Cell adhesion” and lipid 
metabolism genes are also regulated in deep quiescence by Notch, indicating Notch 
signalling may play an important role in regulating these aspects of NSC biology. 
Overall these results suggest Notch plays an important role in regulating metabolism of 
NSCs, protein phosphorylation, and maintaining quiescence of NSCs in lower 
concentrations of BMP4. However, higher concentrations of BMP4 simultaneously 
suppress Notch signalling and incudes Notch target genes. Both Notch and BMP 
signalling are required to maintain the stem cell population in the DG in adult mice, 
therefore it is rational that they can both induce stemness/quiescence genes, and act 
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redundantly. However, it appears that their effects may change depending on the 
concentration of each signal. The role of Notch in deeply quiescent NSCs is subtler, 
perhaps regulating other signalling pathways, such as Wnt or MAPK, that could help to 
maintain the low-level proliferation of NSCs, or by modulating the activity of proteins via 
phosphorylation, or by regulating adhesion or metabolism, indirectly affecting 
quiescence.  
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Figure 5.3. RNAseq analysis of active, shallow quiescent and deep quiescent 
AHNSCs following Notch inhibition (legend next page) 
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Figure 5.3. RNAseq analysis of active, shallow quiescent and deep quiescent 
AHNSCs following Notch inhibition  
(A-B) Overlap of genes significantly up- or down-regulated following 72h 1uM LY treatment, 
as compared to DMSO control samples, in “active” (FGF2), “shallow” quiescent 
(FGF2+BMP4 1ng/mL) and “deep” quiescent (FGF2+BMP4 20ng/mL) NSCs. Upregulated 
genes were determined by a significant Log2-fold change greater than 1, and with a 
minimum expression of 1 FPKM in LY-treated NSCs. Down-regulated genes were 
determined by a significant Log2-fold change less than -1, and with a minimum expression 
of 1 FPKM in DMSO-treated NSCs.  
(C-D) Expression of Notch target genes Hes1, Hes5 and Hey1 in NSCs treated with DMSO 
or 1uM LY for 72h, measured by RNA sequencing. Expression values are shown as FPKM 
from 3 biological repeats. 
(F-K) Gene Ontology terms associated with genes up- or down-regulated in active, 
“shallow” quiescent or “deep” quiescent NSCs treated with 1uM LY for 72h, compared to 
DMSO-treated control NSCs. Shown for each term are the number of genes associated 
with the ontology, and its significance (Log10 p-value). Dots are coloured based on their 
ontology terms - light blue: cell cycle/division; dark blue: DNA repair/replication; light green: 
Protein phosphorylation/modification; dark green: signalling, transcription; orange: 
adhesion/cytoskeleton; yellow: ion-related; pink: brain/nervous system related; purple: 
metabolism; red: oxidation/reduction. 
(L) Overlap of genes regulated in LY-treated “deep” quiescent NSCs and cell cycle genes 
(list from Qiagen.com.) None of the 313 cell cycle genes are regulated by Notch in “deep” 
quiescent NSCs.   
3 independent biological repeats were processed for RNA sequencing.  
 
5.2 Investigating the effect of Notch signalling on Id4 in vivo 
Manipulating Notch signalling in vitro has produced contradictory data to the role of 
Notch reported for RGLs in vivo, however there are many caveats for the in vitro model 
(discussed in Section 6), and I saw a small effect of inhibiting Notch signalling on Id4 
expression. I was therefore interested to examine whether Notch signalling induces Id4 
expression in RGLs in vivo, which could explain part of the molecular mechanism by 
which Notch maintains RGL quiescence. The use of LY in vitro results in indiscriminate 
inhibition of all Notch receptors. I used a similar approach in vivo, via conditional 
deletion of RBPJk, the downstream effector of Notch signalling. Loss of RBPJk will 
result in a block of all Notch signalling. I crossed mice with a floxed RBPJk allele to the 
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GlastCreERT2; Rosa26-EYFP mice, in order to conditionally delete RBPJk specifically in 
RGLs of adult mice.  
 
5.3 Notch-RBPJk signalling is not required to maintain Id4 expression in 
RGLs 
In order to examine whether Notch-RBPJk signalling is required for Id4 expression in 
RGLs in vivo, RBPJk control or floxed (RBPJkcKO) mice were treated with tamoxifen for 
5 days to induce Cre-mediated recombination in RGLs, and then analysed 5 days later 
(P70), in order to allow time for the stable RBPJk protein to degrade (Andersen et al., 
2014) (Figure 5.4A). Immunostaining for Id4 did not show any striking difference 
between control and RBPJkcKO mice (Figure 5.4B). The fraction of Id4+ YFP+GFAP+ 
RGLs was reduced to a small degree in RBPJkcKO mice (89.83±1.6% in control vs 
81.92±1.6% in RBPJkcKO  mice), however the Id4 fluorescence intensity per RGL 
nucleus was not changed between control and RBPJkcKO mice (Figure 5.4C). Notch 
signalling therefore may be able to induce Id4 to a small degree in RGLs in vivo, as 
was observed in vitro, but it is not required for Id4 expression. RBPJk deletion does 
lead to a large increase in the fraction of Ascl1+ and Ki67+ RGLs (Figure 5.4D,E), as 
has previously been reported (Andersen et al., 2014), likely due to the loss of the 
transcriptional suppression of Ascl1 by Notch/Hes1/5 (Imayoshi and Kageyama, 
2014b). Interestingly, loss of RBPJk also resulted in a large increase in the number of 
Id1+ RGLs (Figure 5.4F). These results suggest that Notch signalling is not the main 
signal inducing of Id4 expression in the DG, and also suggests the maintenance of 
RGL quiescence by Id4 can be bypassed by Notch inhibition, perhaps as a result of the 
large increase in Ascl1 expression.  
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Figure 5.4. Effects of acute deletion of Notch effector RBPJk in RGLs 
(A) Design of the experiment for deleting RBPJk from RGLs of the adult hippocampus 
using RBPJkcKO mice.  
(B) Immunolabelling for YFP, GFAP and Id4 in the DG of RBPJkcKO and control mice 10 days 
after the first tamoxifen administration. Scale bar, 30µm. 
(C) Quantification of the data in (B). The number of Id4 expressing RGLs is mildly 
decreased, while the levels of Id4 are not significantly different in the absence of Notch-
RBPJk signalling. Unpaired t-test (mean±SEM), p>0.05 (ns), p<0.01 (**), p<0.0001 (****). 
n=4 for both control and mutant mice.  
(D-F) Immunolabelling for YFP, GFAP and either Ascl1, Ki67 or Id1 in the DG of RBPJkcKO 
and control mice 10 days after the first tamoxifen administration. Scale bar, 30µm.  
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5.4 Id4 expression in RGLs is independent of both Notch and 
BMP signalling in vivo 
Considering the fact that both BMP and Notch are reported to be important signalling 
pathways for the maintenance of RGL quiescence, and that neither alone are required 
to induce Id4 expression, I asked whether there is redundancy between Notch and 
BMP in the regulation of Id4. To this end, I generated GlastCreERT2;Smad4-
floxed;RBPJk-floxed;Rosa26-EYFP mice (RBPJkcKO;Smad4cKO mice), in which both 
Notch and BMP signalling will be conditionally inactivated in RGLs in adult mice.  
 
5.4.1 Double RBPJk-Smad4 conditional deletion does not strongly affect Id4 
expression in RGLs 
I treated RBPJkcKO;Smad4cKO mice with tamoxifen for 5 days, and then 5 days later 
(P70) analysed the mice (Figure 5.5A), to allow time for both Smad4 and RBPJk 
proteins to be degraded. The fraction of Id4+ YFP+GFAP+ RGLs was reduced, but not 
significantly, in double cKO mice (90.59±3.5% in control vs 79.48±6.7% in 
RBPJkcKO;Smad4cKO), and the fluorescence levels were also mildly decreased (Figure 
5.5C). However, this decrease in Id4 was similar to that observed for the single 
RBPJkcKO mice, suggesting this is mostly a result of loss of Notch. The fraction of 
Ascl1+ RGLs was increased in the RBPJkcKO;Smad4cKO mice (Figure 5.5D), again likely 
as a result of the loss of Notch rather than Smad4. The results suggest that there is not 
redundancy between BMP-Smad4 and Notch-RBPJk with regards to Id4 expression, 
however both signals can regulate Id4 expression in a small way. I also examined the 
effect on Id1 and Id3 protein expression in the double cKO mice. Id1 protein levels are 
increased in RGLs of RBPJkcKO;Smad4cKO mice (Figure 5.5 E), similar to the increase 
in Id1 protein observed in RBPJkcKO mice (Figure 5.4F). Id3 protein levels were not 
noticeably affected by deletion of both RBPJk and Smad4 (Figure 5.5F), suggesting 
Id3 may be regulated by different signals in a similar way to Id4. It is therefore highly 
interesting to investigate the regulation of Id4 further, to determine which of the many 
niche signals converge with Notch and BMP4 to induce Id4, thereby promoting the 
degradation of Ascl1 and maintaining NSC quiescence.  
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Figure 5.5. Effects of acute deletion of both Smad4 and RBPJk in RGLs 
(A) Design of the experiment for inactivating both BMP and Notch pathways in 
hippocampal RGLs. Both RBPJk and Smad4 are deleted using 5 days of tamoxifen  
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administration to Smad4cKO;RBPJkcKO mice, and analysed 10 days after the first tamoxifen 
injection to ensure the elimination of RBPJk protein.  
(B) Immunolabelling for YFP, GFAP and Id4 in the DG of Smad4cKO;RBPJkcKO and control 
mice 10 days after the first tamoxifen administration. Scale bar, 30µm. 
(C) Quantification of the data in (B). The percentage of Id4 expressing RGLs is mildly, but 
not significantly, decreased in Smad4cKO;RBPJkcKO mice. The levels of Id4 protein, 
measured by fluorescence intensity, is significantly decreased in Smad4cKO;RBPJkcKO mice, 
although the change in average levels does not reach significance. Unpaired t-test 
(mean±SEM), p>0.05 (ns), p<0.01 (**). n=3 for both control and mutant mice.   
(D) Immunolabelling for YFP, GFAP and Ascl1 in RGLs of Smad4cKO;RBPJkcKO and control 
mice following tamoxifen treatment. Scale bar, 30µm. 
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Chapter 6. Discussion 
The work presented here has highlighted that a classical mechanism for stem cell 
regulation - the dominant negative regulation of bHLH transcription factors by Id 
proteins - exists in a novel stem cell population, the neural stem cells of the adult 
hippocampal neurogenic niche. I have investigated the molecular mechanisms central 
to controlling the maintenance of adult hippocampal stem cell quiescence, by building 
upon an in vitro model of BMP4-induced quiescence that had been previously utilised 
by our laboratory to investigate quiescence of embryonic stem cell-derived NSCs 
(Martynoga et al., 2013). Using this technique in combination with in vivo analysis, I 
have identified firstly that the activation factor Ascl1 is unexpectedly expressed in many 
quiescent RGLs, and that the inhibitor of differentiation protein Id4 is enriched in 
quiescent RGLs and can mediate Ascl1 protein degradation to maintain a quiescent 
stem cell state. Interestingly, the loss of Id4 in RGLs may be compensated by Id1 
and/or Id3, which is particularly fascinating in light of the fact they appear to be 
negatively regulated by Id4. Finally, I investigated the niche signals upstream of Id4, 
uncovering a complex situation in which it seems likely multiple or non-canonical 
signals induce Id4 expression in the hippocampal niche. By investigating the molecular 
regulation of the quiescent NSC state specifically, this work both provides a deeper 
understanding of the homeostatic regulation of NSC activity, as well as generating 
insight into the mechanistic changes that may occur in NSCs in age-related cognitive 
decline, neurodegenerative disease, and glioma stem cells, potentially leading to novel 
therapies.  
 
In this chapter, I will present a discussion of my results, exploring the implications in 
the context of the field of adult neurogenesis and adult stem cell research. I will also 
suggest improvements of this work, as well as propose future experiments to address 
the remaining questions generated by the data generated here. 
 
6.1 An in vitro model of adult hippocampal neural stem cell 
quiescence 
The adult hippocampal stem cell niche is a complex environment, with many cell types 
regulating the activity of NSCs via direct cell contacts or secreted signalling molecules. 
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This means it is difficult to directly test the function of a gene or signal on a specific cell 
type within the niche, without indirectly affecting activity and signalling elsewhere. This 
is particular true of RGL quiescence, a stem cell state not fully understood or 
characterised. Therefore, there was a strong requirement for a tractable, reductionist 
system for investigating the complex molecular regulation of adult hippocampal NSC 
quiescence. I therefore built upon work by Mira and colleagues (Mira et al., 2010), and 
our lab (Martynoga et al., 2013), to develop an in vitro model of quiescence, using cells 
derived specifically from the adult dentate gyrus, in order to generate a biologically 
relevant method for studying the molecular regulation of this particular population of 
cells (Figure 3.1).  
 
6.1.1 BMP4-treated adult hippocampal neural stem cells robustly model RGL 
quiescence  
Treatment with BMP4 was able to strongly but reversibly suppress the proliferation of 
adult hippocampal neural stem cells (AHNSCs), without affecting their multipotency, 
although I did not quantify the proportion of neurons, astrocytes or oligodendrocytes 
generated from AHNSCs differentiated either directly from an active state, versus 
following reactivation from quiescence. Treatment with BMP4 could potentially affect 
the propensity of AHNSCs to differentiate into the different subtypes.  
 
Interestingly, a small proportion of AHNSCs were still proliferating in BMP4-induced 
quiescence, even after 7 days of BMP4 exposure (Figure 3.2). The percentage of 
Ki67+ and EdU+ NSCs in BMP4 conditions was very similar to the percentage of Ki67+ 
or EdU+ RGLs observed in the DG of P60 mice (around 8% and 2% respectively 
(Andersen et al., 2014; Urban et al., 2016)). This could suggest BMP4-treated 
AHNSCs in vitro represent the whole population of quiescent and active RGLs in vivo, 
with similar mechanisms regulating spontaneous cell cycle entry and return to 
quiescence. It also highlights that quiescent NSCs are not senescent, rather appear to 
be poised to activate as soon as the appropriate activating signals are received. This 
could be why CyclinD1 expression increases so rapidly following re-activation (Figure 
3.2); CyclinD1 is an early cell cycle gene that induces G1 progression, therefore would 
be a primary responder to an activation signal. CyclinD1 is also a known target of Ascl1 
(Andersen et al., 2014; Castro et al., 2011), and could mediate activation induced by 
Ascl1.  
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The cycling AHNSCs in BMP4-induced quiescence were likely a result of spontaneous 
entry of the population of cells into the cell cycle. However, they could also represent a 
subpopulation of NSCs that were refractory to BMP, and not induced to quiescence. If 
this was true, the reactivation of AHNSCs from BMP4-induced quiescence could in fact 
represent the expansion of NSCs that were never quiescent. I therefore employed an 
EdU-BrdU pulse-chase paradigm, combined with Ki67 expression in order to identify 
whether the same cells were repeatedly dividing, or if new cells entered the cell cycle, 
as well as to see whether some cycling cells returned to quiescence. I was able to 
observe all combinations of label incorporation, including cells that had returned to 
quiescence having previously divided, as well as the recruitment of cells into the cell 
cycle that had not previously divided. These results suggest the cycling cells in BMP4-
induced quiescence represent a population-level spontaneous entry into the cell cycle. 
Moreover, I observed many cells that were negative for pan cell cycle marker Ki67, 
suggesting they are in a true G0 state, as opposed to a paused or elongated G1 state.  
 
As described in Section 1.5.2, adhesion to the niche and cell-cell contacts can directly 
regulate NSC quiescence. I therefore demonstrated that BMP4-induced quiescent 
AHNSC can reactivate without disrupting their extracellular matrix and cell-cell 
contacts, therefore proving it was the removal of BMP4 that led to reactivation. 
AHNSCs reactivated without enzymatic dissociation from their culture plastic took 
longer to reactivate, which could be because BMP is sequestered by the ECM 
(Sedlmeier and Sleeman, 2017), causing BMP signalling to be maintained even after 
the cells are washed and cultured in only proliferation media. However, it could also be 
because disrupting cell adhesion and cell-cell signalling shuts down quiescence signals 
such as Notch, enabling a faster exit from quiescence. This highlights the importance 
of cell-cell contacts and adhesion in NSC regulation, and suggests the in vitro model is 
able to functionally recapitulate this regulation.   
 
BMP4-induced quiescent AHNSCs were also able to very quickly reactivate and 
differentiate following 1month in the quiescent state (Figure 3.2). It could have been 
expected that the longer the cells were exposed to BMP4, the deeper the state of 
quiescence, perhaps due to epigenetic modifications, and therefore would take longer 
to reactivate after a month of BMP4 exposure compared to 3 days. This phenomenon 
has been observed in fibroblasts induced to quiescence by contact-inhibition (Kwon et 
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al., 2017). However, AHNSCs were able to reactivate as quickly after 1 month of BMP4 
as 3 days (Figure 3.2). It is possible that AHNSCs need a longer exposure to BMP4 to 
induce epigenetic changes that affect the rate of reactivation. Alternatively, it is likely 
there are other factors in the cell culture medium that promote NSC activation, such as 
insulin, which could maintain BMP4-treated AHNSCs in a more readily activated state, 
even after long-term BMP4 exposure. It would be interesting to try and remove these 
factors from the media, or provide other pro-quiescence signals such as GABA (Song 
et al., 2012a), to test whether AHNSCs are harder to reactivate after long periods in a 
deep quiescence. This could potentially model the mechanisms that cause 
hippocampal RGLs to become more quiescent and difficult to activate with increasing 
age, providing insights into possible interventions for the age-related decline in 
neurogenesis.  
 
6.1.2 Modulating extrinsic factors in vitro generates different NSC states 
EGF and FGF2, as well as BMP4, actively regulate AHNSCs in vitro. Culturing the cells 
in the presence of EGF seemed to induce a more intermediate progenitor-like cell 
identity. It has not been reported that EGF signalling regulates RGLs in the dentate 
gyrus, however AHNSCs in vitro are capable of responding to EGF. It became 
apparent that removal of EGF from the media induced many transcriptional changes in 
AHNSCs that were previously assumed to be BMP4-specific. I therefore refined the 
model to eliminate EGF completely, and showed that 20ng/mL FGF2 alone was 
sufficient to maintain a self-renewing stem cell state. Modulating the levels of these 
factors can functionally affect the stem cells, and I have shown that titrating the 
concentration of BMP4 allowed us to induce different depths of quiescence in 
AHNSCs. By treating cells with 1ng/mL or 20ng/mL BMP4, we were able to induce a 
‘shallow’ and ‘deep’ state of quiescence, respectively. RNA sequencing analysis of the 
transcriptional response of AHNSCs in shallow vs deep quiescence showed many 
more genes are regulated by high concentrations of BMP4, compared with low 
concentrations. This has implications for potentially modelling more accurately the 
physiological level of BMP4, as well as enabling a better understanding of the cross-
regulation of BMP with other niche signals. Moreover, part of the heterogeneity of 
RGLs observed in vivo could be due to the cells receiving different levels of signals, 
including BMP, therefore titrating the concentrations of these factors in vitro could allow 
us to better understand the source of RGL heterogeneity.  
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6.1.3 BMP4-treated AHNSCs model multiple features of neural stem cell 
quiescence 
Quiescence is more than a cell cycle state, rather characterised by specific energetic 
and metabolic profiles, as well as by the expression of a transcriptional ‘signature’ of 
quiescence (Beckervordersandforth et al., 2017; Bracko et al., 2012; Cheung and 
Rando, 2013; Codega et al., 2014; Morizur et al., 2018; Shin et al., 2015). Qualitative 
analysis of transcription and translation, as well as the pattern of mitochondria in active 
and quiescent AHNSCs, demonstrated the clear differences between the two states. 
The pattern of nascent protein synthesis in quiescent AHNSCs, as visualised by OPP 
staining, showed localisation to small puncta in the cytoplasmic processes (Figure 
3.5D). This could suggest protein synthesis occurs in locally in quiescent NSC 
processes, which is reminiscent of the export and local translation of mRNA in the 
axons of neurons (Riccio, 2018), which highlights an interesting similarity between 
quiescent RGLs and post-mitotic neurons, and some aspects of their regulation could 
be shared. The mitochondria in quiescent AHNSCs were larger and more tubular than 
in active AHNSCs (Figure 3.5A), a difference which has been observed for RGLs and 
IPCs in vivo (Beckervordersandforth et al., 2017). The intensity of Pyronin Y staining 
was also lower in BMP4-treated compared to active AHNSCs (Figure 3.5B), potentially 
reflecting reduced transcriptional activity, which is suggested to be a feature of 
quiescent stem cells (Cheung and Rando, 2013). These qualitative measures support 
the notion that BMP4 can induce a state of quiescence in AHNSCs that is biologically 
similar to other quiescent stem cells and RGLs in vivo, therefore further supporting the 
use of this model to investigate the molecular regulation of adult hippocampal NSC 
quiescence.  
 
Analysis of the transcriptional changes that occur in AHNSCs upon BMP4 treatment 
provided further evidence that multiple aspects of the quiescent state were acquired in 
these cells with BMP4. The ontologies of genes induced by BMP4 treatment highly 
reflected those identified in ‘signatures’ of quiescent neural stem cells, including “cell 
adhesion”, “cell-cell signalling” and metabolism ontologies (Figure 3.6). Overlapping 
the top enriched genes in quiescent adult NSCs with BMP4-treated AHNSCs showed a 
high degree of overlap (Figure 3.6). These results strongly suggest that adult 
hippocampal-derived NSCs treated with BMP4 acquire a state of quiescence highly 
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representative of quiescent adult NSCs in vivo, suggesting that using this model to 
investigate the molecular regulation of quiescence will generate meaningful and 
biologically relevant results, expediting the costly and time-consuming in vivo analysis. 
Comparison of the transcriptional signatures in AHNSCs and NS5 NSCs demonstrated 
that there are many transcriptional differences between adult-derived NSCs and 
embryonic stem cell-derived NSCs (Figure 3.6), including the presence of the ‘learning 
and memory’ ontology (comprised of genes involved in adult neurogenic processes 
and diseases) exclusively in BMP4-treated AHNSCs, justifying the use of adult 
hippocampal-derived NSCs to specifically model adult hippocampal NSC quiescence.  
 
An issue with this culture system was in determining whether the cells cultured in vitro 
were definitely neural stem cells, and not reactive astrocytes. The two populations 
would be very similar, both being astrocytic-like cells expressing GFAP and GLAST, 
with an ability to activate, self-renew and generate neuronal progenitors. Astrocytes 
have been shown to become mitotically active in vivo in conditions of inflammation or 
injury (Liddelow and Barres, 2017). Moreover, deriving cells from the DG or striatum 
and subsequently culturing them in the presence of BMP4 is a common protocol for 
culturing astrocytes in vitro, therefore it could not be immediately ruled out that the 
AHNSCs used here were in fact reactive astrocytes. However, the cells had impressive 
self-renewal properties, and the transcriptional profile of AHNSCs so closely resembled 
adult NSCs isolated from the hippocampus and SVZ, including absence of several 
known markers of adult astrocytes, that it strongly suggests the cells cultured here are 
neural stem cells. Moreover, maintaining FGF2 in the culture medium is known to 
inhibit the differentiation of NSCs into astrocytes (Sun et al., 2011), therefore the 
presence of FGF2 provides a culture condition more permissive for maintenance of 
neural stem cell identity. A full comparison of the transcriptomes of AHNSCs and 
prospectively isolated astrocytes would provide a stronger picture of whether AHNSCs 
are indeed true NSCs and distinct from reactive astrocytes.  
 
6.1.4 Future uses of the in vitro model of AHNSC quiescence 
Establishing a reliable and robust in vitro model of adult hippocampal NSC quiescence 
has opened up the possibility of investigating many aspects of the molecular regulation 
of NSC quiescence and activation. The model could be used in the future to investigate 
other signalling pathways either already implicated or novel in the regulation of NSC 
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quiescence. Delineating the mechanisms by which Wnt, Shh, and GABA regulate 
quiescence for example could generate highly interesting insights, particularly for 
understanding the cross-talk of these signals with BMP and each other. Moreover, the 
in vitro system allows for the generation of huge numbers of cells for a single 
experiment, therefore analyses which require large volumes of cellular material could 
be achieved using the culture system, such as investigating the epigenetic changes 
that occur in quiescence, or probing the protein-protein interactions by mass 
spectrometry. The culture system would also allow for relatively easy live cell imaging 
We are able to reproduce the in vitro model of quiescence using NSCs derived from 
transgenic reporter mice (such as the Ascl1KiGFP and Ascl1Venus mice reported here). 
This is especially advantageous, as these lines could be used to image endogenous 
transcriptional and protein dynamics, both of which have been shown in this thesis to 
be important for regulating NSC activity. Long-term culture of AHNSCs in the presence 
of BMP4 and other factors is possible, and could generate insights into the changes 
that occur in NSCs with age. There is also huge scope to further develop the model 
beyond a 2-D homogenous monolayer. Co-culture with other niche cells is a technique 
already widely used and would be easily applied to this in vitro system, to further 
investigate the mechanisms by which niche cells regulate NSC activity. RGLs are also 
a highly polarised cell type and this morphology has been linked to differential signal 
reception by different subcellular compartments (Urban and Guillemot, 2014). In other 
words, the characteristic morphology of RGLs may be required to receive distinct 
regulatory signals, and may result in asymmetric distribution of signalling components 
which could have functional consequences for quiescence and activation (Urban and 
Guillemot, 2014). It would therefore be very interesting to test whether the polarised 
morphology of RGLs can be recapitulated in vivo, by utilising cell culture substrates 
micro-patterned with factors that promote polarised morphology, or 3-dimensional 
culture systems, both of which have been used for other stem cells in culture 
(Griessinger et al., 2014; Joo et al., 2015; McKee and Chaudhry, 2017). Finally, the 
hypothesis that RGLs exist in either a resting or dormant quiescent state (Urban et al., 
2016) has raised the intriguing question as to what mechanisms dictate the difference 
between these two states. Dormant RGLs are difficult to identify in vivo, due to the fact 
identification relies on absence of proliferation markers in EdU-retention assays. By 
definition, dormant NSCs are those that have never activated, therefore the current 
culture system of AHNSC quiescence presented in this thesis very likely represents the 
resting state of RGLs, and cannot model the dormant state. Despite this limitation, the 
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in vitro system of adult hippocampal neural stem cell quiescence presented here can 
enable the investigation of molecular mechanisms regulating multiple aspects of 
hippocampal NSC biology, providing an invaluable tool to complement more complex 
and time consuming in vivo analysis.  
 
6.2 The unexpected expression of Ascl1 in quiescent RGLs 
6.2.1 Ascl1 mRNA is expressed in quiescent NSCs, but suppressed at the 
protein level 
The Ascl1KiGFP mouse line was originally used to investigate the transcriptional 
regulation of Ascl1 in SGZ RGLs in vivo, but led to the surprising discovery that Ascl1 
may be expressed in more than 80% of RGLs in the adult mouse DG (Figure 4.1). 
Considering only around 8% of RGLs are proliferating at any given time (Andersen et 
al., 2014; Urban et al., 2016), this suggested that many quiescent RGLs express Ascl1, 
and was confirmed by combination in situ hybridisation of Ascl1 and Ki67 with 
immunocytochemistry for RGL markers. This was surprising both because Ascl1 is an 
activation factor, and also because Ascl1 protein was only detected in a tiny fraction of 
RGLs (Figure 4.1), suggesting Ascl1 is post-transcriptionally suppressed in quiescent 
hippocampal NSCs. The in vitro model of AHNSC quiescence similarly showed Ascl1 
expression in BMP4-indcued quiescence but suppressed levels of Ascl1 protein, again 
confirming the in vitro system can closely model in vivo RGL quiescence (Figure 4.2). 
By utilising the model, we were able to show that Ascl1 protein is indeed expressed in 
quiescent conditions, but rapidly degraded in a proteasomal-dependent manner (Figure 
4.3), suggesting a quiescence factor actively inhibits Ascl1 at the protein level in 
quiescent NSCs.  
 
An interesting observation was that the range of intensities for nuclear GFP in 
quiescent RGLS in the Ascl1KiGFP mice was far greater than for active RGLs (Figure 
4.1). The RGLs with high GFP intensity could reflect a peak of Ascl1 transcription, prior 
to Ascl1 translation and activation, thereby identifying RGLs that may be close to 
activation, or would activate if the inhibitory factor regulating Ascl1 protein is 
simultaneously repressed. The range in GFP intensities might also reflect oscillations 
of Ascl1 transcription. Oscillatory expression has been observed for Ascl1, Hes1 and 
Olig2 in embryonic NSCs (Imayoshi et al., 2013) therefore Ascl1 expression might also 
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oscillate in RGLs to dynamically regulate RGL activation. Live imaging of hippocampal 
stem cells in vivo expressing GFP reporters has been recently achieved (Pilz et al., 
2018), therefore it might be possible to live-image RGLs in Ascl1KiGFP mice, to observe 
in real-time whether Ascl1 transcription oscillates, and whether peaks of transcription 
corresponds to stem cell activation. A limitation of the Ascl1KiGFP reporter is that the 
GFP may not have the same protein dynamics as Ascl1 mRNA, and so may not be a 
true readout of Ascl1 transcriptional dynamics.  
 
The Notch target genes Hes1 and Hes5 are known transcriptional repressors of Ascl1. 
Both Hes genes are expressed in hippocampal NSCs (Ehm et al., 2010; Lugert et al., 
2010) therefore it would be predicted that they inhibit Ascl1 transcription in RGLs. 
However, the fact that I observed Ascl1 mRNA in most RGLs analysed (Figure 4.1) 
indicates that Hes proteins do not fully repress transcription of Ascl1 in these cells. 
However, Ascl1 expression is strongly enhanced when the Notch effector gene RBPJk 
is deleted (Figure 5.4D), suggesting that the Notch-RBPJk-Hes pathway partially 
represses Ascl1 and maintains Ascl1 expression at low levels. Therefore, there 
appears to be a multi-level regulation of Ascl1 in RGLs, both transcriptionally and 
translationally, reflecting the importance of regulating Ascl1 and RGL activation. This is 
logical, as aberrant activation would result in fast exhaustion of the stem cell pool, as 
observed in mice with conditional deletion of RBPJk in RGLs (Ehm et al., 2010).  
 
As described in Section 4.4.3, detecting Ascl1 protein in adult mouse tissue by 
monoclonal antibody immunostaining is challenging, and can be very easily affected by 
tissue fixation. The expression of Ascl1Venus fusion protein in RGLs of the Ascl1Venus 
transgenic mouse line indicates that more RGLs express Ascl1 protein than are 
detected by immunostaining (Figure 4.1B,C). It would be worth investigating whether 
different fixation techniques could improve monoclonal antibody detection of Ascl1, 
such as using a lower percentage PFA for perfusions, or by post-fixing tissue sections 
from flash-frozen fresh brain samples. The latter would allow for very precise fixation 
conditions, which could enable us to identify the ideal fixation conditions for Ascl1 
immunodetection. We could also utilise the Ascl1Venus  transgenic mouse line more 
frequently, however the fusion protein might not always behave exactly like 
endogenous Ascl1, therefore improving Ascl1 immunodetection would be the ideal 
course of action.  
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Overall, these results strongly suggested the existence of a post-translational regulator 
of Ascl1 expressed in quiescent NSCs. Huwe1 is an E3-ubiquitin ligase which had 
already been identified and characterised by our lab to be a post-translational regulator 
of Ascl1 in SGZ RGLs in vivo (Urban et al., 2016). However, Huwe1 did not appear to 
be required to maintain RGL quiescence in vivo (Urban et al., 2016) therefore we 
hypothesised an alternative post-translational mechanism regulates Ascl1 in quiescent 
RGLs or BMP4-treated AHNSCs. To confirm that Huwe1 was dispensable for BMP4-
mediated repression of Ascl1 protein levels, I conditionally deleted Huwe1 in AHNSCs 
derived from Huwe1flx mice. In the absence of Huwe1, BMP4 treatment was still able 
to suppress Ascl1 protein levels, detected by immunostaining (Figure 4.4). This 
experiment requires repeating and further confirmation of loss of Huwe1 protein and 
Ascl1 protein levels by Western blot analysis. However, the results complement the in 
vivo data that Huwe1 prevents active RGLs from returning to quiescence, but does not 
result in the activation of quiescent RGLs (Urban et al., 2016), implying that a second, 
Huwe1-independent mechanism negatively regulates Ascl1 protein stability in 
quiescent NSCs. 
 
These data imply that rather than being in a state of cellular ‘shut-down’, quiescent 
RGLs are in fact actively transcribing and translating, and poised to activate. This is 
supported by the report that quiescent RGLs express many different cell-signalling 
components, suggesting they are receiving and actively processing multiple cues from 
the niche (Shin et al., 2015). By actively transcribing and translating an activation 
factor, RGLs only require the inhibition of one factor, the post-translational regulator 
inhibiting Ascl1 protein, in order to leave quiescence. Suppression of said protein could 
be achieved rapidly by phosphorylation for example, targeting it for degradation. This 
dynamic state may represent the ‘resting’ state of RGLs, which are quiescent but with a 
high propensity to activate quickly (Urban et al., 2016). It would be interesting to see 
whether the dormant population of RGLs do not actively transcribe or translate Ascl1 
protein, which could explain their dormancy despite inhabiting the same niche 
environment – therefore potentially receiving similar activating cues – as resting RGLs. 
Alternatively, dormancy could be a result of stabilising the inhibitor of Ascl1. Factors 
involved in dynamic regulatory networks often have short half-lives, to facilitate rapid 
modulation of the network. This is true of Ascl1 which has a reported half-life of around 
30 minutes in embryonic NSCs (Gillotin et al., 2018; Urban et al., 2016). In this thesis, I 
have presented Id4 as the candidate for regulating Ascl1 protein in quiescent RGLs, 
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and in support of the hypothesis that this regulatory network consists of dynamically 
regulated proteins with short half-lives, Id4 has also been reported to have a short half-
life of around 1 hour (in 3T3-L1 cells) and be degraded following ubiquitination 
(Bounpheng et al., 1999). Interestingly, Id4 has been shown to be less sensitive 
compared to the other Id proteins to proteasomal degradation (Bounpheng et al., 
1999), suggesting it is uniquely regulated at the protein level. It would be intriguing to 
identify dormant and resting RGLs using an EdU retention assay, and use in situ 
hybridisation to determine whether there is a difference in Ascl1 mRNA levels between 
dormant and resting cells. Moreover, it would be interesting to measure the stability of 
Id4 in dormant vs resting cells. However, this would be far more challenging as it would 
require either live imaging of Id4 expression dynamics in these cells, or prospective 
isolation of dormant RGLs. Specific isolation of dormant and resting RGLs has so far 
not been attempted, however it could be possible by use of a Ki67CreERT2;tdTomato 
transgenic mouse line. Inducing recombination in these mice would enable labelling of 
resting RGLs with tdTomato, while dormant RGLs could be isolated based on their 
negativity for tdTomato in combination with the GFP/YFP reporter expression of GFAP 
or GLAST. Once isolated, Ascl1 mRNA expression could be measured, and it might be 
possible to analyse the protein stability of Id4, by culturing cells in the presence of the 
protein synthesis inhibitor cycloheximide, or by Western blot analysis of Id4 
ubiquitination.  
 
6.3 Identification of Id4 as a candidate for regulating Ascl1 
protein in quiescence 
6.3.1 Id4 is a marker of quiescent RGLs  
Analysis of protein expression in vivo showed that Id4 is highly expressed in RGLs in 
the DG, and co-staining with Ki67 showed Id4 is enriched in quiescent RGLs (Figure 
4.5). In contrast, Id1 was shown to have higher expression in active (Ki67+) RGLs. The 
difference between Id1 and Id4 expression suggests an interesting dichotomy in the 
function of these two Ids. Id1 is perhaps functioning as a more classical Id protein, 
promoting stem cell self-renewal, as in embryonic stem cells (Romero-Lanman et al., 
2012). This is contrast however to the reported role for Id1 in promoting quiescence of 
SVZ NSCs (Niola et al., 2012), which could either reflect a context-dependent function 
for Id1, or differences in the regulation of NSCs between the SVZ and SGZ. Id4 is the 
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most diverged Id protein at the sequence level (Figure 1.7), and could therefore 
regulate SGZ RGLs differently to Id1. Id3 is also expressed in the DG, albeit in few 
cells, however it would be interesting to fully characterise and quantify Id3 expression, 
especially in combination with Ascl1 and proliferation markers, to determine if it is 
enriched in active RGLs, as was shown by Bonaguidi and colleagues (Bonaguidi et al., 
2008). This would be particularly useful in light of the upregulation of Id3 in the DG 
following conditional Id4 deletion (discussed further below in Section 6.3.3.2). It would 
also be interesting to immunostain combinations of Id proteins, to determine if there is 
co-expression; unfortunately, the antibodies against Id proteins used here are all raised 
in rabbit, preventing co-immunostaining.  
 
6.3.2 Id4:E47 interaction is observed in quiescent AHNSCs 
Based on the reports in the literature that Id proteins inhibit bHLH proteins 
predominantly indirectly by interacting with E-proteins (Duncan et al., 1992), I checked 
to see whether E-proteins were expressed in SGZ RGLs in vivo and AHNSCs in vitro. 
Our RNA sequencing data from active and quiescent AHNSCs showed that tcf3, tcf4 
and tcf12, the genes encoding E2A, E2-2 and HEB respectively, were all expressed in 
both conditions (Figure 4.7). Western blot analysis for E47 (splice variant of E2A) 
confirmed the expression of the protein in both active and quiescent AHNSCs. Western 
blots for the other E-proteins were attempted, however we did not manage to find 
reliable antibodies to detect them. The E47 antibody, whilst sufficient for Western blot 
detection of the protein, does not work for immunocytochemistry, therefore I was 
unable to confirm the expression of E47 in RGLs in the adult DG. However, the 
publically available single cell RNAseq datasets of adult mouse dentate gyrus 
generated by the Linnarsson lab (linnarssonlab.org/dentate/) shows the expression of 
all three tcf genes in subsets of RGLs. This is promising evidence that Id4 and E-
proteins could interact in RGLs, mediating the inhibition of Ascl1 protein. We also 
demonstrated in BMP4-induced quiescent AHNSCs in vitro by co-immunoprecipitation 
(Co-IP), that Id4 and E47 do indeed physically interact in the quiescent state (Figure 
4.7C), therefore potentially preventing binding of E47 and Ascl1, causing Ascl1 to be 
unable to bind its target DNA and ultimately targeted for degradation. Id4 is expressed 
at a low level in active AHNSCs, so might be expected to also interact with E47 in this 
condition, however no interaction was detected. Whilst this cannot confirm the two 
proteins do not interact in active AHNSCs, it may indicate that the relative levels and 
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stoichiometry of Id4, E47 and Ascl1 are important for dictating the balance of 
interactions. The levels of Id4 in active AHNSCs may be too low to sequester E47 from 
Ascl1.  
 
An unexpected interaction was observed between Ascl1 (GFP/Ascl1Venus) and E47 in 
BMP4-induced quiescent conditions. Our hypothesis suggests BMP4-induced Id4 
protein levels should be high enough to block all Ascl1:E47 interaction in BMP4 
conditions, thus resulting in Ascl1 protein degradation and maintenance of quiescence. 
However, although Ascl1 protein is strongly suppressed in the presence of BMP4, it is 
not completely absent. Similarly, BMP4-treated AHNSCs still proliferate at a low 
frequency, which could be a result of residual and possibly functional levels of Ascl1 
protein in BMP4 conditions. We could test this hypothesis, by knocking down Ascl1 in 
quiescent AHNSCs, and examining whether further reduction of Ascl1 results in a 
further reduction in proliferation. If so, a small amount of Ascl1:E47 interaction could be 
expected to be detected in quiescent conditions.  
 
Perhaps the Ascl1 protein detected in quiescent conditions is non-functional, and 
despite some level of interaction with E47, is still targeted for degradation. It has been 
recently demonstrated that long poly-ubiquitin chains can be detected on Ascl1 when it 
is targeted for E3-ubiquitin ligase mediated degradation, whilst short ubiquitin chains 
are observed when it is in the nucleus bound to chromatin and not degraded (Gillotin et 
al., 2018). Analysis of the poly-ubiquitin chains on Ascl1 by Western blot in quiescent 
AHNSCs could reveal whether the low levels of Ascl1 protein are in fact non-functional 
and on their way to be degraded.  
 
The observed interaction between Ascl1 and E47 could also be an artefact created by 
the Ascl1Venus fusion protein. We utilised the Ascl1Venus stem cell line, as the 
monoclonal antibody against Ascl1 was not sensitive enough to sufficiently pull down 
or detect Ascl1 in the Co-IPs, unlike the much more sensitive anti-GFP antibody which 
detects the Ascl1Venus (GFP) fusion protein. In spite of the report that the expression 
of the reporter is similar to endogenous Ascl1 during development (Imayoshi et al., 
2013), it is possible that the fusion protein affects the endogenous binding properties of 
Ascl1, creating stronger Ascl1:E47 interactions which Id4 cannot overcome. The levels 
of endogenous Ascl1 in non-transgenic AHNSCs could be boosted by treatment with 
the proteasome inhibitor MG132, enabling detection using the monoclonal antibody 
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and avoiding the need to use Ascl1Venus AHNSCs. However, blocking the proteasome 
would also increase the levels of the Id and E-proteins as well, which could affect the 
relative levels of these players, causing them to interact in a different way than they 
would at endogenous levels in quiescent AHNSCs.  
 
These limitations of Co-IP analysis of protein-protein interactions in AHNSCs is in 
addition to the fact it is not a quantitative measure; we cannot know whether there is 
more Id4:E47 than Ascl1:E47 in quiescent conditions, we can only know if the 
interaction is detected. Therefore, the much more sensitive and unbiased analysis by 
mass spectrometry could be necessary, and certainly highly informative, to identify and 
quantitatively measure the relative levels of interaction between the Id proteins, E-
proteins and Ascl1 in AHNSCs.  
 
6.3.3 The function of Id4 in adult hippocampal NSCs 
6.3.3.1 Id4 induces cell cycle exit, Ascl1 protein degradation and subsequent 
inhibition of Ascl1 target genes in vitro 
The in vitro model of AHNSC quiescence has proved highly useful in testing the 
function of Id4. Overexpression of Id4 from a pCbeta-Id4-FLAG construct in active 
AHNSCs was able to suppress the cell cycle and Ascl1 protein levels (Figure 4.8), 
suggesting Id4 is sufficient to induce quiescence, and inhibit Ascl1 protein. Moreover, 
the inhibition of Ascl1 protein by Id4 overexpression led to a decrease in Ascl1 target 
gene expression, confirming the inhibition of Ascl1 function (Figure 4.9). It would be 
useful to further confirm that Id4 causes increased protein degradation of Ascl1 by 
testing the half-life of Ascl1 in Id4-overexpressing vs control AHNSCs. Moreover, we 
could directly test whether Id4-induced quiescence is dependent on Ascl1 degradation, 
by overexpressing stabilised Ascl1 along with Id4. Similarly, the hypothesis that Id4 
mediates Ascl1 degradation by sequestering its E-protein binding partners could be 
directly tested by seeing whether overexpression of E47 can rescue the effects of Id4 
overexpression. This was technically already achieved by overexpression of E47 in 
BMP4-treated AHNSCs (discussed below), however there is the possibility that BMP4 
induces other factors involved in the inhibition of Ascl1:E47, therefore directly 
overexpressing Id4 and E47 in active AHNSCs would rule out the effects of other 
BMP4 targets.  
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Our in vitro overexpression experiments also revealed that Id4 regulates a significant 
proportion of the BMP4-induced quiescence transcriptional profile, suggesting Id4 is a 
major effector of BMP4-induced quiescence (Figure 4.9). This was in stark contrast to 
the effects of Id1 overexpression, which regulated only a fraction of the genes induced 
by BMP4 (Figure 4.11). Interestingly, overexpression of Id1 was sufficient to partially 
suppress the cell cycle of active AHNSCs, to a similar extent as Id4 over-expression. 
However, in contrast to Id4, Id1 overexpression did not strongly affect Ascl1 protein or 
function, as measured by Ascl1 target gene expression. Id1 is required to maintain 
quiescence of SVZ NSCs by promoting adherence to the niche (Niola et al., 2012), 
therefore high expression levels of Id1 in AHNSCs could promote quiescence. One 
caveat for the direct comparison of the genes regulated by Id1 vs Id4-overexpression is 
that the two Ids were overexpressed from different plasmid backbones. Expression of 
genes in different plasmid backbones can be quite different, therefore the differences 
observed between Id1 and Id4 overexpression could simply be a result of different 
levels of overexpression.  
 
Nevertheless, Id4 is able to partially induce quiescence of AHNSCs. This is very similar 
to another transcription factor identified by our group to regulate quiescence of 
embryonic-stem cell derived NSCs, NFIX (Martynoga et al., 2013). Both NFIX and Id4 
are able to regulate a similar proportion of the genes induced by BMP4, therefore it 
would be interesting to compare the genes regulated by each factor, to see if they 
regulate common or independent aspects of NSC quiescence.  
  
In order to inactivate Id4 protein activity, I overexpressed E47 in BMP4-treated 
AHNSCs, providing the binding partner of Ascl1 in excess of Id proteins, which resulted 
in re-stabilisation of Ascl1 protein, subsequent activation of Ascl1 target genes, and 
increased proliferation of BMP4-treated AHNSCs (Figure 4.12-13). This result indicates 
that Id4 induces quiescence via destabilisation of Ascl1 protein, by sequestering its E-
protein binding partner and rendering it unable to bind DNA and targeted for 
degradation. A potential problem with using E47 specifically to inactive Id4, as opposed 
to other E-proteins, is that E47 preferentially homodimerises (Sharma et al., 2015), 
which means overexpression would very likely result in activation of E47 target genes 
in addition to heterodimerising with Ascl1. This may explain the very high number of 
genes regulated by E47 overexpression observed in the RNA sequencing data (Figure 
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4.13). Nevertheless, overexpressing E47 was still able to counteract the inhibition of 
Ascl1 by BMP4/Id4. 
 
A more direct examination of the function of Id4 in BMP4-induced quiescence would be 
direct knockdown. We attempted this by deriving an adult hippocampal stem cell line 
from the Id4flx mice, in order to acutely delete Id4 in BMP4 conditions. However, Id4 
had become genetically silenced during the derivation process, resulting in a Id4 null 
cell line. Id4 null AHNSCs were still able to be induced into quiescence by BMP4 
(Figure 4.14), suggesting the other Ids (or other factors) could also mediate BMP4-
induced cell cycle exit. Interestingly, Ascl1 protein levels were higher in Id4 null 
AHNSCs compared to non-transgenic AHSNCs, and Ascl1 protein was maintained at 
this high level even in the presence of BMP4 (Figure 4.14). This suggests a unique role 
for Id4 in mediating Ascl1 protein degradation, as well as raising the possibility that Id1-
3 could block the activity of Ascl1, thereby inducing quiescence, without affecting its 
protein stability. 
 
The effect of overexpressing Id1 in AHNSCs has raised the question of whether the 
other Id proteins can also regulate Ascl1 stability and quiescence, especially in light of 
the fact all the Id proteins are expressed in BMP4-treated AHNSCs. Therefore, 
overexpression of Id2 and Id3 in active AHNSCs would be a worthwhile experiment, 
followed by measurement of Ascl1 protein levels and stability, as well as cell 
proliferation rates and RNAseq to generate a full picture of Id-protein regulation of NSC 
quiescence. 
 
6.3.3.2 The function of Id4 in adult hippocampal RGLs in vivo 
The combination of the expression pattern of Id4 in vivo, along with the functional in 
vitro experiments, strongly suggested Id4 has a unique function in regulating 
quiescence of RGLs in the adult mouse DG, specifically by negatively regulating Ascl1 
protein levels. I directly tested this by conditionally deleting Id4 in RGLs in the adult 
mouse hippocampus, via Cre-mediated recombination of the floxed exons 1 and 2 of 
the Id4 alleles in GLAST-expressing stem cells. Acute deletion resulted in a modest 
increase in the fraction of RGLs positive for Ascl1 protein and cell cycle marker Ki67, 
as well as increased Ascl1 protein levels across all RGLs (Figure 4.15), indicating Id4 
functions to suppress Ascl1 protein levels and maintain quiescence of adult 
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hippocampal neural stem cells. However, it was curious that the observed effect of Id4 
deletion was not bigger, considering its strong and widespread expression in quiescent 
RGLs. One possible explanation could be due to the limitations of the Ascl1 
monoclonal antibody, as I discussed in Section 6.2.2., meaning it may have not been 
detecting all of the Ascl1 protein expressed by the RGLs in vivo. However, an 
argument against this hypothesis is the concurrently modest increase in Ki67. 
Presumably increased expression of Ascl1 would induce activation of RGLs and entry 
into the cell cycle, directly resulting in Ki67 expression. Therefore, if Id4 deletion 
resulted in greater de-repression of Ascl1 than observed because I was under-
detecting Ascl1, I should still observe a bigger fraction of proliferating RGLs. 
Alternatively, increased levels of Ascl1 protein in quiescent RGLs may not directly 
result in cell cycle entry and Ki67 expression. One way to distinguish this would be to 
co-immunostain Ascl1 and Ki67 in the DG of Id4cKO mice; if co-expression is observed, 
we can conclude that the effect of loss of Id4 on Ascl1 protein levels and RGL 
quiescence is in fact modest.  
 
An alternative and perhaps more likely explanation, is that redundancy exists between 
the other Id proteins and Id4, resulting in compensation by the other Ids following Id4 
deletion. The enrichment of Id1 in active RGLs in vivo would not immediately implicate 
it as a compensatory factor for Id4, and the functional investigation of Id1 in vitro 
suggests this Id protein may not strongly suppress Ascl1 protein levels. Id1 has also 
recently been shown to have a role in the activation of hematopoietic stem cells upon 
stress signals (Singh et al., 2018). However, when over-expressed at high levels in 
AHNSCs in vitro, Id1 was able to repress the cell cycle. Moreover, Id1 protein levels 
were highly increased in RGLs immediately following Id4 deletion (Figure 4.15). It is 
plausible that in the context of higher-than-normal expression levels, Id1 function shifts 
to suppress the cell cycle, and could therefore mediate a possible compensatory effect 
for Id4 deletion. Id3 protein levels are also dramatically increased following acute Id4 
deletion (Figure 4.15). I had not examined which cell types express Id3 in normal 
conditions, so I therefore do not know whether Id3 is more enriched in quiescent or 
active RGLs, nor had I tested the function of Id3 in AHNSCs in vitro. However, much 
like Id1, higher-than-basal levels of Id3 protein may confer a redundancy with Id4 
function, providing another possible explanation for why the effect of Id4 deletion is not 
more severe. The upregulation of Id1 and Id3 following Id4 deletion is in itself a 
fascinating result, suggesting another function of Id4 is to actively repress the other Id 
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proteins (I did not check Id2 protein levels in RGLs in Id4cKO mice) something which 
has been observed at the mRNA level for Id1, Id2 and Id3 in the telencephalon of 
Id4null embryos (Yun et al., 2004). Repression of Id1-3 by Id4 has also been 
suggested by a study which overexpressed recombinant Id1-4 in lung cancer cells; the 
authors showed Id4 can physically interact with Id1-3, and has a higher affinity for Id1 
than E47, meaning Id4 blocks the inhibition of E-proteins by Id1-3 (Sharma et al., 
2015). It is not clear whether physical interaction between Id4 and the other Ids could 
result in suppression of their protein levels, but possible mechanisms include Id4 
sequestering the E-proteins from the other Ids, preventing E-protein-mediated 
stabilisation of Id1-3 (Lingbeck et al., 2005), thereby exposing Id1-3 to cytoplasmic E3 
ubiquitin ligases, which target them for degradation.  
 
Due to the difficulties in obtaining enough Id4cKO mice 30days post-tamoxifen and good 
quality Ascl1 immunostaining (discussed in Sections 4.4.1, 4.4.3 and 6.2.2), data is 
lacking to determine the long-term effects of Id4 deletion in Id4cKO mice. The fraction of 
YFP+Ki67+ RGLs is still mildly increased 30days post-tamoxifen, but the difference is 
only significant compared to Id4fl/fl mice that were not injected with tamoxifen (control*), 
whereas the difference between tamoxifen-injected Id4cKO and Id4wt/wt (control) mice 
was not significant (Figure 4.16). As discussed above, the other Id proteins may 
compensate for Id4 in Id4cKO mice, resulting in loss of the phenotype by P90. It will be 
very interesting to see whether Ascl1 protein levels are still significantly increased at 
P90 in Id4cKO mice, despite the proliferation rates returning to control levels (Figure 
4.16). It is possible that the suppression of Ascl1 protein is a unique function of Id4, so 
while Id1 and Id3 - which are still highly upregulated at P90 in Id4cKO mice – could 
compensate for maintaining RGL quiescence, they cannot fully suppress Ascl1 protein 
levels. Rather, they may directly inhibit cell cycle progression, or perhaps could 
interfere with DNA binding of Ascl1, thereby blocking its transcriptional activity without 
affecting its protein stability. This mechanism is plausible, based on the observation 
discussed above that Id4 null AHNSCs can be induced into quiescence by BMP4, 
despite the lack of Id4 and high Ascl1 protein levels. It would be very interesting in the 
future to conditionally delete Id4 along with Id1 and/or Id3 in SGZ RGLs, to determine 
whether these other Ids can functionally compensate for Id4.  
 
A thorough examination of the fate of Id4cKO RGLs would also be useful, in determining 
the broader function of Id4 in SGZ neurogenesis. For example, do Id4cKO RGLs 
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become exhausted? Quantification of the total numbers of RGLs at P90 or later should 
be carried out to answer this question. Is neurogenesis increased, with respect to the 
number of newborn neurons, in Id4cKO mice? My thesis research focussed on the 
regulation of stem cell quiescence, therefore I did not investigate broader 
neurogenesis, however it would be interesting to discover whether Id4 could mediate 
neurogenic stimuli. Alternatively, perhaps Id4cKO RGLs are differentiating into 
oligodendrocytes? Id4 deletion increases the levels of Ascl1 in RGLs, and Ascl1 
overexpression in RGLs has been shown to induce oligodendrocytic differentiation, 
despite RGLs generating only neuronal precursors in basal conditions (Jessberger and 
Gage, 2008). Therefore, staining for oligodendrocyte precursor markers would be 
useful to determine whether Id4 is required to maintain neuronal fate of RGLs.  
 
The modest effect of Id4 deletion could reflect a role for Id4 beyond maintaining RGL 
quiescence in homeostasis. Id4 might also function downstream of neurogenic stimuli, 
regulating RGL quiescence in response to environmental inputs or injury. This could be 
investigated by testing Id4cKO mice with a neurogenic stimulus, such as exercise or 
kainic acid-induced mild seizures. The absence of Id4 may result in much greater 
levels of activation upon stimulation in Id4cKO mice compared to control mice, revealing 
Id4 as a brake to prevent RGL over-stimulation. This is a plausible hypothesis, 
considering the reported role for Id4 as a tumour suppressor including in glioblastoma 
(Martini et al., 2013).  
 
The Notch target genes, Hes1 and Hes5, are bHLH transcription factors with roles in 
neural stem cell maintenance and differentiation, and as bHLH factors they are can 
also be regulated by Id proteins. Hes proteins auto-repress their own expression, by 
binding to their own promoters, and Id proteins can inhibit this auto-repression when 
expressed at low levels, by binding the HLH domain of Hes proteins, reducing their 
capacity to bind DNA. Id4 therefore may play a dual role in maintaining RGL 
quiescence, firstly by partially stabilising Hes protein expression and thereby maintain 
a mild repression of Ascl1 transcription, and secondly by sequestering the E-protein 
binding partners of Ascl1, causing the remaining low levels of Ascl1 to be degraded. 
 
Having begun collaborative experiments with our colleagues at the ICM in Paris, using 
the Id4flx mice, I discovered that the transgene containing the floxed Id4 allele also 
contained a GFP reporter construct, outside of the loxP sites (structure of the 
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transgene is shown in Figure 4.14A). We realised this could cause a major issue for 
our analysis, due to the fact we use a YFP reporter of Cre-mediated recombination. 
Immunostaining for YFP would also detect the GFP induced by Id4 expression, which 
would still be active following recombination (unless Id4 protein is necessary for its own 
expression), as the loxP sites surround exons 1 and 2, but not the Id4 promoter. 
However, we reasoned that the complete ablation of Id4 observed by immunostaining 
following tamoxifen administration in Id4cKO mice (Figure 4.14B) would mean that all 
GFP+RGLs analysed, whether Id4GFP+ or Rosa26YFP+, would all lack Id4 protein, 
therefore could be included in our analysis. To further verify that Id4 ablation was 
definitely comprehensive enough to justify continuing to analyse these mice, I checked 
Id4 immunostaining in Id4cKO mice 30 days post-tamoxifen, and did not observe any 
Id4+GFP+ cells, although I did not quantify this. This is important to quantify if lineage 
tracing experiments were to be carried out, for example, as this relies on identification 
of recombined cells that would not necessarily express Id4 anymore, therefore there 
would be no way to be sure whether Id4 was deleted in the first place. For future 
experiments, it would be better to cross the Id4flx mice to a strain harbouring a reporter 
of recombination in a different fluorophore than GFP; for example, our lab is currently 
breeding GlastCreERT2;Id4flx;tdtomato mice, ensuring recombined cells (tdTomato+) 
can be differentiated from Id4 expressing-GFP+ cells.  
 
6.4 Hippocampal niche signals other than canonical BMP and 
Notch regulate Id4 expression 
Many lines of evidence pointed to induction of Id4 in RGLs by BMP signalling in the 
DG. There is literature evidence for BMP-induced Id4 expression in neural progenitor 
cells, in addition to the powerful induction of Id4 by BMP4 in the in vitro model of 
AHNSC quiescence presented here, as well as the reported increase in BMP signalling 
in the DG with age and concurrent increase in RGL quiescence. If Id4 is a direct target 
of BMP signalling in the hippocampal niche, Id4 could be responsible for mediating the 
age-related increase in BMP and decline in RGL activity (Yousef et al., 2015b).  
However, we were surprised to observe no decrease in Id4 expression following 
conditional Smad4 deletion, and in fact a slight increase in protein levels (Figure 4.20). 
Deletion of Smad4 was sufficient to strongly reduce the expression of Id1 in SGZ 
RGLs, indicating the Smad4 was definitely ablated, and that it is functional in RGLs. 
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Interestingly, RGLs did not activate following Smad4 deletion, further highlighting the 
observation that Id1 does not maintain quiescence of RGLs, in contrast to Id4. A 
possible explanation for the lack of effect on Id4 is that BMP signalling does induce Id4, 
but in a Smad-independent mechanism. In my introduction, I described the different 
studies which have identified Smad-independent BMP signalling, such as by BMP-
induced p38/MAPK signalling (Section 1.5.2.9). Alternatively, Smad4 deletion may be 
compensated by the expression of a cofactor, such as Trim33. Redundancy of Smad4 
by Trim33/Tif1γ has been observed in the developing forebrain (Falk et al., 2014).  
 
The preliminary in vitro data generated from the neural stem cell line derived from 
Smad4flx mice, corroborated the results observed in vivo (Figure 4.21). Loss of Smad4 
in BMP4-induced quiescent AHNSCs led to a reduction in Id1 and Id3 protein levels, 
but did not affect Id4 protein expression, suggesting Id4 is induced by alternative 
pathways more strongly than Smad4-mediated induction. It would be interesting to 
examine the levels of Id3 in Smad4cKO mice, to see whether it is similarly regulated by 
Smad4 in vivo as in vitro.  
 
Notch signalling was another promising candidate to regulate Id4 expression in the DG. 
Notch has been shown to induce the expression of Id proteins in embryonic stem cells 
(Meier-Stiegen et al., 2010), and is required to maintain quiescence of SGZ NSCs (as 
described in Section 1.5.2.2). However, similar to Smad4, inhibition of Notch signalling 
by the conditional ablation of the transducer RBPJk in RGLs only very mildly reduced 
Id4 protein levels, but not significantly (Figure 5.4). Id1, however, was strongly induced 
following RBPJk deletion, raising the possibility that Notch maintains quiescence by 
suppressing Id1 expression. This suggests Id1 expression is important for stem cell 
self-renewal, a function which has already been observed for Id1 in embryonic stem 
cells and mammary stem cells (Romero-Lanman et al., 2012; Shin et al., 2015). This 
hypothesis also complements the observation that Id1 is enriched in active RGLs 
(Figure 4.5F). Alternatively, the increase in Id1 expression could be an indirect result of 
the increase in Ascl1 expression in RBPJkcKO mice; Id1 has been shown to be a 
transcriptional target of Ascl1 in the embryonic telencephalon (Castro et al., 2011), 
therefore upregulation of Ascl1 could result in a concurrent upregulation of Id1 and 
subsequent proliferation of RGLs.  
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Considering neither BMP/Smad4 nor Notch/RBPJk signalling alone was necessary to 
induce Id4 expression, it was highly plausible that both signals redundantly induce Id4 
in vivo, therefore compensate for each other in the single conditional mutants. 
However, conditional deletion of both pathways in RGLs still did not affect Id4 levels, 
with the observed increase in Ascl1 protein and RGL proliferation likely a primary effect 
of RBPJk deletion (Figure 5.5).     
 
Overall, there is still much to be discovered regarding the regulation of Id4 by the 
hippocampal niche. As I have mentioned, non-canonical BMP signalling may be 
responsible, which would explain the strong induction of Id4 by BMP4 in vitro, even in 
the absence of Smad4. Investigating the effects of manipulating p38/MAPK, ERK1/2, 
JNK or Pi3k/Akt signalling either in vivo, or in AHNSCs in vitro, could shed some light 
on the transcriptional regulation of Id4.  
 
6.5 Crosstalk between BMP and Notch signalling 
Both BMP and Notch signalling maintain RGL quiescence in the adult DG (Ables et al., 
2010; Ehm et al., 2010; Mira et al., 2010) therefore there could be a degree of crosstalk 
between the two pathways, something that has been reported to occur in other 
contexts (Kluppel and Wrana, 2005). I was very interested to explore further the 
coordination between Notch and BMP4 signalling in the regulation of hippocampal 
NSCs in vitro, as well as to determine more precisely whether Notch signalling 
regulates Id4 in BMP4-induced quiescence. I therefore inhibited Notch signalling at the 
level of the receptors using a gamma-secretase inhibitor, in active, ‘shallow’ quiescent 
(1ng/mL BMP4) and ‘deep’ quiescent (20ng/mL BMP4) AHNSCs. I chose to investigate 
the role of Notch in both ‘depths’ of quiescence, because Notch is highly context 
dependent, therefore the interaction with BMP signalling may vary depending on BMP 
concentration. This was certainly the case, as shown by the expression of Hes5; while 
being strongly suppressed in active and shallow quiescent AHNSCs following Notch 
inhibition, Hes5 expression was maintained in deep quiescent AHNSCs the absence of 
Notch (Figure 5.2B). This result indicates BMP4 is able to induce some canonical 
target genes of Notch. One could speculate that in the hippocampal niche, stem cells 
could become refractory to the regulation of Notch signalling, if they receive high levels 
of BMP signalling. In the aged hippocampus, RGLs are less active, and BMP signalling 
is higher (Yousef et al., 2015b); perhaps BMP signalling in the aged DG is dominant 
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over Notch signalling. Notch signalling is dynamically regulated in RGLs of the DG, via 
cell-cell signalling with IPCs and astrocytes. Perhaps RGLs receiving higher levels of 
BMP signalling are less able to activate because dynamically regulated Notch target 
genes that induce quiescence are instead stably induced by BMP. The oscillatory 
versus stable expression dynamics of Ascl1, Hes1 and Olig2 are known to regulate 
self-renewal versus differentiation of NPCs in the embryonic mouse (Imayoshi et al., 
2013). The difference between Notch-induced and BMP4-induced Hes5 expression 
could be the difference between oscillatory and stable expression, therefore 
determining whether a stem cell self-renews or becomes more deeply quiescent, or 
differentiates. BMP4-induced quiescent AHNSCs did in fact become more deeply 
quiescent following Notch inhibition (Figure 5.2Giii), suggesting Notch signalling is 
required to maintain the low-level of self-renewal observed in quiescent AHNSCs in 
vitro. This result was surprising, as the opposite was expected; loss of Notch signalling 
via RBPJk deletion in RGLs in vivo leads to a massive activation of the stem cell pool 
(Ehm et al., 2010), therefore Notch inhibition in vitro might have been expected to 
activate BMP4-induced quiescent AHNSCs. This discrepancy could be explained by 
the difference between inhibiting Notch at the level of the effector RBPJk and the 
receptors. Studies in which Notch signalling was inhibited by the ablation of Notch1 
receptor show a more modest phenotype, with a loss of maintenance of the active RGL 
fraction, but with no effect on quiescent RGLs (Ables et al., 2010; Lugert et al., 2010). 
Notch1 ablated RGLs cultured in vitro lose the capacity to form self-renewing 
neurospheres (Ables et al., 2010), a phenotype very similar to what I observe in Notch 
inhibited quiescent AHNSCs. Notch signalling therefore is required to maintain self-
renewal of BMP4-induced AHNSCs, possibly by maintaining oscillatory expression of 
Hes1/5 and Ascl1. These results also suggest that the in vitro model of quiescence 
developed in this thesis is able to recapitulate the behaviour of RGLs in vivo, even with 
respect to complex signal cross-regulation, further demonstrating it is a highly useful 
and relevant model for studying adult neural stem cell quiescence.   
 
The method I used to inhibit Notch signalling did not discriminate between the different 
Notch receptors, rather inhibiting all at the same time (as well as other gamma-
secretase regulated receptors). This indiscriminate inhibition could also explain why I 
see loss of proliferation, rather than activation, of quiescent AHNSCs in vitro, because 
while Notch1 has been shown to be crucial for RGL self-renewal, Notch3 has been 
identified to maintain quiescence of neural stem cells in the adult zebrafish pallium and 
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mouse SVZ (Alunni et al., 2013; Kawai et al., 2017). It would be interesting to see 
whether specifically knocking-out Notch3 is sufficient to activate AHNSCs in BMP4 
conditions, and how it regulates stem cell activity differently to Notch1 signalling.  
 
RNA sequencing of Notch-inhibited quiescent AHNSCs revealed that Notch regulated 
far fewer genes in the context of high BMP4 concentration, compared to low levels of 
BMP4 (Figure 5.3). This observation further suggests that BMP signalling is able to 
induce Notch target genes when expressed at high levels. It was striking for example 
that when BMP4 concentration was high, Notch regulated none of 313 cell cycle genes 
tested, whereas Notch inhibition in active and shallow quiescent AHNSCs led to the 
upregulation of cell cycle genes. These results suggest that at low concentrations, 
BMP4 synergises with Notch to maintain quiescence, whereas at high concentrations, 
BMP4 dominates over Notch to maintain quiescence. As discussed above, this could 
have implications for homeostasis of RGLs in vivo; if the balance of BMP and Notch 
signalling becomes deregulated, RGLs could become less easily activated.  
 
Finally, I measured Id4 mRNA and protein expression in Notch-inhibited AHNSCs, to 
determine whether Notch can regulate Id4 in vitro. The results reflected those observed 
for RBPJk deletion in vivo, showing Notch does not strongly regulate Id4 in active or 
quiescent AHNSCs. Notch3 specifically regulates quiescent SVZ NSCs (Kawai et al., 
2017), therefore I would be interested to test whether specific knockdown of Notch3 in 
vitro and in vivo can specifically regulate Id4 expression.  
 
6.6 Conclusions and perspectives 
The work presented in this thesis has identified Id4 as a novel quiescence factor, 
required to maintain the quiescent state of adult hippocampal neural stem cells. We 
have also proposed the molecular mechanisms by which Id4 maintains quiescence. 
We show that the activation factor Ascl1 is expressed but actively suppressed at the 
protein level in quiescent RGLs by Id4, which we propose sequesters the E-protein 
binding partners of Ascl1, rendering Ascl1 unable to bind DNA and activate its target 
genes, and rapidly targeted for proteasomal degradation. In Figure 6.1 I present the 
proposed mechanism by which Id4 regulates quiescence, highlighting the complex 
network of interactions between the different Id proteins, the E-proteins and Ascl1 in 
different conditions.   
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Figure 6.1. Proposed mechanisms regulating the active and quiescent RGL state 
and Id4cKO RGLs 
(A) In the active state, Ascl1 (green) and E47 (blue) heterodimerise to bind DNA at E-box 
sites in Ascl1 target genes, inducing expression of activation and cell cycle genes. Id1 
(orange) is expressed in active RGLs downstream of BMP/Smad signalling, and potentially 
induces stem cell self-renewal gene expression. Id1 may be stabilised by E-proteins.  
(B) In the quiescent state, Id4 (red) expression is induced by unknown niche signals, and 
sequesters the E-proteins, rendering Ascl1 monomeric and targeted for degradation. Id4 
also inhibits Id1 protein, possibly by the same mechanism; without E-protein 
heterodimerisation, Id1 may be more unstable and degraded. Activation/cell cycle genes 
are not induced. 
(C) In Id4cKO RGLs, Ascl1 and E47 can heterodimerise, and Id1 and Id3 (purple) proteins 
are highly upregulated. At high levels, Id1 can suppress the cell cycle, possibly 
compensating for the loss of Id4. Id3 might also function in this way. Ascl1 protein is not 
degraded by Id1/3 but competes with the repressive functions of Id1/3 to induce activation 
of its target genes. 
Solid arrows indicate strong evidence for the interaction, dashed lines indicate weak or no 
evidence/speculation. Red asterisk: ubiquitination.  
 
Adult stem cells, including neural stem cells of the neurogenic niches, must be 
regulated carefully to ensure life-long maintenance whilst still enabling the production 
of progenitors for the regeneration of the tissue. The significance of the work presented 
here firstly lies in the identification of Id4 as a novel regulator of RGL quiescence, and 
as a potential target of niche signals regulating the activity of RGLs. Secondly, we have 
made the significant discovery that Ascl1 is even more dynamically regulated in RGLs 
than previously thought. The observation that Ascl1 is actively transcribed and 
translated, but inhibited at the protein level in quiescent hippocampal NSCs, could 
enable rapid response of RGLs to activating stimuli. The multi-level regulation of Ascl1, 
by transcriptional repressors Hes1/5, the E3-ubiquitn ligase Huwe1, and now by Id4, 
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indicates that the tight regulation of Ascl1 has evolved as a crucial mechanism for 
maintaining hippocampal NSCs.   
 
Despite playing central roles in the regulation of neural stem cells during embryonic 
development, the Id proteins have not been thoroughly studied in the context of adult 
neurogenesis. We have shown that Id1-4 have different expression patterns in the DG 
of adult mice, and have demonstrated distinct functions between Id1 and Id4 in the 
regulation of NSC activity, sharing a function in inhibiting the cell cycle, but showing 
differential regulation of Ascl1, highlighting Id4 as a unique regulator of Ascl1 protein. 
Future studies should investigate the function of Id1-3 in the hippocampal niche, to 
identify novel mechanisms of NSC regulation as well as identifying whether these Ids 
can compensate for Id4 in maintaining NSC quiescence.   
 
We have also presented a highly tractable in vitro model of adult hippocampal neural 
stem cell quiescence (Figure 3.1), which enabled identification of Id4 as a quiescence 
factor, as well as elucidating its molecular mechanism. This in vitro model of AHNSC 
quiescence holds tremendous potential for elucidating many more mechanisms of 
AHNSC regulation.  
 
The full picture of the mechanisms regulating adult NSC quiescence is yet to be fully 
painted, therefore the discovery of novel mechanisms can help address the gap in our 
knowledge, particularly regarding the heterogeneity in the response of RGLs to 
neurogenic stimuli. This knowledge has important clinical implications, including the 
understanding of why NSCs become more quiescent with age, stress or depression. 
This knowledge can then be applied to target Id4 for NSC activation as a therapeutic 
intervention in these disorders, as well as in neurodegenerative diseases. 
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